Radiation doses in interventional radiology: issues for patients and staff within the UK by Elliott, Alex et al.





Committee on Medical Aspects  





Radiation doses in interventional radiology: issues for 
patients and staff within the UK. 
 
 
Chairman: Dr C J Gibson  
 
  
Committee on Medical Aspects of Radiation in the Environment (COMARE) – 19th report 
 
Produced by Public Health England for the Committee on Medical Aspects of Radiation in 
the Environment. 
 











Published August 2021 
PHE gateway number: GW-8689 
Committee on Medical Aspects of Radiation in the Environment (COMARE) – 19th report 
 
Table of contents 
 
Preface 
Lay summary .................................................................................................................... 1 
Background ................................................................................................................... 1 
Conclusions .................................................................................................................. 2 
Key points of COMARE’s recommendations ................................................................. 2 
Chapter 1: Introduction ..................................................................................................... 4 
Interventional Radiology (IR) ......................................................................................... 4 
Chapter 2: Applications and benefits of IR ........................................................................ 7 
Introduction ................................................................................................................... 7 
Vascular IR (VIR) .......................................................................................................... 8 
Non-vascular ............................................................................................................... 10 
Interventional Cardiology ............................................................................................ 11 
Paediatric Interventional Cardiology ......................................................................... 13 
Interventional Neuroradiology (INR) ............................................................................ 14 
Oncology ..................................................................................................................... 16 
Interventional oncology procedure categorisation .................................................... 17 
Conclusions ................................................................................................................ 19 
Chapter 3: Effects associated with radiation exposure from IR ....................................... 20 
Introduction ................................................................................................................. 20 
Describing radiation dose exposure levels in medicine ............................................... 20 
Biological effects associated with radiation exposure.................................................. 24 
Biological consequences of stochastic effects in somatic cells ................................. 25 
Biological consequences of stochastic effects in germ cells ..................................... 26 
Tissue reactions caused by ionising radiation in tissues........................................... 27 
Radiation exposure and age..................................................................................... 31 
Foetal exposure ....................................................................................................... 34 
Radiation exposure and genetic susceptibility .......................................................... 34 
Conclusions ................................................................................................................ 36 
Chapter 4: The UK Radiation Protection Framework ...................................................... 38 
Radiation protection of staff and patients .................................................................... 38 
The Ionising Radiations Regulations 2017 (IRR17) .................................................. 38 
Radiation protection adviser (RPA) .......................................................................... 39 
Committee on Medical Aspects of Radiation in the Environment (COMARE) – 19th report 
 
Radiation protection supervisor (RPS) ..................................................................... 39 
Medical Physics Expert (MPE) ................................................................................. 41 
Conclusions ................................................................................................................ 42 
Chapter 5: Radiation protection of the patient ................................................................. 43 
Patient protection ........................................................................................................ 43 
Types of procedure .................................................................................................. 43 
Measures to reduce patient exposure ...................................................................... 43 
Considerations for paediatric patients ...................................................................... 46 
Considerations in Interventional Cardiology ............................................................. 47 
Patient radiation dose measurements ......................................................................... 47 
Peak Skin Dose ........................................................................................................ 49 
Radiation Dose Structured Report ............................................................................ 50 
Conclusions ................................................................................................................ 51 
Chapter 6: Radiation protection for staff.......................................................................... 52 
Factors affecting staff exposure to radiation during IR procedures ............................. 52 
Effects of occupational radiation exposure ............................................................... 52 
Radiation exposure to staff ....................................................................................... 53 
Mitigation of staff doses using protective equipment ................................................ 56 
Personal Dosimetry .................................................................................................. 60 
Consequences of dose limits ...................................................................................... 62 
Conclusions ................................................................................................................ 64 
Chapter 7: Image optimisation and diagnostic reference levels ...................................... 65 
Radiation dose and image quality in IR ....................................................................... 65 
Optimisation of interventional procedures ................................................................... 66 
Diagnostic reference levels (DRLs) ............................................................................. 67 
Dose Surveys, DRLs and skin dose ............................................................................ 69 
Skin dose monitoring in fluoroscopically guided procedures ....................................... 71 
Reporting Requirements ............................................................................................. 75 
Conclusions ................................................................................................................ 75 
Chapter 8: Patient pathway ............................................................................................. 77 
Informed consent ........................................................................................................ 77 
Post IR surveillance .................................................................................................... 79 
Conclusions ................................................................................................................ 80 
Chapter 9: Staffing issues and governance .................................................................... 81 
Committee on Medical Aspects of Radiation in the Environment (COMARE) – 19th report 
 
Workforce ................................................................................................................... 81 
Medical Physics Experts .......................................................................................... 84 
Training ....................................................................................................................... 85 
Regulation of radiation exposure during a working life ................................................ 86 
Classification of staff exposed to radiation in the workplace ..................................... 87 
Conclusions ................................................................................................................ 87 
Chapter 10: Survey of IR practice in the UK 2015 to 2017 .............................................. 88 
Introduction ................................................................................................................. 88 
Survey distribution ...................................................................................................... 89 
Radiology ................................................................................................................. 89 
Cardiology ................................................................................................................ 90 
Interventional Neuroradiology ................................................................................... 93 
Conclusions ................................................................................................................ 94 
Chapter 11: International comparisons ........................................................................... 95 
Introduction ................................................................................................................. 95 
Elective abdominal aortic aneurysm repair ............................................................... 95 
Cardiology ................................................................................................................... 96 
Neurointervention........................................................................................................ 98 
Oncology ..................................................................................................................... 99 
DRLs ........................................................................................................................... 99 
Conclusions .............................................................................................................. 102 
Chapter 12: Conclusions ............................................................................................... 104 
Chapter 13: Recommendations .................................................................................... 108 
Recommendation 1 ................................................................................................... 108 
Recommendation 2 ................................................................................................... 108 
Recommendation 3 ................................................................................................... 108 
Recommendation 4 ................................................................................................... 108 
Recommendation 5 ................................................................................................... 108 
Recommendation 6 ................................................................................................... 109 
Recommendation 7 ................................................................................................... 109 
Recommendation 8 ................................................................................................... 109 
Recommendation 9 ................................................................................................... 109 
Recommendation 10 ................................................................................................. 109 
Recommendation 11 ................................................................................................. 110 
Committee on Medical Aspects of Radiation in the Environment (COMARE) – 19th report 
 
References ................................................................................................................... 111 
Appendix A: Abbreviations and Glossary ...................................................................... 128 
Appendix B: Organisation of an IR suite ....................................................................... 139 
Appendix C: Total number of cases submitted to the National Congenital Heart Disease 
Audit (NCHDA) in financial years 2003 to 2017 ............................................................ 142 
Appendix D: Reproduction of a procedure information leaflet from Guys and St Thomas’ 
NHS Foundation Trust .................................................................................................. 143 
Appendix E: Survey of interventional radiology (IR) practice in the UK 2015 to 2017 - 
Questionnaire ............................................................................................................... 147 
Appendix F: The Committee on Medical Aspects of Radiation in the Environment ....... 156 
COMARE Reports ..................................................................................................... 157 
COMARE Membership ............................................................................................. 159 
COMARE Medical Practices Subcommittee (IR) Membership .................................. 162 
 
  




i. The Committee on Medical Aspects of Radiation in the Environment (COMARE) is a 
Department of Health and Social Care (DHSC) expert committee that provides 
independent expert advice to the UK Government on the health effects of natural 
and man-made radiation. In over 30 years the committee has provided advice on a 
range of issues from childhood cancer clusters in the vicinity of nuclear installations 
to sunbeds and to radiation doses resulting from the use of computed tomography 
(CT) in the UK. 
ii. The aim of this COMARE report is to provide advice to DHSC on the radiation dose 
issues associated with the use of interventional radiology (IR), both for staff and 
patients. A particular concern is the recent reduction in the dose limit to the eye and 
the potential impact this may have on staffing numbers. 
iii. The report provides an introduction to IR and an overview of the benefits, including 
shorter hospital stays and reduced mortality and morbidity, of these procedures in 
comparison to other possible treatments. In many cases the use of IR has 
revolutionised the ease and effectiveness of treatments. However, one of the main 
associated risks is the exposure to some level of ionising radiation. This report 
explains the level of risk and provides an overview of the wide range of radiation 
protection measures to minimise risks to both patient and staff. 
iv. Initially to establish whether relevant data were available, letters were written to 
several bodies including the Health and Safety Executive (HSE), the Institute of 
Physics and Engineering in Medicine (IPEM), Public Health England (PHE) and the 
Royal College of Radiologists (RCR). Some radiologist staffing information was 
kindly supplied by RCR in their annual reports. The British Cardiovascular 
Intervention Society (BCIS) also permitted access to its audit data relating to 
percutaneous cardiac intervention (PCI). Aside from these, few data were extant. 
v. The Subcommittee therefore had to carry out a sample survey of hospitals across 
the UK, using the questionnaire shown in Appendix E, to obtain better information 
on the range and numbers of procedures being undertaken, staff numbers involved 
and the range of radiation doses to patients and staff. From these and other data, 
the Subcommittee has attempted to forecast the future requirements for facilities, 
equipment and staff. 









S.1 The use of real-time X-ray imaging to guide a wide range of minimally invasive 
surgical and therapeutic treatments has developed significantly in recent years. An 
example would be angioplasty, which is used to dilate narrow segments of blood 
vessels in many body areas. This field of health care is known as interventional 
radiology (IR) and it has both replaced many existing surgical procedures and 
enabled treatments which were not possible before. This report describes common 
IR procedures and some of their implications. 
S.2 Following a request from the Department of Health and Social Care, COMARE’s 
Medical Practices (IR) Subcommittee considered the application of IR in vascular 
and non-vascular, cardiac, neurosurgical and oncological practice. The most 
common application of IR in paediatric medicine is cardiology, and this was 
considered separately. 
S.3 An IR service requires specialised equipment housed in operating theatre-standard 
conditions and is provided by a multi-disciplinary team which mainly includes 
clinicians, radiographers and nurses. 
S.4 The radiation dose received during IR procedures carries with it a small risk of 
harmful health effects This applies to both patients and staff, and the risks are 
described in the report, along with the UK regulatory framework governing the use 
of IR. This requires radiation doses to be kept As Low As Reasonably Practicable 
(ALARP).  
S.5 While patients experience direct health benefits from the IR procedures, this is not 
the case for staff, who will be exposed (albeit to much lower radiation dose levels 
per procedure) throughout their careers. Techniques are described to minimise the 
radiation exposure of both patients and staff, while maintaining the image quality 
necessary for a successful outcome. There is a balance to be achieved. 
S.6 From a national perspective, it is therefore important to understand the extent of IR 
practice and the relative performance of health care providers from a radiation 
safety perspective. However, the Subcommittee found there was a lack of good 
quality data available, and so found it necessary, to conduct an indicative survey of 
UK IR practice. 
S.7 The survey looked at UK Diagnostic Reference Levels (DRLs), which are used in 
radiology to permit each healthcare provider to carry out audits of their own 
practice to ensure that the associated radiation doses are reasonable when 
compared to national values. The only (limited) UK DRLs available for IR 
procedures are some years old. 
S.8 Staff training and governance issues are discussed along with a description of the 
patients’ experience of IR. 
S.9 Where available, comparisons with international practice are included. It appears 
that there are several areas in which the UK performs relatively fewer IR 
procedures (for example, per million population) than other European countries.  




S.10 The benefits of IR procedures to patients are considerable and significantly 
outweigh any detriment due to the associated radiation exposure. 
S.11 While formal training exists for some staff groups, there is a need to extend 
existing, and to provide new, courses.  
S.12 The UK has a relatively low number of IR specialists compared to many other 
countries and has difficulty in maintaining an adequate out-of-hours service at most 
sites. 
S.13 There is a need for the UK to develop updated DRLs for IR radiation doses to 
better monitor and audit performance. This is of particular importance for paediatric 
practice since there is a relatively higher potential risk to children from any given 
radiation exposure. 
S.14 There is also a need to improve the transparency of IR practice. Mandatory annual 
reporting of the numbers of procedures carried out on each site, the range of 
associated patient radiation doses and the range of cumulative staff radiation 
doses (whole body, eye and hand) should be introduced.  
S.15 Further research into IR procedures, particularly those utilised in paediatric 
practice, should also be supported. 
S.16 Manufacturers should be encouraged to develop standardised systems to measure 
patient dose and permit output into the patient record. 
Key points of COMARE’s recommendations 
1.  COMARE recommends that formal training which includes radiation protection for 
staff and patients should be completed by all healthcare staff undertaking image 
guided procedures in the UK. Existing courses should be updated regularly. New 
courses may be established through liaison between the Department of Health and 
Social Care (DHSC), the Health Departments of the devolved administrations and 
appropriate professional organisations, as required. The radiation dose structured 
report (RDSR) should be included in all existing and future IR training curricula.  
2.  COMARE recommends that minimum acceptable out of hours staffing 
arrangements for service provision are recommended by DHSC, the health 
departments of the devolved administrations and relevant professional 
organisations.  
3.  COMARE recommends that NHS England and the Health Departments of the 
devolved administrations ensure that the recommendations 1 and 10 of the 
National Confidential Enquiry into Patient Outcome and Death 2013 report 
(NCEPOD 2013) are fully implemented across the UK. 
4.  COMARE recommends that international efforts to harmonise data outputs from 
current IR equipment is supported by the UK, with manufacturers adopting 
standard radiation measurement methods and ensuring that these can be 
downloaded to Radiology Information Systems for inclusion in the patient record. 
Committee on Medical Aspects of Radiation in the Environment (COMARE) – 19th report 
3 
 
5.  COMARE recommends that the use of real-time electronic personal dosemeters 
(APDs) should be promoted for all staff. 
6. COMARE recommends the rapid establishment and reinforcement of national IR 
DRLs, particularly for paediatric IR procedures, with the UK collaborating with the 
International Commission for Radiation Protection (ICRP) and international 
partners to develop an agreed methodology. Resources should be made available 
to enable Public Health England and its equivalents in the devolved 
administrations to include IR procedures in UK dose surveys, supporting regular 
updating of national DRLs. 
7. COMARE recommends that a requirement for health care providers (both NHS and 
private) to submit IR procedure numbers and summarised patient and staff dose 
data on an annual basis should be included within regulations by DHSC and the 
Health Departments of the devolved administrations. 
8. COMARE reiterates the recommendation made in the 16th COMARE report 
(COMARE 2014; Recommendation 1, page 69) that the UK is actively involved in 
further research of radiosensitivity of high-risk groups as a factor in a range of 
clinical applications involving ionising radiation. Professional bodies and medical 
and scientific societies should continue to provide educational opportunities to 
increase the understanding of clinical staff regarding all the potential risks to 
patients, and not just the dose received, from radiological procedures. This is 
particularly relevant for children and other groups with genetic disorders associated 
with an increased susceptibility to ionising radiation, predominantly autosomal 
recessive conditions. 
9. COMARE recommends that further research into paediatric IR procedures and 
associated radiation doses is supported by appropriate grant-funding bodies, 
particularly for those procedures associated with the treatment of congenital heart 
disease (CHD). 
10. COMARE reiterates recommendation 7 from its 16th Report, that optimisation of 
protocols offers significant potential for dose reduction. COMARE recommends 
that in conjunction with the production of new regulations for medical exposures, 
the DHSC provides supporting guidance on optimisation, including a requirement 
for radiology services to consider formally appointing a team of radiation protection 
champions, consisting of a radiologist, a radiographer and a medical physicist. 
11. COMARE recommends that the overall safety regime for IR when introducing new 
technology and in training for staff includes a role for equipment manufacturers in 
all procurement and on-going maintenance contracts, to maximise the benefits of 
new technology. 
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Chapter 1: Introduction 
Interventional Radiology (IR) 
1.1 In the last 4 decades the number and scope of medical procedures guided by 
interventional radiology (IR) have increased enormously. IR procedures (also 
referred to as Fluoroscopically Guided Intervention (FGI) procedures) are minimally 
invasive treatments performed under imaging guidance that play a vital role in both 
elective and emergency patient care. In many situations they have replaced 
standard surgical procedures, providing many benefits for patients; the minimally 
invasive nature of the procedures significantly reduces the risk of post procedure 
complications and decreases recovery periods, often allowing procedures to be 
carried out on a day case basis or with significantly shortened stays in hospital. In 
addition, elderly patients with poor performance status are often eligible for IR 
interventions whereas major surgery would be untenable.  
1.2 This report identifies the importance and benefits of IR in modern medicine. 
However, since the vast majority of procedures require exposure of the patients to 
low doses of ionising radiation it is recognised that there is a small risk associated 
with this exposure. In addition, staff involved in delivering IR procedures on a daily 
basis will have a cumulative exposure to radiation which poses a potential risk to 
their health. This report considers these issues and provides guidance on how to 
ameliorate the radiation risks to both patients and staff while acknowledging the 
clear benefits of IR in many situations. 
1.3 IR encompasses a wide range of procedures. Interventions are principally aimed at 
treating vascular disease, haemorrhage control, benign and malignant tumours, 
renal dialysis support and intervention to relieve obstruction of the gastrointestinal 
(GI), urinary and hepatobiliary systems. A large number of procedures are also 
carried out on patients with heart problems including a considerable number of 
infants and young children. Table 2.1 provides a list of examples of current 
procedures. 
1.4 This report considers IR procedures to treat disease in the vascular and non-
vascular system and includes cardiac, oncological and paediatric IR and 
neurointerventional radiology.  
1.5 The report has not considered any diagnostic IR procedures such as biopsy and 
has also excluded consideration of image guided drainage procedures. The reason 
for exclusion is because many biopsy and drainage procedures do not require the 
use of ionising radiation. Those which do are usually short duration procedures 
with an associated limited exposure.  
1.6 Common interventional vascular procedures include angioplasty/stent insertion, 
used to dilate narrow segments of blood vessels in many body areas; stent 
graft/lined stents used to seal across swelling of blood vessels (aneurysms); and 
embolisation, used for occlusion of blood vessels to stop haemorrhage or treat 
tumours.  
1.7 Common non-vascular treatments include stent insertion, used to open areas of 
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narrowing of the GI tract and urinary tract, and ablation techniques used to treat 
solid tumours in a variety of locations.   
1.8 IR procedures are often less invasive than traditional surgical procedures, reducing 
morbidity and mortality and allowing more rapid patient recovery and discharge 
from hospital. The majority of procedures use skin incisions less than 5 mm 
performed under local anaesthesia and hospital discharge can often be the same 
day. 
1.9 Technical developments in the range of available medical devices used in IR have 
been instrumental in extending the range of potentially treatable conditions. 
Notable developments in the technology of stent - grafts has permitted treatment of 
common vascular conditions such as aortic aneurysms. In the non-vascular 
system, the development of techniques to ablate solid tumours has led to safer 
effective treatment for a wider range of patients.  
1.10 Some of the newer devices available have increased the complexity of possible 
treatments which may be reflected in an increased period of radiation exposure for 
both staff and patients.  
1.11 The minimally invasive nature and low morbidity of IR procedures has been 
particularly appropriate to deliver treatment for the ageing patient population and 
this has been an additional factor driving up the number of procedures undertaken.  
1.12 There has been a significant increase in the number of procedures undertaken 
within all areas of IR. A survey by the Royal College of Radiologists showed an 
increase in IR procedures by 21% in the period between 2010 and 2012 (RCR 
2014).  
1.13 Both ionising and non-ionising radiation are used for image guidance during IR 
procedures.  
1.14 Conventional X-ray including fluoroscopy and digital subtraction angiography is by 
far the most commonly used imaging modality for imaging guidance in the vascular 
system.  
1.15 Non-vascular interventions use a wider range of imaging techniques including 
ultrasound, computed tomography (CT) and less commonly magnetic resonance 
imaging (MRI). Non-vascular intervention will sometimes use a combination of 
imaging modalities including fluoroscopy to deliver treatment.  
1.16 The treatments are delivered by a diverse group of physicians dependent on the 
clinical specialty. The main physician groups delivering treatment are Interventional 
Radiologists (vascular and non-vascular body treatments), Interventional 
Cardiologists (cardiac treatments) and Interventional Neuroradiologists (treatments 
for the brain and spinal cord). 
1.17 Treatment delivery teams also include several other staff such as radiographers, 
specialist nurses, clinical physiologists, healthcare assistants and anaesthetic staff 
(including operating department practitioners (ODP)). The numbers and types of 
staff required depend on the type of procedure being performed. 
1.18 The clinician most closely involved with the patient is invariably the radiologist. Also 
adjacent to the patient there is frequently a scrub nurse and further away will be 
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the radiographer and other nursing staff who may be managing sedation or 
supplying equipment. 
1.19 Following a description of IR applications, the report covers radiation biology, 
radiation risks and appropriate elements of the UK radiation protection framework, 
emphasising the importance of justification and optimisation. Operational factors 
contributing to patient and staff radiation doses are described, together with 
techniques to reduce these while maintaining image quality. 
1.20 Data on UK practice are presented and compared with those from other countries. 
Staffing and governance issues are included, with an emphasis on dose reduction 
and formal training schemes. 
1.21 Chapter 12 presents the Committee’s conclusions, from which 11 
recommendations are derived. 
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Chapter 2: Applications and benefits of IR 
Introduction 
2.1 IR has revolutionised the treatment of many medical conditions, reducing very 
considerably the need for surgery with all its attendant risks. In addition, many 
more conditions can be treated in a fast, efficient and minimally invasive manner, 
where previously they were only treatable by surgery or not at all.  
Table 2.1: Common IR procedures 
IR procedure Body area1 Frequency2 Age3 
Radiology 
a) Vascular 
Peripheral angioplasty/ stent / embolisation  Peripheral  Common  50+ 
Aortoiliac angioplasty/ stent  Abdomen pelvis  Common  50+ 
Mesenteric angioplasty/ stent /embolisation  Abdomen pelvis  Moderate  50+ 
Endovascular stent graft- abdominal aorta  Abdomen pelvis  Moderate  50+ 
Endovascular stent graft- thoracic aorta  Thorax  Rare  50+ 
Transjugular intrahepatic portosystemic shunt (TIPS) Abdomen  Moderate  30+ 
Central venous catheter or port insertion  Thorax  Common  All 
Selective Internal Radiotherapy (SIRT)  Abdomen  Rare  50+ 
Transcatheter chemoembolisation  Abdomen  Moderate  50+ 
Uterine Fibroid Embolisation  Pelvis  Moderate  30-50 
b) Renal dialysis intervention 
Fistula angioplasty/ stent  Peripheral  Common 50+ 
Fistula thrombectomy  Peripheral  Moderate  
Dialysis line insertion  Peripheral Common  
c) Non-vascular 
Nephrostomy Insertion  Torso  Common  All 
Ureteric stent insertion  Torso  Moderate  50+ 
Percutaneous Nephrolithotomy  Torso  Rare  30+ 
Gastrointestinal stent insertion  Thorax/ Torso  Moderate 30+ 
Biliary drainage / stenting  Torso  Moderate  30+ 
Vertebroplasty  Torso  Rare  50+ 
Interventional Cardiology 
Coronary angioplasty/ stent  Thorax  Common  50+ 
Pacemaker insertion  Thorax  Common  50+ 
Device deployment / balloon intervention Thorax Moderate All 
Electrophysiological mapping /ablation  Thorax  Rare  All 
Percutaneous valve insertion  Thorax  Rare  
Interventional Neuroradiology 
Coil embolisation aneurysm  Cranial  Moderate  30+ 
Embolisation of AVM  Cranial  Rare All 
Spinal AVM embolisation  Cranial  Rare  All 
1 Body area – area of body exposed to the highest dose of ionising radiation during the IR procedure 
2 Frequency indicates how often the procedure is performed 
3 Age indicates the predominant age group that is likely to require the procedure 
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2.2 The benefits of IR procedures across many medical disciplines are clearly 
illustrated in the following sections detailing the range of conditions now amenable 
to IR procedures. Given the benefits of these techniques it is likely more will 
become available in the ensuing years.  
2.3 The risk / benefit ratio for such diverse indications will vary considerably and while 
some vascular IR (VIR) procedures treat malignant or immediately life-threatening 
conditions, it should be noted that a significant proportion treat benign non-life-
threatening conditions. It follows therefore that a single value for an acceptable 
radiation dose is not appropriate. This issue is discussed further in Chapter 5.  
2.4 The complexity and technical prerequisites of IR requires the provision of 
dedicated IR suites in all hospitals where the procedures are performed (see 
Appendix B for more detail). 
Vascular IR (VIR) 
2.5 VIR includes a wide variety of minimally invasive image guided procedures. The 
term endovascular surgery is sometimes used to describe a subset of VIR 
procedures for the treatment of atherosclerotic and aneurysmal vascular disease. 
The vast majority of VIR interventions are now with therapeutic intent. Advances in 
non-invasive cross-sectional vascular imaging techniques utilising MRI and CT 
provide the vast majority of diagnostic vascular imaging. 
2.6 The diversity of possible targets for vascular intervention means that a variety of 
different specialist groups may undertake these procedures including interventional 
radiologists, endovascular surgeons, cardiologists and interventional 
neuroradiologists. 
2.7 The initial indication for VIR was in the treatment of atherosclerotic disease, the 
first peripheral angioplasty being undertaken in 1964. As technology and expertise 
have developed, the number of potential therapeutic targets has expanded greatly 
over several decades and more particularly in the last 20 years. The development 
of new imaging equipment and interventional procedures has revolutionised the 
way vascular abnormalities are treated. These techniques now provide methods to 
treat a very wide range of lesions in an efficient and much less invasive manner 
than was possible previously.  
2.8 VIR procedures are now used to treat a wide spectrum of conditions including 
atherosclerotic disease, aneurysmal disease, control of haemorrhage, some forms 
of cancer therapy, venous and dialysis access procedures and also in the 
treatment of a number of benign conditions such as uterine fibroids and prostatic 
hypertrophy. 
2.9 There is no single database that captures the number of VIR procedures 
performed. Certainly, there is evidence of expansion in the use of these techniques 
and of conversion of previous conventional surgical procedures to endovascular 
procedures. For example, trends over the last 10 years indicate a switch to the 
majority of elective aneurysm repairs undertaken by endovascular 
techniques rather than operative repair (Waton and others 2019). 
2.10 The reduction in the requirement for surgery has had a major benefit. Recovery 
from VIR procedures is much quicker since it only requires minimally invasive 
interventions which can mostly be carried out as day procedures. The risks of 
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general anaesthesia and surgery are also avoided, and this allows more frail and 
elderly patients the possibility of successful treatment that was not available to 
them previously. However, there is a risk associated with the use of imaging 
techniques requiring ionising radiation. Although the dose required is moderate to 
low (see Table 3.2), the actual dose is dependent on a number of factors, in 
particular the X-ray exposure time required to complete the intervention, which are 
addressed further in this report. 
2.11 Atherosclerosis is the most common form of vascular disease. This involves 
narrowing (stenosis) or occlusion of blood vessels, which is usually treated with 
percutaneous angioplasty or stent insertion respectively. These techniques have 
revolutionised the treatment of atherosclerosis providing a relatively simple, non-
invasive method for treating something which was previously life threatening. After 
a simple day procedure, most patients can return to a relatively normal life with 
minimal after-effects. 
2.12 The radiation dose to patient and operator during interventions for atherosclerosis 
is dependent upon a number of interlinked factors including the anatomical location 
of the lesion, the complexity of the required intervention and thus the required 
beam angulation, staff proximity to the beam and the screening time. Doses are 
typically highest for procedures within the abdomen and pelvis; for example, renal 
and iliac intervention. 
2.13 The treatment of aneurysms (weakness or bulging of an artery wall) ranges from 
small intracerebral lesions measuring a few millimetres to much larger aneurysms 
arising from the thoracic or abdominal aorta. The treatment of aneurysms involves 
more complex interventions. The radiation dose may vary substantially, primarily 
dependent on the duration of the procedure and location of the lesion. In elderly 
patients this is unlikely to have any consequences, but in younger patients there is 
a potential risk of associated detriment (discussed in detail in Chapter 3).   
2.14 Embolisation refers to the deliberate occlusion of blood vessels with a variety of 
liquid, particulate and mechanical devices depending on the particular indication. 
Embolisation techniques are used in the treatment of a diverse range of conditions 
including gastrointestinal haemorrhage, treatment of malignant tumours (for 
example, transarterial chemoembolisation) and in the treatment of benign 
conditions such as varicocele, uterine fibroids and prostate embolisation. Typical 
radiation doses vary depending on the site of intervention, complexity of 
intervention and individual patient factors. Embolisation can also be used in 
emergency situations to control haemorrhages which are often life threatening.  
2.15 The risk from the radiation incurred is heavily outweighed in emergency cases by 
the control of haemorrhage by embolisation. Such cases vary enormously in their 
complexity; however, it should be noted that in a previous study a significant 
number of GI embolisation procedures accounted for higher doses.  
2.16 Embolisation is also used in the treatment of a range of non-life-threatening 
conditions such as uterine fibroids and more recently prostatic hypertrophy.  
2.17 The prevalence of diabetes in the population today is also driving the need for 
peripheral interventions to combat vascular disease resulting in lower limb 
ischaemia (Reekers 2016). 
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2.18 IR has a pivotal role in the maintenance and preservation of the vascular access 
grafts and fistula used for renal dialysis. The preservation of function of 
arteriovenous grafts and fistula is a lifeline for patients and is increasing in parallel 
with the use of dialysis in an increasingly aged population. Dialysis access is 
particularly prone to the development of venous stenoses due in the main to 
increased arterial pressure and the need for repeated needle access. The majority 
of the interventions relate to upper limb access and doses to the patient and 
operator are relatively low (typically 0.05 mSv) (Huang and others 2019) but will be 
double for more central lesions. Dialysis access intervention are usually fairly rapid 
procedures but, while the dose per individual intervention may be modest, the 
potential is present for a significant cumulative dose.  
2.19 Vascular interventions are now very widely used in medicine with great success 
and the benefits to patients are substantial. However, the use of radiation to guide 
imaging during the interventions has an associated risk, although this is normally 
very small. The risk / benefit ratio for such diverse indications varies considerably 
and while some VIR procedures treat malignant or immediately life-threatening 
conditions, it should be noted that a significant proportion treat benign non-life-
threatening conditions. Age of the patient is also a major determining factor in 
determining risk. The influence of this and other factors is considered later in this 
report. 
Non-vascular 
2.20 The techniques used in IR extend to almost every body system, particularly the 
biliary, gastrointestinal and genitourinary systems. In the acute setting, IR plays a 
very significant role in the management of sepsis in these body systems as it offers 
a minimally invasive technique to drain sources of infection in sites that would often 
only otherwise be accessible by major abdominal or pelvic surgery. This is 
particularly important in the severely ill patient with sepsis as IR techniques offer 
effective treatment with much lower morbidity and mortality than conventional 
surgical approaches.  
2.21 Non-vascular procedures use a variety of imaging modalities to guide the 
intervention. In solid organ procedures (for example, the urinary system and the 
biliary system) percutaneous procedures most often use a combination of 
ultrasound and fluoroscopy. Dose to the operator is potentially higher with these 
procedures as the access point is directly adjacent to the organ system and the 
operator is closer to the primary beam. In the vascular system, access is more 
often remote to the site of intervention and therefore the operator is standing 
further from the primary beam. These procedures vary in their complexity, but 
typically highest dose would be incurred in percutaneous transhepatic 
cholangiography (PTC) as this often requires more prolonged fluoroscopy, 
sometimes at oblique angulation.  
2.22 In the urinary system, IR may be used to treat obstruction by benign or malignant 
processes. The technique of percutaneous nephrostomy provides lifesaving relief 
of obstruction by placement of a percutaneous drainage catheter into the collecting 
system using imaging guidance. The technique of antegrade ureteric stent 
placement is often performed after percutaneous stent placement and achieves 
internal drainage by inserting a stent within the ureter (a tube that connects the 
kidney to the bladder) to bypass the obstruction.  
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2.23 In the obstructed biliary system, endoscopic retrograde cholangio-pancreatography 
(ERCP) or PTC may be used to achieve drainage of the biliary system and relieve 
jaundice. Both of these techniques offer a minimally invasive alternative to major 
surgery which is now rarely performed because of the effectiveness of these 
techniques and their significantly lower morbidity and mortality.  
2.24 In the gastrointestinal system, IR techniques are used to relieve obstruction and to 
achieve access for enteral feeding. The insertion of metallic stents is used to 
relieve the symptoms of obstruction in multiple different areas of the 
gastrointestinal tract. Percutaneous access can also be used to achieve access to 
the stomach to permit enteral feeding, a procedure known as a percutaneous 
gastrostomy which avoids the need for a surgical procedure.  
Interventional Cardiology 
2.25 Interventional cardiology (IC) is a subspecialty of IR whereby traditional surgical 
procedures have been replaced, for many indications, by interventions performed 
using cardiac catheterisation. This has provided very considerable benefit in the 
treatment of heart disease providing day procedure solutions in place of major 
heart surgery in many cases. The techniques used, have also considerably 
widened the scope of treatable cardiac conditions. 
2.26 IC includes a range of minimally invasive procedures involving insertion of 
catheters/other devices through superficial arterial access, facilitated by 
fluoroscopic imaging to guide practitioners. Diagnostic cardiac catheterisation was 
first introduced in the 1940s and angiocardiography was well established by the 
1950s (Bourassa 2005). The first human percutaneous coronary intervention (PCI) 
using a balloon angioplasty catheter was performed in 1977 (Grüntzig and others 
1977). In recent years there have been very significant advances in technology 
greatly extending the range and complexity of cardiac defects that can be treated 
using cardiac catheterisation in both adults and paediatric patients. 
2.27 Common IC procedures involve opening or widening narrowed areas with balloons 
and stents and/or closing unwanted vessels with coils or intravascular devices thus 
regularising blood flow to the heart. In adults the most common IC procedures 
performed in the UK and Ireland include coronary angiography (CA), PCI, CA with 
PCI and permanent pacemaker insertion (PPI) (D'Helft and others 2009), and 
emergency primary PCI (PPCI) for patients with ST-segment elevation myocardial 
infarction (STEMI) (Banning and others 2015). Another treatment now seen as a 
safe, reliable alternative to open heart surgery is trans-catheter valve 
replacements, resulting in much shorter recovery times and less risk of 
complications (Shemin 2016). 
2.28 Closure of adult secundum atrial septal defects (ASD) by IC procedure has been 
shown to be very successful and new devices continue to be introduced (for 
example, de Hemptinne and others (2017)), while the AHA/ACC Guidelines 2019 
(Stout and others 2019) set out exclusion guidelines where surgery is still the 
recommended course.  
2.29 Soma and others (2019), reported a successful staged closure of combined patent 
ductus arteriosus and atrial septal defect. 
2.30 Noting that the use of transcatheter aortic valve replacement (TAVR) is being 
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extended to younger patients and that there is a paucity of data on the lifespan of 
transcatheter heart valves, Landes and others (2020) evaluated the success rate of 
repeat TAVR. It was found that the repeat procedure was relatively safe and 
effective, with low complication rates and substantial symptomatic improvement. 
2.31 PCI is now being delivered to patients with chronic total occlusion (CTO) who 
would have previously been deemed high risk or inoperable. Complex lesions now 
account for more than 40% of total PCIs being performed in interventional suites 
(Fazel and others (2013). Although these treatment methods provide many 
benefits, it should be noted that the more complex multi-vessel and CTO 
revascularization procedures can often result in some of the highest radiation 
exposures in IR. 
2.32 The National Cardiac Audit Programme in the UK (NCAP) (NCAP 2018a, b) 
annually collates the data on both surgical and catheter-guided interventions for all 
the most common cardiac conditions. In 2016 to 2017 there were over 380,000 
treatments performed. The data shows that there is a continuing increase in 
treatments for cardiac disease over many years; a considerable proportion of the 
increase is due to the increase in catheter-guided treatments. This increase is 
illustrated by statistics from the British Heart Foundation (BHF) on the treatment of 
coronary artery stenosis. The data show a very significant increase in the use of 
PCI, which has been shown to provide a reliable, non-invasive alternative to open 
heart surgery with many advantages for patient recovery, with a corresponding 
decrease in the number of open-heart surgical procedures (Figure 2.1). Similar 
increases are found for other treatment interventions in cardiology (Kinnaird and 
others 2018). 
Figure 2.1: Number of Coronary artery bypass graft operations (CABG) and 
Percutaneous coronary interventions (PCI) per year, United Kingdom 1980 to 20151 
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2.33 With advances in medical technology the use of IC as a diagnostic and therapeutic 
tool has continued to increase as new and more complex interventions are 
developed. However, the rise in the use of IC has resulted in reports of 
deterministic injuries (see Chapter 3) to both adult and paediatric patients due to 
radiation exposure (Sun and others 2013). Patients who were treated in earlier 
years may have been exposed to a higher dose of radiation due to the use of older 
image intensifiers. In more recent years modern flat panel systems have helped to 
reduce the radiation dose (Livingstone and others 2015), though this reduction is 
somewhat offset by the development of more sophisticated and prolonged 
procedures requiring additional imaging time. 
Paediatric Interventional Cardiology 
2.34 The use of IC in infants and adolescents has improved the life expectancy of 
individuals born with congenital heart disease (CHD). The most recent annual 
NCAP audit underlines the continuing increase in CHD treatments. In 2016 to 2017 
there were 13,018 procedures performed; 9,011 were paediatric cases and 4,007 
were adults with ongoing problems associated with CHD (NCAP 2018a). Only 43% 
of cases were solely surgical procedures and the remainder were performed wholly 
or in part in cardiac catheterisation departments. This increased reliance on IC, 
and the increase in availability of new techniques means that the numbers treated 
using IC will continue to increase. In addition, the very considerable success of IC 
procedures in treating infants with CHD, has resulted in an increase in these 
individuals returning several times over the duration of their lifetime for follow up 
assessment and, in a proportion of cases, additional treatment (see Appendix C). 
2.35 In paediatric IC the most common procedures involve balloon interventions or 
device deployment. Balloon interventions include diagnostic catheterisation, 
pulmonary valvuloplasty, pulmonary artery angioplasty, co-arctation of the aorta, 
aortic valvuloplasty and septostomy. Device deployments include patent ductus 
arteriosus (PDA), atrial septal defects (ASD), ventricular septal defects, pulmonary 
artery angioplasty + stenting and occlusion) and collateral vessels (McFadden and 
others 2013a). 
2.36 Some 85% of ASDs are closed by IC, the main contraindication being an 
insufficient rim of viable tissue around the defect (Fraisse and others 2018). A 
comparison of transcatheter and surgical closure of ASD in children was carried 
out by Ooi and others (2016), who found the advantages of the IC procedure to be 
a shorter length of stay (4 vs 1.5 days), reduced risk of infection (odds ratio 3.73) 
and reduced risk of procedural complications (odds ratio 6.64). They also 
calculated a cost advantage of $19K versus $25.5K. There was no mortality in 
either group.  
2.37 Heart defects are diagnosed in at least 1 in 180 births in the UK, that is, 12 babies 
born daily with further cases being identified in the early years after birth2. The aim 
of cardiac services for infants is to diagnose heart disease as early as possible and 
preferably in utero. The use of routine ultrasound imaging during pregnancy has 
greatly improved diagnosis and currently almost 50% of CHD is diagnosed 
antenatally (NCAP 2018a). In the early 1960’s the majority of these babies would 
not have survived to their first birthday; currently 8 out of 10 survive to adulthood 
 
2 British Heart Foundation heart statistics 
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as a result of the use of IC and ongoing technological advancements. The 
prognosis for patients undergoing IC for CHD is excellent and their quality of life as 
adults with simple grown-up congenital heart (GUCH) disease, is similar to the 
quality of life of adults in the general population; the only difference found was that 
physical activity and health perception was lower (Petersen, 2003) 
2.38 The application of IC procedures for the diagnosis and treatment of heart disease 
in infants and children has provided a major improvement in treatment methods 
and survival and with reduced post treatment morbidity. Although it is well 
recognised that children are at a higher risk from exposure to ionising radiation 
than adults (Rassow and others 2000, Koenig and others 2001), the risks at all 
ages are generally small and will be substantially outweighed by the benefits of the 
use of IC. Furthermore, the risks of more invasive surgery are almost always 
higher than any potential risk of radiation detriment (discussed further in Chapter 
3). 
2.39 In summary, overall the development of cardiac catheterisation techniques has 
saved many lives. It has made successful treatment possible in both paediatric and 
adult practices for many conditions that were previously inoperable or for which 
their treatment was associated with much more severe risk. For most IC 
procedures the benefits very much outweigh the risks associated with older 
surgical techniques. 
Interventional Neuroradiology (INR) 
2.40 Interventional Neuroradiology (INR) encompasses a variety of minimally invasive 
image guided procedures (most with level 1A evidence) that have become 
established practice in the treatment of a range of cerebral and spinal vascular 
conditions including hyperacute ischaemic stroke, cerebral aneurysms (ruptured 
and unruptured), arteriovenous malformations (AVM), arteriovenous fistulae of the 
brain and spine, angioplasty and stenting (intra and extra cranial) and also 
adjunctive tumour therapy. As in VIR, non-invasive cross-sectional vascular 
imaging techniques provide the vast majority of initial diagnostic vascular imaging 
in the clinical Neurosciences. 
2.41 There is no single database that captures the number of INR procedures 
performed but the Sentinel Stroke National Audit Project (SSNAP) captures the 
great majority of stroke thrombectomy procedures performed in the UK excluding 
Scotland (where thrombectomy numbers are currently low). Ultimately, stroke 
thrombectomy will be the highest volume procedure performed in the INR setting 
with an estimated 10,000 per annum eligible for it in the UK annually (McMeekin 
and others 2017). 
2.42 A meta-analysis by Goyal and others (2016) documented a 20% absolute increase 
in patients assessed as ‘alive + functional independence’ at 90 days after stroke for 
thrombectomy performed by an expert neurointerventionist together with best 
medical therapy compared with best medical therapy alone. The number needed to 
treat with thrombectomy to achieve one person with less disability was 3. From 
around 300 mechanical thrombectomies per annum just prior to the publication of 
this level 1A trial evidence, thrombectomy numbers have risen steeply in the UK to 
almost 1600 per annum at the end of 2019.  
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2.43 However, the UK should as a nation be performing many more thrombectomy 
procedures and that will be the clear direction of travel over the next 3 to 5 years 
towards a 10,000 annual target. Mechanical thrombectomy for stroke is a time 
critical procedure with better outcomes the quicker thrombectomy is achieved and 
in most cases the time window to achieve this is within 7 hours of stroke onset. As 
a result, it is a very disruptive innovation to established care paradigms and 
pathways requiring a step change in stroke imaging as well as delivery of the 
intervention where appropriate. 
2.44 The endovascular treatment of cerebral aneurysms, developed in the early 1990s, 
has become established since 2002 (Molyneux and others 2002) as the treatment 
of choice for most cerebral aneurysms in most UK units. An absolute benefit of 
more than 7% in the ‘alive + independent’ category was demonstrated for 
endovascular coiling over neurosurgical clipping, with the number needed to treat 
to prevent one death or disabled outcome being 13. A follow-up paper (Molyneux 
and others 2015) demonstrated that this advantage for endovascular coiling was 
sustained at 10+ years 
2.45 A report by the National Confidential Enquiry into Patient Outcome and Death 
(NCEPOD) in November 2013 reviewed the care received by patients with 
aneurysmal subarachnoid haemorrhage (NCEPOD 2013). They reported the 
overall coiling rate for ruptured aneurysms coming to treatment in UK 
Neuroscience units as 85% endovascular to 15% neurosurgical clipping. That 
equates to about 4,000 INR ruptured aneurysm embolisation procedures per 
annum in the UK. There has been a steady slow downwards trend in the 
population rate for subarachnoid haemorrhage (SAH) but as techniques have 
improved since the 1990s, an ever-greater proportion of ruptured aneurysms has 
been treated endovascularly, such that nationally the numbers treated by INR 
remain fairly stable. The national guidance is to aim to secure ruptured aneurysms 
(in good grade patients) within 48h of aneurysmal SAH being confirmed (RCP 
2016), which requires weekend service provision of INR. 
2.46 Johnston and others (2000) highlighted that the recovery period for elective 
aneurysm treatment (50% return to normal) was 25 days for INR versus 1 year for 
surgery. Endovascular treatment of unruptured intracranial aneurysms (UIA) now 
account for 30 to 40% of total aneurysm procedure activity in most UK units, 
approximately 2,000 procedures per annum, although there is more variation in 
practice between individual units than for ruptured aneurysms. This UIA caseload 
is rather lower than most international comparators as there is a stronger practice 
towards conservative management of small incidental UIAs in the UK than many 
countries operating under different healthcare economies and different 
reimbursement systems. As a result, the unruptured aneurysms treated in the UK 
are often larger, more complex lesions than a typical ruptured aneurysm and the 
radiation doses are correspondingly rather higher on average. 
2.47 The radiation dose to patient and operator during interventions in INR is dependent 
upon a number of interlinked factors including the pathology (AVMs often requiring 
considerably longer procedures with more fluorography and screening), anatomical 
location of the lesion (brain or spine), the complexity of the required intervention, 
the need for biplane screening/fluorography, staff proximity to the beam and the 
screening time. 
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2.48 Other INR procedures are much lower in volume and tend to use a range of 
techniques including liquid and/or particle embolisation, vessel occlusion with coils 
or other plug devices, angioplasty, stenting. 
2.49 Non-vascular neurointerventional procedures are also performed though usually at 
appreciably lower volumes – including spinal vertebral procedures (vertebroplasty, 
kyphoplasty, sacroplasty), blood patches for cerebrospinal fluid (CSF) leaks, 
therapeutic nerve root and facet joint injections, percutaneous injection of facial 
malformations. These are more varied around the UK, both in terms of volumes 
and the clinical speciality of those who perform them than the endovascular INR 
procedures, which remain overwhelmingly delivered by Neuroradiologists.  
2.50 Most INR procedures, particularly the endovascular ones, treat immediately life-
threatening conditions in adults (often late middle aged or more elderly) – major 
ischaemic stroke, ruptured brain aneurysms and vascular malformations. As such, 
the associated risk of radiation is exposure is usually a fairly minor consideration in 
assessing the overall risks and benefits of INR procedures. 
2.51 Paediatric INR procedures are rare, some of them being very complex, and as a 
result tend to be concentrated in just 2 or 3 units in the UK, primarily the Great 
Ormond Street Hospital London which operates the National Vein of Galen service. 
Oncology 
2.52 There are currently many established specialties providing ‘interventions’ for the 
treatment of cancer (for example, surgery, radiotherapy and systemic drug 
therapy). More recently ‘interventional oncology’ involving specific IR procedures 
has become available for selected cancer patients, in some cases replacing 
existing therapeutic procedures and also providing options for previously 
untreatable conditions. 
2.53 The rationale for many oncological treatments/procedures is prolongation of life 
and/or quality of life, without necessarily eradicating the cancer. IR interventions 
are frequently aimed at achieving equivalent benefits to surgery but with lower 
morbidity. Palliative interventions are aimed at reduction in the severity of 
symptoms without necessarily prolonging survival, in which case minimising or 
avoidance of toxicity is important. Consequently, the measured outcomes for 
oncological interventions are normally evidence of extension of life and/or 
improved quality of life. 
2.54 Over the last decade IR has continued to evolve with a burgeoning role in the 
management of cancer patients. The skills and competencies of an interventional 
radiologist required to provide IR procedures in the context of cancer management 
are an important component of the cancer multi-disciplinary team (MDT).  
2.55 However, because of the relatively recent introduction of many techniques and the 
dependency on availability of local skills, the application of IR is not entirely uniform 
across the UK throughout different cancer services, although the Royal College of 
Radiologists (RCR) has defined professional and service standards for the 
incorporation of IR procedures into the management of patients with cancer (RCR 
2017b).  
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Interventional oncology procedure categorisation  
2.56 Interventional oncological procedures can be considered under 2 main headings 
with respect to their primary intent. The following provides an indication of the 
types of procedures which may be undertaken.  
Supportive or symptomatic procedures  
2.57 Supportive procedures refer to those which support the provision of definitive 
treatment but are not in themselves directed at treating the tumour or its effects; in 
other words, adjuncts to enable systemic anti-cancer therapy (SACT), radiotherapy 
or surgery. An example of this is Portal Vein Embolization (PVE) which is a 
preoperative IR procedure to initiate hypertrophy of the anticipated future liver 
remnant several weeks prior to a liver resection. This involves injecting the right or 
left portal vein with embolic material to occlude portal blood flow. As a result, blood 
is diverted to healthy parts of the liver and induces hyperplasia. This may allow for 
a more extensive resection which would otherwise be contraindicated, resulting in 
better surgical oncological outcomes. 
2.58 Furthermore, the IR procedures themselves may minimise the need for these 
interventions to be performed. For example, Selective Internal Radiation Therapy 
(SIRT) can be a substitute for systemic anti-cancer chemotherapy.  
2.59 Symptomatic procedures provide relief from tumour-related symptoms but do not 
necessarily modify the underlying malignant disease process. The main supportive/ 
symptom-relieving techniques are summarised in Table 2.2. The availability of 
these procedures has added extra options to facilitate cancer treatments and 
alleviate symptoms. 
Table 2.2 IR procedures used for managing and treating cancer patients 
Procedures Examples Benefits 
Central venous access  Insertion of central venous lines for 
chemotherapy administration 
Safer administration of 
chemotherapy 
Enteral tube placement  Radiologically inserted gastrostomy (RIG) Support of nutrition 
Stenting Including: vena cava, gastro-intestinal 
nephrostomy and ureteric stenting  
Relief of obstruction due to 
malignancy 
Image-guided insertion 
of fiducials  
Used as markers for stereotactic ablative 
radiotherapy (SABR) or other forms of 
image-guided radiotherapy 




Pleural and ascetic aspiration Symptom relief 
Vena cava filtration  Inferior vena cava filter insertion Prevention of pulmonary 
embolus 
Biliary drainage and 
stenting  
Endoscopic biliary drainage  Relief of obstructive jaundice 
Neo-adjuvant 
embolisation  
Portal vein embolisation  Improves outcome of 
hepatic resection for 
malignant disease 
Ascitic diversion Peritoneo-venous or peritoneo-cystic 
shunt/pump 
Relief of symptoms 
Image-guided ablation Radiofrequency ablation (RFA) and 
Cryoablation for tumours 
Used for patients not 
suitable for surgery. 
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Disease-modifying procedures  
2.60 Disease-modifying procedures are those where the intent is to modify malignant 
progression and/or to modify the prognosis. Patients may potentially be suitable for 
a range of therapeutic options, for example stereotactic ablative radiotherapy 
(SABR), radiofrequency ablation (RFA), microwave ablation (MWA), irreversible 
electroporation (IRE), cryotherapy (CRYO) or selective internal radiotherapy (SIRT) 
for liver metastases. Radiofrequency ablation (RFA) and cryoablation are the 2 
most commonly used ablation modalities. RFA destroys tumours by coagulation 
necrosis from temperatures above 60°C. Cryoablation causes tumour necrosis by 
intracellular dehydration and disruption of cell membranes from temperatures 
below -20°C. 
2.61 Examples of disease modifying procedures are summarised in Table 2.2. In many 
cases these options provide an alternative or additional approach to targeting 
therapy directly to the tumour site. 
2.62 Trans-arterial chemo-embolisation (TACE) is a good example of the use of IR in 
oncology to treat patients with primary liver tumours and/or liver metastases. TACE 
is the current standard of care for patients with intermediate-stage hepatocellular 
carcinoma (HCC) and relatively well-preserved liver function. In a meta-analysis of 
randomised controlled trials TACE has been demonstrated to improve median 
survival from 16 to 20 months. A development from TACE, embolic drug-eluting 
bead (DEB) has been shown to substantially improve the pharmacokinetic profile 
of TACE. In randomised trials, DEB-TACE significantly reduced liver toxicity and 
drug-related adverse events compared with conventional TACE.  
2.63 SIRT is also referred to as transarterial radio-embolisation or radio-embolisation. It 
is a form of arterially delivered brachytherapy and involves delivering microspheres 
containing yttrium 90 (Y-90), a beta-emitting radionuclide, directly into the tumour 
via the hepatic artery using a percutaneous transarterial approach. In the UK 
colorectal cancer (CRC) is the fourth most frequent cancer. Liver metastases are 
common among patients with CRC and a frequent cause of death. In selected 
patients, resection of the metastatic disease, if feasible, is the recommended 
approach. However, for the majority of patients this approach is not possible. 
SACT (systemic anti-cancer chemotherapy) is the standard treatment for 
unresectable metastatic disease, which may be combined with other biological 
agents. Patients failing first and second line SACT have few treatment options and 
have a median overall survival from 2.4 months to 6.6 months. Loco-regional 
therapies, such as SIRT or DEB-TACE are currently under evaluation as potential 
new techniques to prolong survival. A systematic review of the evidence (NICE 
2017) from studies of unresectable, chemotherapy-refractory patients with CRC 
liver metastases treated with SIRT has identified 23 studies involving 2,517 
patients for which the overall median survival was 9.6 months. A critical factor in 
deciding how SIRT should be used is appropriate patient selection in order to 
identify those likely to benefit.  
2.64 In summary, IR now has a significant role to play in the treatment of cancer 
patients. Considerable benefits accrue from its use, and for many patients there is 
a measurable increase in their survival time. The advantage of using IR techniques 
in these patients is that they are minimally invasive and generally less toxic. In 
general, toxicities associated with IR for oncology patients are negligible compared 
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to the many toxicities these patients have to incur due to the nature of most of the 
alternative available treatments such as major surgery, external beam 
radiotherapy, the use of systemically administered cancer chemotherapy drugs and 
often a combination of some or all these.  
Conclusions 
2.65 IR has revolutionised many medical procedures providing for an extensive range of 
treatments that were previously impossible or only achieved using conventional 
surgical techniques. This had led to many benefits. 
2.66 The availability of alternative IR procedures has reduced the number of (often) long 
and expensive surgical procedures that require opening of body cavities with 
consequent prolonged recovery and convalescence of the patients.  
2.67 Elderly and frail patients are more likely to be deemed fit for IR procedures which 
require limited anaesthetic intervention.  
2.68 The cost of the procedures is much reduced compared to conventional surgery 
(see, for example, paragraph 2.36) though this is offset by the burgeoning increase 
in the number of IR procedures that are performed or by the need for repeat 
procedures (see, for example, paragraph 11.13). 
2.69 Many of the IR procedures can be carried out within the working day or with a 
minimal length of stay in hospital, much reducing the demand on hospital beds.  
2.70 Patient recovery rates are much quicker and more successful than conventional 
surgical procedures. 
2.71 IR has provided a huge benefit to the treatment of many conditions. It is likely that 
this will increase as the technology evolves and more interventional techniques are 
developed.  
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Chapter 3: Effects associated with radiation 
exposure from IR 
Introduction 
3.1 The use of IR has had a major beneficial effect on advancing therapeutic 
approaches in clinical medicine for many conditions. Indeed, IR has revolutionised 
the treatment of many conditions as discussed in Chapter 2. However, there are 
small potential detriments associated with its use. In the context of this report there 
is a need to balance the major benefits to be gained from an IR-guided procedure 
against the potential harm that might be caused by the radiation exposure.  
3.2 It should be noted that there are other risks, independent of radiation exposure, 
which also result from IR procedures and must be explained to patients (see 
paragraph 8.2). These include complications of the vascular access site (Gewalt 
and others 2018), non-radiation related dermatological complications (Ramirez and 
others 2019), bacterial infection (Sutcliffe and others 2015) and allergic reaction to 
contrast agents although this has a very low incidence (Hunt and others 2009). In 
this report, however, the focus is on the level of risk associated with exposure to 
ionising radiation both to the patient and the staff involved in the interventional 
procedures.  
Describing radiation dose exposure levels in medicine 
3.3 The fundamental physical quantity for assessing radiation dose is termed absorbed 
dose and is a measure of the energy deposited in any material as a result of its 
exposure to radiation. Absorbed dose is measured in gray (Gy) and has units of 
Jkg-1. At diagnostic and interventional X-ray energies the absorbed dose to air is 
numerically equivalent to a quantity called air kerma, which can be readily 
measured and is also recorded in Gy (see also paragraph 5.49). 
3.4 The harm caused to body tissues resulting from ionising radiation can be divided 
into 2 main types, stochastic and deterministic (ICRP 2007) (see paragraph 3.15 et 
seq.) Tissue reactions, or deterministic effects, occur above specific absorbed 
dose thresholds for specific organs and their severity increases as the radiation 
dose increases. They can manifest shortly after an exposure or after a delay of 
many months or years. The organ of most concern, with regard to tissue reactions 
in IR, is the skin. Threshold values for a range of skin effects are shown in Table 
3.3. Stochastic effects, mainly cancer, occur by chance, without a dose threshold 
level; the probability of a transformation occurring is proportional to the dose, but 
the severity is independent of the dose. As explained in paragraphs 3.9 to 3.11 the 
detriment associated with stochastic events can be related to a quantity called 
effective dose. 
3.5 The absorbed and effective radiation doses received by patients undergoing 
interventional procedures can be calculated from the directly measurable quantity 
incident air kerma (IAK) and its derivatives. The word ‘incident’ is used to reflect 
the fact that it is the amount of radiation that is incident on the patient. The most 
commonly recorded quantities derived from IAK are kerma-area product (KAP), 
which is a measure of all the radiation entering the patient at any projection and 
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cumulative air kerma (CAK), which is the total IAK that builds up during a 
procedure and so provides a measure of the total amount of radiation incident on 
the patient. A further metric, entrance surface air kerma (ESAK), which provides a 
measure related to the absorbed dose to the skin surface, can be derived from IAK 
or measured using dosemeters placed on the skin.  
3.6 The absorbed dose to different organs in the body cannot be measured directly. 
However, the mean absorbed dose to an organ can be estimated from IAK, KAP or 
ESAK using data that are readily available. 
3.7 Radiation detriment is a concept used by the International Commission on 
Radiological Protection (ICRP) to quantify the overall potential harm to health from 
low-level radiation exposure, based on the possible risk from stochastic effects 
occurring in different parts of the body (ICRP 2007). The main stochastic effect of 
concern is cancer, but detriment also includes a small precautionary contribution 
from heritable effects (see paragraph 3.26). The primary source of information on 
cancer caused by radiation is the life span studies (LSS) of the Japanese survivors 
of the atomic bombings at Hiroshima and Nagasaki in 1945. Estimates of lifetime 
risks of cancer incidence derived from studies of these populations, supplemented 
by other epidemiological data, are transferred and averaged across Asian and 
Western populations, adjusted for severity and years of life lost, and summed with 
a component of estimated risk of heritable effects to provide overall stochastic 
detriment values. A linear non-threshold (LNT) dose response relationship is 
assumed to apply to stochastic effects at low doses, consistent with the cancer 
data from the LSS. 
3.8 Effective dose (E) is a measure of radiation dose related to the detriment, which 
has the unit sievert (Sv) (ICRP 2007). E takes into account that body tissues have 
different radiosensitivities and that different types of radiation can produce more or 
less damage per Gy. The effective dose is the weighted sum of the mean absorbed 
dose to each radiosensitive organ, thus: 
E = ∑T wT ∑R wR DT,R     
where E is the effective dose in Sv, wT are the tissue weighting factors, wR are the 
radiation weighting factors and DT,R is the mean absorbed dose in Gy for organ or 
tissue, T, and radiation, R. For the X-rays used in diagnostic radiology and IR, the 
radiation weighting factor is 1 (ICRP 2007).  
3.9 Effective doses are calculated for so-called Reference Persons of specified ages 
(ICRP 2009a). For this, male and female digital phantoms have been developed by 
ICRP, based on tomographic images of real individuals, adjusted to body and 
organ masses of the reference male and female adult (ICRP 2002). ICRP has also 
developed reference phantoms for children of different ages (ICRP 2020). 
Simulations of radiation exposures are used to calculate equivalent doses to all 
organs and tissues within pairs of male and female phantoms. The results for every 
organ are then averaged to give the sex-averaged equivalent doses, and from 
these the effective dose to the Reference Person is calculated using the equation 
above. This methodology fulfils the primary purpose of providing a quantity for use 
in the control of radiation exposures of members of the public and workers, 
including medical personnel. Effective dose was not designed to provide a 
measure of dose relating to risk to individuals and so the assessment of possible 
risk to specific patients requires care (see below).  
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3.10 One use of effective dose in medicine is to compare relative doses received by 
patients from examinations involving different parts of the body or of the same part 
of the body using different techniques. It is useful for taking the possible risk of 
radiation exposure into account for purposes of justification and optimisation of a 
proposed procedure, bearing in mind that the dose and associated risk apply to a 
sex-averaged Reference Person. Investigations can also be grouped into broad 
categories according to levels of effective dose and possible associated risks to 
facilitate risk communication to both patients and clinicians. 
3.11 The tissue weighting factors, as defined by ICRP (2007), are given in Table 3.1. 
These values are simplified and rounded from relative detriment values 
representing the contribution of individual organs and tissues to overall detriment of 
7.3 x 10-2 Sv-1 applying to a population of all ages and both sexes. As shown in 
Table 3.1, contributions from just 5 organs (bone marrow, breast, colon, lung and 
stomach) make up 60% of the total risk in this simplified scheme. However, it 
should be recognised that the epidemiological evidence shows that lifetime risks of 
cancer, and hence detriment, are generally greater in females than males and 
greater at younger ages of exposure (see paragraph 3.45). The various cancer 
types show differing patterns of dependence on sex and age at exposure; for 
example, thyroid cancer is much greater in young children, particularly females, 
than in adults, while risks of lung cancer appear less dependent on these factors. 
When using effective dose to gain an approximate idea of possible stochastic risks 
at low doses, it is helpful to be aware that the risks per Sv are likely to be higher in 
children than adults, generally by a factor of 2 to 3, as well as lower for older 
patients (see paragraph 3.45). 
Table 3.1: Recommended tissue weighting factors* 
Tissue wT ∑T wT 
Bone-marrow (red), Colon, Lung, Stomach, Breast 0.12 0.60 
Gonads 0.08 0.08 
Bladder, Oesophagus, Liver, Thyroid 0.04 0.16 
Bone surface, Brain, Salivary glands, Skin 0.01 0.04 
Remainder tissues: Adrenals, Extrathoracic region, 
Gall bladder, Heart, Kidneys, Lymphatic nodes, 
Muscle, Oral mucosa, Pancreas, Prostate (♂), Small 
intestine, Spleen, Thymus, Uterus/cervix (♀) 
0.12/13 0.12 
Total  1.00 
* Tissue weighting factors as described in the ICRP report 103 (ICRP 2007). 
3.12 IR is used in a wide range of procedures (see Table 2.1). Most IR procedures 
result in absorbed doses to patients that are below the threshold for the induction 
of deterministic skin effects. Some do not, and deterministic skin effects are 
observed. Any patient irradiation, either diagnostic or therapeutic, will result in 
potential risk from stochastic effects. Effective and absorbed doses in IR can vary 
considerably; they depend on the part of the body being investigated, the length of 
time required to complete the procedure, the techniques used and the way the 
equipment is operated. Because of the risk of both deterministic and stochastic 
events occurring, all procedures involving the irradiation of patients must by law be 
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justified – that is, the benefit to the patient must be evaluated as being greater than 
the risk - prior to their taking place (see Chapter 4). The regulations also require 
that exposures to patients are kept as low as possible without compromising the 
intended outcome – this is termed optimisation (see Chapter 4). 




Equivalent period of 
natural background 
radiation 1 
Term used to 
describe risk 
Chest X-ray  
(single posteroanterior projection)  
0.015 2.5 days Negligible 
Abdomen X-ray  0.4 2 months Minimal 
CT - head 1.8 10 months Very low 
CT - chest  6.6 3 years Very low 
PET-CT body  18 8.1 years Low 
Short IR procedure, for example, 
Hickman line insertion 
0.12 16 days Negligible 
Cardiac diagnostic coronary 
angiography 
3.93 18 months Very low 
PTCA (1 stent / 2 stents) 6.8 / 10.42 32 / 48 months Very low 
Prolonged procedure, for example, 
endovascular aneurysm repair (EVAR) 
35 16 years Low 
1 UK average natural background radiation dose = 2.2 mSv per year 
2 Derived from Hart and others 2012 
3 Wall and others 2011 
3.13 Representative effective dose from some widely used IR procedures and a range 
of diagnostic procedures are shown in Table 3.2; these are contextualised by 
comparison with the exposure experienced by the general population from natural 
background radiation. Standard terminology for the risks associated with each 
procedure is included in Table 3.2 (ICRP In press).  
3.14 Although effective dose is calculated as a sex-averaged dose using male and 
female reference phantoms using a single set of simplified tissue weighting factors, 
it can provide an approximate indication of possible risk. The doses under 
consideration are in many cases below the levels at which direct epidemiological 
observations of excess cases of cancer are available and risk estimates are 
uncertain. However, the most straightforward interpretation of the available 
scientific evidence for the purposes of radiological protection is that a nominal 
lifetime fatal cancer risk of about 5 x 10-2 per Sv applies at low doses or low dose-
rates; that is < 10-4 per mSv. The evidence also shows differences in risk between 
males and females and particularly with age at irradiation. Such differences should 
be taken into account when estimating individual risk. The use of effective dose to 
provide an approximate indication of possible risk of low dose procedures is not a 
substitute for the use of best scientific data in more rigorous assessments of doses 
and risks. Such analyses would consider organ / tissue absorbed doses derived for 
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a phantom approximating the build of the patient, together with age, sex- and 
population-specific risk estimates for individual cancer types, addressing 
uncertainties in the dose and risk estimates. 
Biological effects associated with radiation exposure 
3.15 The harm within body tissues resulting from ionising radiation can be divided into 2 
main classes, stochastic and deterministic, alternatively called ‘tissue reactions 
(ICRP 2007). 
3.16 Stochastic effects occur by chance and the general assumption for radiological 
protection purposes is that the LNT model applies, that is, that the risk at low doses 
is proportional to dose with no threshold level below which there is no risk (see 
paragraph 3.7). Thus, the probability of a deleterious effect is proportional to dose, 
but the severity is independent of the dose. The primary cause of stochastic effects 
is the acquisition of a radiation-induced mutation by induction of double strand 
breaks (DSBs) in the deoxyribonucleic acid (DNA) of individual cells. If radiation 
induces a mutation in the DNA of somatic cells, this may lead to cancer formation. 
If a germ cell is affected this may lead to a heritable effect. 
3.17 Tissue reactions result from radiation-induced cell killing in tissues. They occur 
above specific dose thresholds for individual organs and their severity increases as 
the radiation dose increases. They can manifest shortly after an exposure when 
the radiation dose is above the threshold. This threshold varies for different tissues 
and is also determined by the sensitivity of individual people to ionising radiation 
damage. This variation is not fully understood but is thought to be related to 
genetic predisposition. For some individuals, who have a genetically inherited 
disease these effects are much greater (see paragraphs 3.54 et seq). When no 
initial deterministic effect is observed this does not mean that no damage has been 
done; under certain circumstances tissue reactions will occur after a delay of many 
months or years (see paragraph 3.27 et seq). 
3.18 When cells are exposed to ionising radiation a wide range of damaging lesions are 
caused, including base damage, single strand breaks (SSBs), double strand 
breaks (DSBs) of varying complexity and DNA cross links. If this results in cell 
death, the frequency of this, at the radiation doses experienced during IR 
procedures, is normally of minimal consequence. Cells also have very effective 
repair pathways, which in many cases can result in an efficient repair of a range of 
different DNA damaging events. However, misrepair can occur, especially since 
ionising radiation often causes complex cluster damage. This results in a loss of, or 
insertion of, abnormal information within the DNA (Jeggo and Löbrich 2006, 
Mavragani and others 2017). The DNA-damaging events can also result in a range 
of different types of chromosomal aberrations such as terminal deletions, 
translocations and dicentric chromosomes (Manning and Rothkamm 2013). 
Misrepair can also result in genetic instability predisposing cells to further 
mutational events (Mavragani and others 2017). All of these changes can be 
crucial for the initiation of a cell’s predisposition to tumour formation.  
3.19 Radiation hormesis (or adaptive response) is the suggestion that very low doses of 
radiation may prevent rather than cause disease. Although there is evidence of 
effects at a cellular level, there has been no linking evidence to disease outcomes 
(Shibamoto and Nakamura 2018). 
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Biological consequences of stochastic effects in somatic cells 
Cancer risk 
3.20 When stochastic damage occurs in somatic cells, this has the potential to result in 
the development of a cancer a number of years later. The probability of a 
deleterious stochastic change occurring as a consequence of exposure to the 
ionising radiation dose normally used in IR procedures is very small (Suzuki and 
Yamashita 2012).  
3.21 The primary source of information on cancer caused by radiation is the life span 
studies (LSS) of the Japanese survivors of the atomic bombings at Hiroshima and 
Nagasaki in 1945. The LSS cohort is a very large group of individuals (>93,000) 
who were exposed to ionising radiation during the bombing and controls who were 
not in the cities at the time (>26,000). This cohort has been extensively studied for 
over 60 years to analyse the detriments associated with whole body radiation, 
including estimation of the likelihood of cancer development (Ozasa and others 
2019). Evidence from this cohort, for whom there were dose estimates shows that 
for leukaemias the highest excess risk appears after approximately 5 years (Hsu 
and others 2013); though the risk falls off with time it remains for over 55 years 
especially for acute myeloid leukaemia. The potential for development of solid 
tumours is not normally evident for over 10 years after an initial radiation exposure; 
however, the risk is apparent for over 60 years (Grant and others 2017). One 
exception is thyroid cancer, which has about a 5 to 10 year latency period and is 
particularly a risk for individuals exposed as children; the risk diminishes 
significantly in older age groups (Iglesias and others 2017). It should be noted that, 
while studies of the LSS cohort have provided important information on cancer 
incidence at low dose exposures, these individuals were exposed to whole body 
irradiation. Patients exposed during a medical procedure, including IR, have a 
much more limited area of body exposure, this considerably reduces their risk 
compared to the LSS cohort. The importance of age of exposure to cancer risk is 
discussed more fully below. 
3.22 In general, the epidemiological evidence from the LSS and other studies confirms a 
linear dose-response relationship between cancer rates and absorbed dose from 
gamma rays from around 100 mGy to a few Gy (ICRP 2007, UNSCEAR 2008, 
NCRP 2018) . Attempts are being made to extend observations to lower 
doses/dose-rates, notably studies on large worker cohorts (Richardson and others 
2015, Sokolnikov and others 2015, Haylock and others 2018, Richardson and 
others 2018) and studies of children receiving CT scans (Pearce and others 2012, 
Mathews and others 2013, Berrington de Gonzalez and others 2016, Meulepas 
and others 2019). The CT studies reported some statistically significant elevation 
of cancer rates at doses of a few 10s of mSv. However, caution has been advised 
in the interpretation of these studies (Walsh and others 2013, 2014, Boice 2015). A 
number of problems were identified including lack of information on the reasons for 
the scans and lack of individual dose reconstruction. It is considered that the 
patients may well have had undetected cancers that prompted their CT 
examinations, an example of reverse causation, or that factors that predispose to 
cancer also lead to medical conditions that require CT scans, an example of 
confounding by indication (UNSCEAR 2013, Walsh and others 2013, 2014, Boice 
2015). 
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3.23 A number of assumptions and judgements are made in quantifying low dose/dose-
rate cancer risks (ICRP 2007). Based on epidemiological analyses from the 1990s, 
a Dose and Dose Rate Effectiveness Factor (DDREF) of 2 was applied to the solid 
cancer risks derived from the LSS studies. Currently, epidemiology provides limited 
evidence of a DDREF >1 for solid cancer in humans, although analyses continue 
(Rühm and others 2016, Shore and others 2017), but animal and in vitro data 
indicate curvilinear dose response relationships that provide some support for the 
use of a DDREF >1. For leukaemia, the LSS study data are consistent with the use 
of a linear-quadratic dose response relationship, with the dose-response being 
linear at doses less than 0.1 Gy. Having obtained cancer risk estimates for 
exposures at low doses of a few 10s of mGy, an LNT dose-response relationship is 
assumed. This LNT dose-response assumption is considered to represent a 
prudent interpretation of current evidence including mechanistic understanding of 
radiation-induced cancer at low doses or low dose-rates (Preston and others 2003, 
ICRP 2007, Preston and others 2007, UNSCEAR 2012). In a review of all relevant 
epidemiological studies, NCRP (2018) concluded that current data support the 
continued use of the LNT dose-response relationship for radiological protection 
purposes, with no other model representing a more pragmatic or prudent 
interpretation. 
3.24 During IR procedures, patients inevitably receive a concomitant skin exposure. 
Some studies have shown an increase in non-melanoma skin cancer (NMSC) 
caused by occupational exposure to IR (Wang and others 2002) and during 
radiation treatment (1 to 8 Gy) for a range of benign indications. Other reports have 
failed to confirm this finding, including a study of tuberculosis patients exposed to 
multiple fluoroscopies (average 77) during treatment (Davis and others 1989, 
McKeown and others 2015). The most common NMSC is basal cell carcinoma 
(BCC). The lifetime risk of development of a radiation-induced BCC was estimated 
to be approximately 0.006% based on 100 cm2 skin treated to a mean dose of 3 
Gy; although it should be recognised that this figure is very much smaller than the 
spontaneous lifetime risk of BCC which is >20% (Trott and Kamprad 2006). The 
ICRP (2007) has assumed a population-averaged risk of skin cancer incidence of 
10-1 per Gy. Previously this risk was thought to be increased in a sun-exposed field 
by an order of magnitude compared to skin not exposed to the sun (ICRP 1991b). 
However, more recent studies have resulted in conflicting conclusions and the 
issue of interaction of effects is considered to be unresolved (ICRP 2015). It should 
be noted these BCCs can usually be treated successfully, although some studies 
suggest that BCCs resulting from ionising radiation exposure are more aggressive 
than those arising spontaneously and should ideally be excised with wider margins 
(Hassanpour and others 2006). There is evidence from studies of the LSS and of 
radiotherapy patients that risks are substantially higher for exposure at younger 
ages (ICRP 2015). Consequently, long-term surveillance and reporting of 
suspicious changes in irradiated skin is advised, especially in individuals exposed 
to ionising radiation as children and those who have had prolonged IR procedures, 
especially when young. 
Biological consequences of stochastic effects in germ cells 
3.25 Stochastic effects can also occur in cells of the reproductive system, resulting in 
the potential to cause genetic changes that can be passed on to future 
generations. In animal models transgenerational effects have been shown to affect 
offspring of exposed males (Dubrova 2003, Niwa 2003, Barber and others 2006). It 
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has also been shown that radiation exposure can cause both overt DNA damage 
and also epigenetic effects in germ cells leading to genomic instability (Morgan 
2003b, a, Merrifield and Kovalchuk 2013).  
3.26 LSS studies of genetic diseases in offspring of A-bomb survivors showed no 
evidence that paternal or maternal radiation dose was associated with an 
increased risk of any multifactorial diseases in either male or female offspring 
(Tatsukawa and others 2013), although it was noted that the study population 
(11,951 individuals) was in mid-life and will experience much of the studied disease 
incidence in the future decades. ICRP (2007) concluded that, while there is no 
reliable direct evidence from human epidemiological studies of deleterious 
heritable effects of radiation, the inclusion of a heritable risk in overall stochastic 
risks is a prudent interpretation of the evidence of heritable effects observed in 
experimental animals and understanding of mutation rates in humans. Estimates of 
heritable risk over 2 generations were applied in calculations of radiation detriment, 
referring to detailed analyses by UNSCEAR (2001). Several other publications 
have reported there is no conclusive evidence to suggest that human health has 
been significantly affected by transgenerational changes induced by radiation 
(Little and others 2013, UNSCEAR 2013, Kamiya and others 2015). For practical 
radiation protection purposes, recent advice (BIR 2020) has confirmed that 
gonadal protection is unnecessary, although good technique is encouraged and 
there may be some exceptions, that is, where the patient care pathway requires a 
number of repeat examinations, particularly in the case of paediatric patients. 
Tissue reactions caused by ionising radiation in tissues 
3.27 Tissue reactions (previously called deterministic effects) involve impairment of 
tissue and organ function due to gross cell killing, which become evident above 
dose thresholds with the severity increasing with increasing dose (Little 2003, 
ICRP 2007). Originally tissue reactions were described as overt reactions observed 
during and/or shortly after exposure to ionising radiation which result from cell 
killing and inflammatory reactions within tissues, for example skin inflammation / 
desquamation / epilation (ICRP 1991a). It is now recognised that other tissue 
effects occur that are not manifest at the time of irradiation, but can become 
evident sometime later (ICRP 2007).  
3.28 The tissue reaction most likely to occur following IR procedures is damage to the 
skin at the site of the highest dose exposure (Ramirez and others 2019). Other 
effects of potential importance which have been classified as deterministic are 
cardiovascular damage and cataractogenesis. Whereas skin effects normally occur 
above 2 to 3 Gy and within about 90 days of exposure. the latter effects are harder 
to quantify since they occur at some considerable time after exposure. It should be 
noted that a lower threshold for tissue reactions of around 0.5 Gy may apply for 
damage to the eye and circulatory system. Indeed, the evidence suggests that 
these events are not classically deterministic as they do not depend upon cell 
killing alone, but also on cell transformation. As discussed below, thresholds may 
not apply. 
3.29 The staff team who experience regular radiation exposure during their working life 
in the interventional suite may be at risk of subsequently developing tissue 
reactions. The interventionalist who operates closest to the radiation beam is most 
at risk, as are staff who spend considerable lengths of time in the working week 
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within the radiation suite supporting more than one physician (for example, 
radiographers and nurses). The operator may also receive a relatively high 
cumulative dose to the extremities, which needs careful monitoring. Tissue 
reactions most important to staff are discussed in paragraphs 3.35 et seq) and 
radioprotection measures to reduce the staff risks are discussed in detail in 
Chapter 6. 
Tissue reactions in skin  
3.30 The probability and severity of skin damage can be estimated from the local or 
peak skin dose. ICRP (ICRP 1991b, 2007) recommends assessment of dose to the 
most exposed 1 cm2 of skin at a nominal depth of 70 µm corresponding to the 
basal layer of the epidermis. This is a separate consideration from that of cancer 
risk, for which the average dose to the skin of the whole body is assessed. In a 
review of skin reactions following IR procedures, the response was found to be 
related to the peak skin dose and time after irradiation.  
3.31 Many IR procedures are short and involve very low doses of ionising radiation and 
skin reactions are not normally expected. However, acute skin reactions can be 
observed following more complicated/longer procedures; these occur within about 
90 days of exposure when the dose exceeds about 2 to 3 Gy, with patients 
exhibiting a dose-dependent erythematous reaction (Wagner 2007, Balter and 
Miller 2014, Ramirez and others 2019). Previous radiation exposure may also 
influence responses. Even when the skin looks normal following an initial 
exposure, it may be more sensitive to subsequent exposure(s) (Balter and others 
2010). 
3.32 The likelihood of skin reactions is often linked to the fluoroscopy time of the 
procedure. However, in a study of radiation dose exposure during IR procedures, 
the variation in the relationship between peak skin dose and fluoroscopy time was 
found to vary over 2 orders of magnitude (Miller and others 2003). The severity of 
reactions can be influenced by factors including the area of the body exposed, and 
fluoroscopic dose rates (Balter and others 2010). Thus, fluoroscopy time should 
not be relied on as the sole metric for predicting deterministic skin reactions 
following complex interventional procedures 
3.33 The time of onset following medical exposure to ionising radiation and the type of 
deterministic effect is shown in Table 3.3. Erythema and epilation occurring at 
doses of a few Gy are reversible but are likely to become permanent as doses 
increase towards 10 Gy. Late effects culminating in necrosis are seen after doses 
above about 25 Gy (Wojcik and Martin 2015), although it should be noted that 
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Time of onset 
2 to 8 weeks 
Later 
0 to 2 No effect   
2 to 5 Transient 
erythema 
Epilation Recovery from hair loss within 1 year 
5 to 10 Transient 
erythema 
Erythema, epilation Recovery; prolonged erythema and 






possible dry or moist 
desquamation 
Prolonged or permanent epilation; dermal 
atrophy / induration and skin likely to be 
weak in long term 
* Radiation Dose: measured as Entrance Surface Air Kerma (ESAK) 
3.34 Hair loss can also be a problem for patients undergoing neurological IR 
procedures. In an 8-year follow-up study of patients, hair thinning and hair loss was 
found to occur primarily in patients receiving a cumulative surface air kerma dose 
to the scalp of above 4.5 Gy (Corrigall and others 2020).  
Tissue reactions in the eye 
3.35 For many years it has been known that the lens of the eye is sensitive to cataract 
induction by radiation. A comprehensive review (ICRP 2012) of all the 
epidemiological and experimental data on cataract formation following radiation 
exposure, included data from the LSS, studies of Chernobyl accident liquidators, 
astronauts, medical patients and radiation workers. The data suggested that acute 
and protracted exposures were similarly deleterious and were consistent with the 
assumption either of a low threshold of around 0.5 Gy or of a non-threshold 
relationship. This threshold of 0.5 Gy is significantly lower than the previous values 
of 2 Gy for acute exposures and 4 to 5 Gy for fractionated and protracted 
exposures. The ICRP therefore recommended an annual occupational limit of eye 
lens exposure of 20 mSv (equivalent dose); more precisely, 20 mSv/year averaged 
over defined periods of 5 years, with no single year exceeding 50 mSv (ICRP 
2012). This change in the limit was supported by further review of the evidence by 
the Health Protection Agency (HPA) in the UK (Bouffler and others 2012). 
3.36 A recent extensive review (Ainsbury and others 2016) has evaluated the 
importance of a wide range of factors that are implicated in cataractogenesis 
resulting from exposure to low dose ionising radiation, but acknowledges that there 
is a need for further studies to reveal any true effect at low doses. Human studies 
show that radiation-induced changes in the eye lens result, primarily, in posterior 
subcapsular cataracts. A range of intracellular processes have been implicated, 
including oxidative damage, DNA damage/response pathways, telomeric effects, 
genetic background and intracellular communication. Latency periods are known to 
range from just over one year in a patient who has received high-dose radiotherapy 
(40 to 60 Gy), to many years at lower levels of exposure (Chodick and others 2008, 
Ainsbury and others 2009, ICRP 2012, Neriishi and others 2012). When exposure 
occurs in childhood, an increased risk of approximately 50 % for 1 Gy exposure to 
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the lens has been reported (Hall and others 1999). When exposed at age 10 years, 
children had an odds ratio of 1.44 at 1 Sv, which decreased significantly with 
increasing age of IR exposure (P=0.022) (Nakashima and others 2006).  
3.37 Radiation-induced cataracts are unlikely to occur in patients as they will normally 
only experience ionising radiation exposure on a few occasions during their 
lifetime, and with limited exceptions, primarily to areas moderately distant from the 
eyes. However, eye protection is advised if a patient is likely to receive a significant 
dose to the eye as in some INR procedures. Their exposures may increase if they 
are exposed to additional diagnostic ionising radiation imaging techniques (for 
example, CT scanning to the upper body area) and also if they receive 
radiotherapy in the region of the eye. 
3.38 Of particular concern, in relation to radiation-induced cataractogenesis, is the 
exposure of the staff team to this risk, since of necessity they are exposed to 
ionising radiation every time they work in the IR suite, and often regularly over 
months or years of a career in radiology. 
Tissue reactions in the cardiovascular system 
3.39 The radiation doses pertinent to IR and IC are unlikely to be sufficiently high to 
cause cardiovascular changes that result in overt symptoms in patients. However, 
it may be possible that unidentified changes could lead to a sensitivity of the 
cardiovascular system to other treatments (particularly repeated ionising radiation 
exposures and some forms of chemotherapy used in cancer treatments 
(Lenneman and Sawyer 2016, Zamorano and others 2016)). 
3.40 It is now clear that radiation exposure involves a dose-dependent risk of changes 
to the heart and vasculature (cardiovascular disease; CVD) that are apparent at 
both high (radiotherapy) and high (radiology) doses; these changes are normally 
manifested several years after treatment (ICRP 2012, Stewart and others 2013, 
Little 2016). At higher radiotherapy doses the risk of cardiac damage, though small, 
has clearly been shown (Jaworski and others 2013, Armanious and others 2018). 
Above 30 Gy the risk of CVD can manifest within one year of exposure (Darby and 
others 2010). Recent studies have also suggested that damage may result from 
lower doses relevant to IR procedures. Such effects have a longer latency period, 
normally over 10 years (Little 2016).  
3.41 The ICRP (2012) have concluded that a threshold dose as low as 0.5 Gy may 
apply to cardiovascular and cerebrovascular diseases which are caused by 
ionising radiation doses delivered to the vicinity of the heart and brain. ICRP 
indicated the need for medical practitioners to be aware that doses to patients of 
this magnitude can be reached during complex interventional procedures. In a 
meta-analysis of individuals exposed to whole-body low-dose radiation (< 0.5 Sv; 
or at a low dose rate < 10 mSv/day), it was shown that if the data are interpreted in 
terms of a LNT dose-response relationship, the resulting risks are of a similar 
magnitude to those inferred for cancer detriment at these doses/dose-rates (Little 
and others 2012, Little 2016). However, a recent review of clinical studies by the 
National Council on Radiation Protection and Measurements (NCRP) concluded 
that there is insufficient evidence that absorbed doses to the heart ≤0.5 Gy cause 
cardiovascular diseases (NCRP 2018). 
3.42 An analysis of the risk of death from circulatory disease in the LSS cohort (>86,000 
individuals) 50 years after exposure to estimated radiation doses of 0 to >3 Gy 
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(86% received <0.2 Gy), showed an elevated risk of both stroke and heart disease 
at doses above 0.5 Gy. The excess relative risk (ERR)/Gy for stroke was 9% (95% 
confidence interval 1% to 17%, P=0.02) and for heart disease was 14% (6% to 
23%, P<0.001). The dose-response effect in individuals exposed to <0.5 Gy was 
not significant (Shimizu and others 2010). A recent evaluation of the LSS cohort 
has also suggested an association between renal failure and radiation dose 
mortality; the renal dysfunction caused may, in part, also result in an increased risk 
of CVD (Adams and others 2012).  
3.43 The increase in heart disease associated with high (radiology) doses <5 Gy is 
markedly different from that associated with high (radiotherapy) doses (>20 Gy). In 
the latter group it is well recognised that raised levels of CVD are linked with 
atherosclerosis, primarily causing an increase in ischaemic heart disease and 
myocardial infarction. In the lower dose range associated with IR an increase is 
found in rheumatic heart disease, hypertensive and congestive heart failure. These 
latter pathologies can be attributed to defects in vascular perfusion, inflammatory 
and fibrotic tissue reactions; analyses of biological markers show evidence of 
persistent DNA damage, inflammatory markers and vascular damage consistent 
with the observed pathologies. Systemic effects causing raised cholesterol, blood 
pressure and inflammatory proteins may also contribute to increased risk of CVD 
(ICRP 2012, Stewart and others 2013, Baselet and others 2016). However, the 
evidence of an effect below 0.5 Gy is lacking, although this could be due to the 
difficulties of identifying a slightly elevated risk against an extensive background of 
heart disease attributable to other causes (Baselet and others 2016). 
3.44 In summary, although there is a marginal risk of CVD following radiation exposure 
during IR, the benefits of these procedures over alternative options indicates that 
this is not a reason for curtailment. However, awareness of these risks is important 
and should be factored into the patient pathway especially for younger age groups 
(see Chapter 8). 
Radiation exposure and age 
3.45 It is recognised that the lifetime risks of cancer (per Gy) following exposure to 
ionising radiation are higher in children than adults, although different cancer types 
show different age-at-exposure dependence (UNSCEAR 2013, Kutanzi and others 
2016). This greater sensitivity of children is mainly due to their significantly longer 
life expectancy and the fact that many of their tissues contain more rapidly dividing 
cells and may consequently be more sensitive to induction of stable mutations. In 
addition, children may receive doses to more organs and tissues, from the 
radiation beam and associated scatter (ICRP 2013b). 
3.46 Wall and others (2011) examined the variation of lifetime excess cancer risk with 
cancer type, sex and age at exposure. The cumulative risk of cancer incidence per 
unit organ/tissue absorbed dose (Gy) up to an attained age of 100 years was 
calculated separately for males and females and by category of age at exposure 
(10 age categories of 10 years, from 0 to 9 years to 90 to 99 years), for 11 different 
cancer types (female breast, lung, stomach, colon, bladder, liver, thyroid, 
oesophagus, ovary, leukaemia, and other solid cancer sites). Risk models were 
derived from the LSS cohort (Preston and others 2007), using ICRP (2007) 
methodology. To define baseline incidence rates, Wall and others (2011) used 
ICRP (2007) values for a Euro-American composite population. The results show 
that overall risks from radiation exposure when compared to those in the 30 to 39 
years age group, were about double in the youngest group (0 to 9 years) and 
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about half by age 60 to 69 years. However, the data also show substantial 
differences between cancer types and the contribution of the different cancer types 
to overall lifetime risk varies substantially with sex and age at exposure. The 
variations with age at exposure reflect cumulative lifetime risk of cancer incidence, 
so that reduction of risk with increasing age at exposure reflects mainly the 
reduction in remaining lifetime after exposure rather than a variation of sensitivity 
with age at exposure. Estimates of age and sex differences in cancer risks in a 
Japanese population, calculated using ICRP methodology, resulted in similar 
conclusions (Ogino and others 2016). 
3.47 A considerable body of data on radiation exposures in IR procedures in children 
comes from paediatric IC since these techniques have provided such major 
benefits to the treatment of patients with congenital heart defects. Studies have 
reported the average entrance surface dose to paediatric patients in IC to be 1 to 2 
orders of magnitude higher than common standard X-ray examinations (Li and 
others 2001, Kawasaki and others 2015, Kawasaki and others 2019). A study of 
the estimated effective radiation dose in >2,000 infants and children undergoing 
paediatric IC predicted that children may have a 4 to 8 times higher risk of 
radiation-induced cancer as compared to adults, with infants having the greatest 
risk. It should be noted that the level of increased risk is still very small and greatly 
outweighed by the benefits of the procedure (Rassow and others 2000).  
3.48 A review of available evidence of the risks of cancer following radiation exposure 
found no increase in children undergoing paediatric IC procedures although at the 
time of publication only 2 studies were available for consideration (Kleinerman 
(2006). More recently, no appreciable increased risk of cancer was found in 
children and young adults undergoing paediatric IC when all confounding factors 
were considered, although the follow-up period was relatively short (mean 8.4 
years) (Harbron and others 2018). In another recent retrospective analysis, an 
increased incidence of cancer was found within the first 15 years of life in children 
who underwent paediatric IC below the age of one year (Stern and others 2020). 
However, the study did not show a radiation dose-response relationship, and there 
was no link to any specific cancer types. In addition, no mention was made in the 
latter study of the incidence of transplantation, a factor known to strongly influence 
subsequent cancer risk (Harbron and others 2018). 
3.49 Several recent large studies have shown that adults with CHD have a small, but 
slightly increased risk of cancer that only becomes apparent after many years (Lee 
and others 2015, Gurvitz and others 2016, Cohen and others 2018b). What has 
been more difficult to identify in these studies are the main causative factors for 
this increase. Although it is possible that radiation exposure during treatment (often 
on multiple occasions over a lifetime and involving other imaging modalities) may 
be involved, this is currently not proven, and several other factors are known to 
make a contribution (Cohen and others 2018a, Danieli and others 2019). 
3.50 The HARMONIC project (Health Effects of Cardiac Fluoroscopy and Modern 
Radiotherapy in Paediatrics) is an ongoing large-scale pan-European retrospective 
study of long-term health effects of medical exposure to ionising radiation in 
children treated for cancer or cardiac defects. That part of the study dealing with 
cardiac exposures is designed to evaluate any dose response relationship 
between radiation exposure and health effects, and to investigate modifying factors 
(Harbron and others 2020). 
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3.51 One of the most important concerns in young females relates to the risk of 
developing breast cancer as a result of irradiation of the chest area.  
3.52 The evidence for an association of breast cancer with low dose irradiation comes 
from a variety of different sources. Girls treated for cancer in childhood with chest 
irradiation (median dose 14 Gy; range, 2 to 20 Gy) have a higher risk of 
subsequently developing breast cancer (Moskowitz and others 2014). This was 
supported by a later analysis, which also showed a higher incidence of death from 
other causes than in the matched control group (Moskowitz and others 2019). It 
should be noted that the radiation exposure to the breast in this group is likely to 
be much higher than children receiving interventional procedures, but these data 
indicate that cognisance should be made of the possibility of an increased risk of 
breast cancer in individuals exposed to interventional procedures to the chest 
during childhood. 
3.53 A dose response relationship was also found in female infants whose chest area 
was exposed to low dose radiotherapy for haemangioma with a mean absorbed 
dose to the breast anlage of 0.39 Gy (range <0.01 to 35.8 Gy). A significant dose-
response relationship was found for subsequent breast cancer, with an excess 
relative risk (ERR) of 0.38 at 1 Gy 95% CI 0.09 to 0.85). The ERR increased 
significantly with time after exposure and for ≥50 years, emphasising that this effect 
is present for many years and probably for life (Lundell and others 1996).  
3.54 Previously it was not uncommon for adolescents and young women to be 
monitored regularly for spinal disorders (Ronckers and others 2010) and for 
tuberculosis (Boice and others 1991) using low dose fluoroscopic imaging. The 
ERR per Gy for breast cancer incidence was 2.86 (P=0.058) in those monitored for 
scoliosis (mean dose to the breast was 120 mGy); this risk remained elevated for 
at least 5 decades following exposure. Risks of lung cancer and leukaemia, 
however, were not elevated in either of these 2 groups of patients (Davis and 
others 1989, Ronckers and others 2010).  
3.55 Patients with CHD may undergo interventional procedures which require significant 
imaging times and in a proportion of cases there is a requirement for further 
interventions during the patient’s life, often during their childhood and adolescence 
(Beauséjour Ladouceur and others 2016). In addition, it should be noted that, in 
recent years, patients with CHD are being exposed to increasing numbers of 
procedures involving radiation exposure and at a progressively younger median 
age, reducing from about 5 years to 9.6 months (Beauséjour Ladouceur and others 
2016). The cumulative exposure to radiation during these procedures will increase 
the risk of a radiation-induced cancer, particularly of the breast. 
3.56 Clearly the risks of open-heart surgery are considerably larger than those of PIC, 
even when this requires more than one catheterisation procedure. However, the 
available data underlines the necessity to keep the chest wall/breast dose as low 
as is possible, especially for young girls. One positive factor is a report showing a 
reduction in radiation doses during cardiac catheterisations in children primarily as 
a result of technological improvements (Harbron and others 2015). However, since 
exposure in childhood to even low doses of radiation may increase their life-time 
chance of developing cancer, every effort should be made to keep the radiation 
dose as low as possible commensurate with best clinical practice (Christopoulos 
and others 2016). 




3.57 The foetal central nervous system is particularly sensitive to ionising radiation. A 
foetal dose in excess of 100 mGy may result in a verifiable decrease in IQ, while a 
dose above 1 Gy will result in a high probability of severe mental retardation. The 
sensitivity is highest in weeks 8 to 15 post-conception. 
3.58 The excess cancer risk (up to age 15) for in utero irradiation from 3 to 4 weeks post 
conception is approximately 1 in 13,000 for a 1 mGy dose. This compares to a 
natural cumulative risk of childhood cancer over the same period of some 1 in 500 
(HPA 2009).  
3.59 Potential foetal dose must be considered for both staff (see paragraph 6.37) and 
patients (see paragraph 8.7).  
Radiation exposure and genetic susceptibility 
3.60 In the general population there is considerable variation in response to ionising 
radiation exposure for both stochastic effects and deterministic/tissue reactions. It 
is thought likely that one of the most important underlying factors affecting the 
inter-individual radiosensitivity is the presence of a variety of genes which influence 
the response to differing degrees. However, in healthy individuals, determination of 
the importance of genetic inheritance on an abnormally responsive phenotype is 
considered to be multi-factorial and difficult to elucidate (Applegate and others 
2020).  
3.61 In the last 4 decades a range of rare genetically-inherited conditions have been 
identified that are known to display a markedly increased sensitivity to radiation 
(Gatti 2001). The majority of the autosomal recessive conditions are very rare and 
only occur when an individual inherits a faulty gene from both parents. Diseases in 
this category include ataxia telangiectasia, Fanconi’s anaemia, Bloom’s syndrome, 
Werner syndrome, Nijmegen breakage syndrome and xeroderma pigmentosum 
(see Table 3.4). In most of these syndromes clinical radiosensitivity is clearly 
evident and is problematic for the use of diagnostic and therapeutic radiation in 
these individuals (Turnbull and others 2006, Demuth and Digweed 2007).  
Table 3.4 Examples of some genetic disorders characterised by genomic 
instability and predisposition to cancer (reproduced from COMARE’s 16th Report 
(COMARE 2014)) 











Primarily leukaemia and 










Multiple cancers of all 
types – in vitro studies 
show impaired accuracy 
of repair of double strand 
breaks in breast cancer 
cells in this syndrome‡ 
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WRN Critical for DNA 
replication and 
maintaining DNA 
at the end of 
chromosomes 
(telomere) 
Disruption in DNA 
replication, repair and 
transcription 
Sarcoma, melanoma and 
thyroid cancer 
Xeroderma 




activity, cell cycle 
abnormalities 
Basal cell carcinoma, 
squamous cell carcinoma 
and melanoma 
Xeroderma 





Recognition of bulky 
DNA adducts in 
nucleotide excision 
repair 
Basal cell carcinoma, 
squamous cell carcinoma 
and melanoma 
*  There are 7 interacting FA genes. 
†  Mismatch repair. There are several different MMR genes, inactivation of any one of which will give 
rise to the disorder. 
‡ Tachibana (2004). 
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3.62 The issue of radio-sensitivity in heterozygous individuals is much less clear, that is, 
they have one copy of the faulty gene associated with these autosomal recessive 
conditions. For example, ataxia telangiectasia is characterised by a marked 
radiosensitivity and an increased risk of lymphoid malignancies, but it is uncertain 
whether heterozygotes have increased radiosensitivity (Leong and others 2000, 
Taylor and others 2004). However, there is accumulating evidence that some 
heterozygotes may have an increased risk of breast cancer (Ahmed and Rahman 
2006, Renwick and others 2006). Despite considerable efforts to identity a 
bioassay to quantify the radiosensitivity of normal tissues for apparently normal 
individuals, so far none has been verified (Rajaraman and others 2018). 
3.63 There are also some dominantly-inherited autosomal conditions which predispose 
strongly to certain cancers. Gorlin syndrome is one example, which is 
characterised by development of basal cell carcinomas (BCCs) of the skin from a 
young age (Bresler and others 2016). Some reports suggest an increase in BCC 
within the radiation field following radiotherapy although since this is a rare 
syndrome the evidence is equivocal, except in the case of young children (Baker 
and others 2016). Adult patients with Gorlin syndrome appear to tolerate low dose 
radiation exposure for the treatment of BCC, although high dose radiotherapy is 
not normally advised (Baker and others 2016, Bresler and others 2016). 
3.64 Individuals with genetically-inherited syndromes that exhibit increased 
radiosensitivity also display a wide range of other symptoms, many of considerable 
severity. Moreover, many also manifest an increased susceptibility to cancer (see 
Table 3.4), which unfortunately may indicate the use of radiation requiring 
procedures/therapies. Most of these syndromes are rare. However, if a patient 
presents with one of these syndromes, caution should be exercised in the use of 
radiation-related procedures. Unless essential, procedures involving ionising 
radiation exposure, including IR procedures, should be avoided. Prior to the use of 
any procedure using radiation, it may be advisable to consult a clinical geneticist or 
expert in radiosensitivity disorders.  
Conclusions 
3.65 Ionising radiation is known to cause stochastic changes in DNA resulting in the 
possibility of a slightly increased risk of cancer development in the medium to long 
term following exposure at the doses used in IR. When germs cells are affected the 
genetic change induced will have a chance of being inherited in subsequent 
generations; however, the current evidence for this is limited to animal studies. 
3.66 For most interventional procedures the dose of radiation received by patients is 
very low and, with adequate safeguards, the benefits will be readily judged to 
outweigh the stochastic risks. However, there are some factors which need to be 
considered carefully. These are: 
a. The total dose – the higher the dose the greater the risk of a detrimental effect, 
though even at the higher doses associated with prolonged IR procedures the 
chances of a stochastic event causing cancer are still small. 
b. Age of the patient – older patients have a more limited risk for most detriments; 
however, younger patients have an increased lifetime risk of cancer because 
of their longer life expectancy and greater tissue radiosensitivity. 
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c. The organs or tissues exposed during the IR procedure. This especially 
applies to infants and children since, due to their small size, a wider range of 
tissues will be included within the radiation field. 
3.67 Radiation exposure also causes tissue reactions, normally observable only above 
a threshold of above 0.5 Gy (the exact threshold depends on the individual 
patient’s radiation sensitivity). This may be an issue for some patients and is more 
likely shortly after a prolonged IR procedure. 
3.68 Tissues that may be particularly affected by tissue reactions in IR procedures are 
the skin, the lens of the eye and the cardiovascular system, although cataract and 
CVD may not conform to the classical definition of effects occurring above a dose 
threshold. Any risks at lower doses will be very small.  
3.69 The treatment of paediatric patients for a range of conditions (especially CHD), has 
been revolutionised by the development of IR protocols. These patients are often 
treated very successfully using IR early in their life. Currently there is no specific 
evidence that this may increase their lifetime risk of a subsequent malignancy. 
Further research and awareness training are required to ensure that the radiation 
dose used during IR on paediatric patients is kept to a minimum. Clinical protocols 
need to be closely evaluated to ensure that best practice is being implemented 
(discussed further in Chapter 5). 
3.70 There is also a concern over the cumulative dose received by staff during IR 
procedures since they are exposed on many occasions over a working life. 
Awareness training is crucial in the education of all the staff involved, especially as 
there is an increasing range of specialists using IR techniques.  
3.71 Genetic susceptibility syndromes are rare. However, practitioners should be aware 
of the full range of these disorders and seek advice should they need to treat an 
affected patient. 
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Chapter 4: The UK Radiation Protection 
Framework 
Radiation protection of staff and patients 
4.1 Protection of the patient in radiology is regulated in the UK by the Ionising 
Radiation (Medical Exposure) Regulations 2017 (IR(ME)R 2017) and the Ionising 
Radiation (Medical Exposure) Regulations (Northern Ireland) (IR(ME)R(NI) 2018), 
while protection of staff and members of the public is regulated by the Ionising 
Radiations Regulations 2017 (IRR 2017). 
4.2 Under these pieces of legislation, the over-riding requirement is that any human 
radiation exposure, irrespective of level, should be As Low As Reasonably 
Practicable (ALARP). This leads to the principle of optimisation. In the international 
literature, the term As Low As Reasonably Achievable (ALARA) is used but this 
carries the qualifier ‘economic and social factors being taken into consideration’. 
UK legislation and regulation use ALARP.  
4.3 A second common principle is that of justification, which states that no practice 
involving exposures to radiation should be adopted unless it produces sufficient 
benefit to the exposed individuals or to society to offset the radiation detriment it 
causes.  
4.4 Many IR procedures are life-saving and are performed in patients who are not 
suitable or fit enough to undergo surgery. The benefit greatly outweighs the risks of 
exposure to the dose of radiation involved. 
4.5 Many procedures are carried out on older patients in whom exposure to the 
radiation dose involved carries a very small risk of consequent complications, 
whereas the benefits to this group can be very significant. In some cases, 
procedures are performed in patients with limited life expectancy when radiation 
risk is even less of a consideration.  
4.6 Of more concern is the use of IR in paediatric and adolescent patients, although for 
many reasons the benefits greatly outweigh the risks (discussed in more detail in 
Chapter 2). 
4.7 Overall, there is a need to protect the patient from unnecessary exposure to 
radiation with the acknowledgement that the clinical benefits normally outweigh the 
risks, and radiation exposures are likely to occur on a very few occasions during 
the life of most patients. Staff on the other hand, spend several days a week in the 
operating theatre and hence there is a different set of priorities when evaluating the 
best way to protect them from the long-term risks of radiation exposure. 
4.8 Many of the techniques that can be used to reduce patient exposure will also result 
in the reduction of radiation dose to staff. 
The Ionising Radiations Regulations 2017 (IRR17) 
4.9 These Regulations are made under the Health and Safety at Work Act 1974 and 
are enforced by the Health and Safety Executive (HSE). 





4.10 Staff receive no direct benefit from the radiation to which they are exposed and 
should be provided with suitable systems of work, protective equipment and a 
working environment that ensures that their radiation doses are kept as a low as 
practicable. Staff must receive training in radiation protection and in techniques to 
reduce their exposure to radiation. All potential exposures to radiation should be 
risk assessed.  
4.11 Staff are subject to dose limits that are the legal upper limit on exposures (that is, 
breaching the dose limit is an offence) and which, in the normal course of events, 
should not be approached during their employment. If there is a likelihood of 
exceeding three-tenths of a dose limit (or the 15 mSv constraint for the eye), the 
individual should be designated as a classified radiation worker. The radiation 
doses of classified staff carrying out IR procedures should be monitored by 
methods and systems approved by HSE (an approved dosimetry service) and it is 
usual for these same methods to be used for non-classified staff. If the employer 
instructs employees to wear personal dosimetry or protective equipment, its use is 
mandatory. 
4.12 The main issues for staff to consider when performing an IR procedure are  
(i) protection of themselves and other employees from radiation to a degree 
that is As Low As Reasonably Practicable (ALARP)  
(ii) limiting exposure of the patient to radiation, also to a level that is ALARP  
(iii) limiting exposure of members of the public, who are not patients, to a level 
which is ALARP 
(iv) performing a successful procedure in a safe manner.  
There is frequently a degree of overlap between the above and consideration of 
one issue will invariably affect another.  
4.13 The Ionising Radiations Regulations 2017 (IRR 2017) explicitly require that every 
employer engaged in work with ionising radiation such as IR must make 
appointments as follows. 
Radiation protection adviser (RPA) 
4.14 The employer must appoint one or more suitable radiation protection advisers 
(RPAs), who must be consulted on the observance of IRR17. The RPA must have 
a detailed understanding of radiation protection in the context of IR and the 
requirements of the regulations, and must have appropriate certification to confirm 
their competence to act as an RPA. The employer must provide their RPAs with 
adequate information and facilities for the performance of the functions. The role of 
the RPA is to provide advice on the requirement of the regulations and the duty of 
compliance remains with the employer. 
Radiation protection supervisor (RPS) 
4.15 The IRR17 (2017) explicitly require that all employers who work with radiation in a 
controlled or supervised area (as defined in these regulations) must draw up local 
rules that identify the main working instructions necessary to restrict exposure in 
that area. The employer must then appoint one or more suitable radiation 
protection supervisors to secure compliance with the local rules when work 





involving radiation is performed. The particular role of the radiation protection 
supervisor (RPS) is to supervise the arrangements set out in the local rules, which 
themselves should identify the RPS. The RPS must consequently have an 
understanding of IRR17 and the local rules and should also command sufficient 
authority to enable them to perform their task effectively. However, overall 
responsibility for compliance with IRR17 always remains with the employer, who 
has a duty to provide the RPS with the appropriate resources required to perform 
their role. 
4.16 Frequently the RPS is tasked with more than overseeing the work performed to 
ensure that it is carried out in accordance with the local rules. However, many of 
these tasks more properly rest with local management unless the RPS is part of 
that management and the appointment of RPSs does not relieve local 
management of their role in radiation protection. Typical tasks involve organisation 
and distribution of personal dosemeters, review of personal dosemeter results, 
periodical assessment of safety and warning systems, participation in the 
arrangements for prevention, preparedness and response for emergency exposure 
situations, investigation of incidents involving unforeseen exposure to radiation, 
ensuring safe storage of PPE, keeping records of inspection of PPE and 
commenting on proposals for changes in work practices. The RPS and local 
management should also work closely with the RPA and should contribute to the 
radiation risk assessments required by IRR17. 
The Ionising Radiation (Medical Exposure) Regulations 2017 (IR(ME)R 2017) and 
The Ionising Radiation (Medical Exposure) Regulations (Northern Ireland) 2018 
(IR(ME)R(NI) 2018) 
4.17 In England, Scotland and Wales, the IR(ME)R (2017) apply to exposures carried 
out using medical radiological equipment. In Northern Ireland the same function is 
performed by the IR(ME)R(NI) (2018). Both regulations place significant onus on 
employers to ensure that there is compliance in the workplace.  
4.18 Patients are not subject to dose limits under IRR17 because they are expected to 
receive a benefit from a radiological procedure. Before an imaging procedure can 
be carried out it must be shown that the benefit to the patient outweighs any 
radiation risk. This first step is termed justification. As will be described in more 
detail in Chapter 7, once an examination has been justified the imperative is to 
produce images that are of sufficient quality for the clinical task or question at hand 
whilst delivering the minimum radiation dose to the patient. This second step is 
termed optimisation. The justification and optimisation of all patient imaging 
procedures are legal requirements. Both are critical elements in the protection of 
the patient. 
4.19 The IR(ME)R do not require employers to formally notify any authority of their 
activities in interventional radiology; this is a requirement of IRR17. 
4.20 The regulations put the onus on the employer to identify and entitle the duty 
holders listed below and to determine their scope of practice. 
a. A Practitioner is a registered health care professional who is entitled by their 
employer to justify and authorise individual medical exposures.  
b. A Referrer is a registered health care professional (medical or dental 





practitioner or other health care professional) who is entitled by their 
employer to refer individuals to a Practitioner for a medical exposure. The 
employer must establish referral guidelines. 
c. An Operator is any person who is entitled by their employer to carry out 
practical aspects of a medical exposure which may affect the patient’s 
radiation dose. 
4.21 The regulations also identify a list of binding matters that must, as a minimum, be 
identified in the employer’s IR(ME)R procedures. Examples are the provision of 
arrangements for: entitling duty holders, correctly identifying patients, providing 
adequate information to patients, obtaining expert advice, recording patient dose, 
recording and reporting unintended or accidental exposures, justification of 
exposures and optimisation of exposures.  
4.22 The regulations require that all exposures should be justified by a practitioner prior 
to any exposure taking place (see paragraph 4.3). In IR, the decision on any 
individual patient will be influenced by the patient’s clinical history and the 
appropriateness of the request, the question of whether the examination will 
contribute to or change the individual’s healthcare management and consideration 
of whether there are alternative techniques that would achieve the same result 
without involving ionising radiation. Optimisation (see paragraph 4.2) of patient 
exposures means ensuring that patient doses are kept as low as reasonably 
practicable without compromising the intended outcome, which in the case of 
interventional radiology is the therapeutic outcome. Any initiative to reduce patient 
dose will generally result in a reduction of radiation dose to staff.  
Medical Physics Expert (MPE) 
4.23 The IR(ME)R explicitly require that every employer engage in work with ionising 
radiation such as IR appoints one or more suitable MPEs with expertise in 
diagnostic radiology. In terms of the regulations, MPEs are classed as operators. 
MPEs are required to give advice on:  
• dosimetry and quality assurance matters relating to radiation protection 
concerning patient exposures; 
• physical measurements for the evaluation of dose delivered to patients; 
• operating characteristics and requirements of medical radiological equipment. 
4.24 IR(ME)R17 and IR(ME)R(NI)18 require the MPE to contribute to the following: 
• optimisation of the radiation protection of patients and other individuals subject 
to exposures, including the application and use of diagnostic reference levels; 
• the definition and performance of quality assurance of radiology equipment; 
• acceptance testing of radiology equipment; 
• the preparation of technical specifications for radiology equipment and 
installation design; 
• the surveillance of the medical radiological installations; 
• the analysis of events involving, or potentially involving, accidental or 






• the selection of equipment required to perform radiation protection 
measurements; 
• the training of practitioners and other staff in relevant aspects of radiation 
protection; 
• provision of advice to an employer relating to compliance with IRMER 2017. 
Conclusions 
4.25 As set out in IR(ME)R 2017, IR(ME)R(NI) 2018 and IRR 2017, the over-riding 
requirement is that any human radiation exposure should be As Low As 
Reasonably Practicable. All procedures must be optimised to ensure that the 
radiation dose to patients and staff is kept to a minimum consistent with a 
successful clinical outcome. 
4.26 Prior to execution, all procedures must be justified, demonstrating that benefits to 
the patient outweigh any detriment. 
4.27 Staff must be provided with suitable systems of work, protective equipment and 
adequate training. Classified workers must be must monitored by a dosimetry 
service approved by HSE to ensure that their radiation doses remain within 
statutory limits; it is usual to utilise such services for non-classified workers also. 
4.28 Employers engaged in IR are required to appoint one or more of each of the 
following duty holders – radiation protection adviser, radiation protection supervisor 
and medical physics expert. 
 
  





Chapter 5: Radiation protection of the 
patient 
Patient protection 
Types of procedure 
5.1 The majority of IR procedures currently performed are listed in Table 2.1. These 
involve a wide range of radiation exposures, although all are very much lower 
when compared with therapeutic doses used for cancer therapy. Typical high 
patient dose IR procedures include: TIPS (transjugular intrahepatic porto-systemic 
shunt creation), embolisation (neuro and non-neuro) and stent procedures 
(visceral, renal). More recently established techniques which result in relatively 
high patient doses include aortic stent insertion (EVAR, thoracic endovascular 
aortic repair (TEVAR), fenestrated endograft (FEVAR)), trans-arterial 
chemoembolisation and SIRT. In contrast, many procedures only expose patients 
to a very low radiation dose, for example, inferior vena cava (IVC) filter insertion, 
pulmonary angiography or nephrostomy insertion for renal obstruction. The total 
dose received by the patient is often dependent on the time it takes to carry out the 
procedure.  
Measures to reduce patient exposure 
5.2 As outlined in Chapter 3, IR procedures carry a risk of inducing both deterministic 
and stochastic effects so vigilance in all aspects of patient protection is required.  
5.3 IR procedures vary considerably in the time they take to perform. Where possible 
the radiation source is turned off to reduce exposure since any prolongation of 
exposure, beyond that which is absolutely necessary, results in an increase in risk 
to the patient and also to the operator and support staff. 
5.4 Examples of the variable time to perform IR procedures include: (i) lower limb 
angioplasty, central venous catheter insertion or fistuloplasty - these may take less 
than 30 mins to perform and will probably only involve 2 to 10 mins screening time; 
and (ii) a GI bleed embolisation procedure - this may take 1 to 2 hrs with 30 to 60 
mins screening time. 
5.5 The experience and skill of the interventionalist performing a procedure is also an 
important factor in determining its duration. Less experienced consultants and 
trainees may take longer to identify an abnormality and manipulate a catheter into 
position. They may also incur greater personal exposure while performing a 
procedure due to focusing on technical aspects and anatomy. 
5.6 The factors affecting patient dose are listed in Table 5.1 and their impact on patient 
dose is discussed below. 
5.7 All X-ray equipment is required to incorporate a minimum of 2.5 mm aluminium 
filtration to remove the low energy component of the X-ray spectrum that does not 
contribute to the image. Additional filtration of between 0.1- and 0.5-mm copper 
can be introduced in modern IR systems to reduce the entrance surface dose to 





the patient and thus reduce the risk of inducing tissue reactions. The disadvantage 
is that there may be some loss in image contrast. However, experienced 
practitioners will be able to balance the need for an adequate image to perform the 
procedure successfully with the need to minimise the radiation dose delivered. 
When contrast agents, such as barium or iodine, are employed in angiographic 
procedures, judicious use of such filters will result in enhanced contrast of the 
vessels being studied. 
5.8 The use of short pulses of radiation results in sharper images and when combined 
with reduced frame rates can also result in lower patient doses for the same 
perceived image quality. 
5.9 Use of last image hold freezes the last frame viewed on the display and thus allows 
detail to be viewed without exposing the patient. It is also possible to use video 
loop technology, in which a number of frames are stored automatically to permit a 
video version of last image hold. 
5.10 Carbon fibre couch tops are generally available on all IR equipment and result in 
reduced patient exposure because they have reduced X-ray attenuation compared 
to conventional couches. 
5.11 Modern flat panel detectors have the advantage of generally better dose efficiency 
when compared to older TV based image intensifier equipment; this results in 
lower radiation doses to patients. Their use requires much less of an increase in 
dose when used in magnification mode and they have better spatial resolution, 
with consequent better visualisation of detail.  
5.12 Reduction of the area of tissue exposure using beam collimation can help reduce 
the extent of tissue reactions in prolonged procedures. It will also improve image 
quality by reducing the amount of scattered radiation and reduce the effective dose 
to the patient. Staff need to be constantly made aware during training of the 
importance of this issue and its importance for the safety of the patient and 
themselves, so that it becomes an automatic component of their practice. 
5.13 Virtual collimation, which allows the X-ray collimators to be moved using last image 
hold images for guidance, results in reduced patient exposure. 
5.14 Anti-scatter grids placed between the patient and the detector result in improved 
image quality by removing X-rays obliquely scattered from within the patient before 
they interact with the detector. However, their use results in increased patient 
dose. The grid or Bucky factor is the dose increase factor associated with the use 
of the grid and is typically in the range 2 to 6 (Poletti 2014). Anti-scatter grids 
should be removed when imaging small/paediatric patients or thin body parts 
(McFadden and others 2013b, Jones 2014). Grid removal should also be 
considered when the detector cannot be placed close to the patient (Partridge and 
others 2006, Gould and others 2017, Roy and others 2017). 
5.15 The use of image magnification will increase patient dose (Nickoloff 2011). In 
traditional image intensifier TV systems, the relationship obeyed a square law, that 
is, a factor of 2 magnification will result in an increase in tube output by a factor of 
4. In modern flat panel systems, the increase should be much less pronounced – it 
is imperative that this is confirmed to be the case by the MPE when IR equipment 





is first accepted and commissioned. 
5.16 The image receptor should be placed as close to the patient as possible and the X-
ray tube kept as far as possible from the patient. Air gap techniques should not be 
employed. In lateral and oblique projections, the X-ray tube can be closer to the 
patient than for a posteroanterior view. Spacers are supplied with IR equipment 
and should be used since their removal can lead to an increase in patient entrance 
dose by 100% (Jones 2014). 
5.17 Patient size affects both patient dose and image quality and this should be 
remembered when undertaking IR procedures. As patient size increases, patient 
dose (and therefore staff dose) inevitably increase and image quality decreases 
because of the additional amount of scatter generated in the patient volume. As 
patient size increases, X-ray generator considerations mean that it might not be 
possible to introduce additional copper filtration, resulting in an increased risk of 
inducing tissue reactions. 
5.18 Radiation dose can also be reduced by modifying tube angulation (see paragraph 
6.14), especially useful when fluoroscopy times are prolonged. Staff awareness of 
this adaption is important and will require discussion between the technician or 
radiographer and the interventionalist performing the procedure, who will normally 
be focused on more clinical patient-related aspects. The variation of tube 
angulation during the procedure will change the beam entrance area and therefore 
will reduce potential skin radiation damage (see paragraph 5.36). 
5.19 The number of ‘cine’ runs (for example to follow contrast) should be kept to the 
minimum required for the procedure since these employ a much higher tube 
current than fluoroscopy. 
5.20 In persons of childbearing age, potential pregnancy must also be considered. 
Some procedures may be performed with no exposure of the foetus. However, 
where the foetus may be exposed, techniques should be used to keep the foetal 
dose as low as reasonably practicable, but patient contact shielding is not 
generally recommended (BIR 2020).  
5.21 Repeat procedures are occasionally required, that is, an initially successful 
embolisation may require further treatment or an aortic stent may not have 
successfully sealed an aneurysm. Paediatric patients may also need repeat IR 
examinations / therapeutic interventions. Where possible, sufficient time should be 
allowed before the next procedure is performed to reduce the risk of tissue 
reactions, although this is not always possible. Again, risk versus benefit needs to 
be considered by the clinical team. Some procedures are deliberately staged for 
this very reason.  
5.22 Pre-treatment planning as part of a multidisciplinary team approach can reduce 
patient exposure. Interventional Radiologists now have extensive prior 3D patient 
imaging data available, which allows them to plan procedures much more 
precisely. This results in more efficient use of their time in the IR theatre and in 
many instances can help to reduce overall procedure time and hence radiation 
exposure. However, pre-procedure imaging can involve the use of multiple CT 
scans. Although the amount of radiation exposure can be reduced by using, where 
applicable, ultrasound and MRI, CT remains the most frequently used assessment 





tool depending on the anatomical site thus adding, to some extent, to the overall 
radiation exposure of the patient. 
Considerations for paediatric patients 
5.23 The use of IR for paediatric patients is increasing in frequency, and also in the 
complexity and length of the procedures (McLaren 2014, Kim 2017). ICRP and 
others recommend that major paediatric interventional procedures, particularly in 
small infants, should be performed by experienced paediatric interventional 
operators for both clinical and radiological protection reasons (RCR 2010, ICRP 
2013b, Donaldson 2017). 
5.24 In neonates, infants, and small children, the detector may well cover the patient 
completely and therefore has the potential to increase radiation exposure if 
collimation is not used appropriately (EC 2000, ICRP 2013b).  
5.25 Techniques used for paediatric IC may require significant modification from those 
used for adult patients (Connolly and othersl 2006, Kim 2017). Most of published 
data on the modifications of technique required for paediatric patients concentrate 
on paediatric IC (Anderson and others 2009), but similar modification principles will 
also apply to all paediatric interventions (Willihnganz-Lawson and others 2014).  
5.26 The variation in protocols and radiation dose for performing PIC can be attributed 
to a variety of parameters that may need modification to adapt to the different size 
of paediatric patients; many of the required changes can increase radiation 
exposure significantly (Hellinger and Pezeshkmehr 2015, Harbron and others 
2016, Osei and others 2016). For example, it may be necessary for the physician 
to stand closer to the paediatric patient due to the small size of patient. It is also 
quite possible that the detector will be bigger than the child and completely cover 
the patient’s body, requiring the physician to work close to the child to get access 
to the body.  
5.27 Increased use of magnification is required when imaging paediatric patients to 
enable visualization of the small area of interest. This is of potential great 
significance especially in older image intensifier TV systems (see paragraph 5.15).  
5.28 In PIC the higher heart rate of the patient often requires higher frame rates for 
digital acquisition. All of these factors will significantly increase the radiation dose 
to the child and the scatter radiation to staff (Harbron and others 2016).  
5.29 Work by the DIMOND group set ‘image quality’ criteria for cardiac images as a 
guide to how angiograms should appear using good techniques. DIMOND III 
(Bernardi and others 2008) provided a review of these criteria and incorporated 
‘aspects of an optimised angiogram’ into the revised guidelines. Further methods 
applicable to PIC have been recommended by Pirault and others (2014). This 
aspect of optimised technique takes into consideration the use of wedge filters on 
bright overexposed areas, frame rates, the number of sequences and images per 
sequence. 
5.30 The DIMOND group guidelines address the more common projections for imaging 
of the coronary arteries in IC, and the most pertinent recommendations for 
paediatric patients are: 





• A frame rate of 25 to 30 frames per second is recommended if the heartbeat is 
faster than 90 to 100 beats per minute or for paediatric patients. 
• Increased numbers of imaging sequences can be used when the patient has 
anatomical anomalies which lead to difficulty (as in congenital anomalies). 
5.31 A prospective study on paediatric IC has identified wide inter and intra hospital 
variation for similar examinations (McFadden and others 2013c). Technical and 
procedural variations between clinical centres have been identified as one of the 
main contributors to dose variations during IC procedures. Some clinical centres 
were reported to routinely remove the anti-scatter grid for patients under 10 kg, 
whilst others do not. This single change of removing the anti-scatter grid can result 
in a significant dose reduction with no compromise to image or procedural quality 
(Ubeda and others 2013). However, at present there are no national guidelines 
detailing standard protocols for paediatric IC; their provision could implement this 
important modification. 
Considerations in Interventional Cardiology 
5.32 The doses received by patients during fluoroscopically guided cardiology 
procedures can be high, and some patients may have several procedures 
performed in a relatively short period of time (ICRP 2013a).  
5.33 Tissue reactions can occur if the dose thresholds for tissue reactions are exceeded 
(see Chapter 3). For IR procedures, the main tissue reaction of concern is skin 
injury, so a major thrust of patient protection is the avoidance of these injuries. 
Trigger levels and follow up should be established in individual centres (see 
Chapter 7). 
5.34 The mean age of patients undergoing PCI is relatively high. The risk of stochastic 
effects is not a great concern for older patients because of the latency period (10 
years or more) for the development of most cancers, and these patients’ shorter 
life expectancies (ICRP 2013a). 
5.35 Patients who undergo electrophysiology (EP) procedures tend to be younger, so 
the risk of stochastic effects in this cohort is of greater potential concern. 
5.36 As with all IR, attention should be paid to the dose reduction methods listed in 
paragraphs 5.2 to 5.22. Operators should avoid steeply angulated projections 
(especially left anterior oblique cranial) as much as possible and vary the C-arm 
angulation slightly to avoid irradiating a single site on the patient’s skin.  
Patient radiation dose measurements 
5.37 The measurement of radiation dose received by a patient is very difficult process. 
Image clarity is normally improved with increasing dose but at the cost of 
increasing patient dose exposure. 
5.38 There is a wide range of doses associated with IR procedures with many having 
cumulative air kerma (CAK) values less than 1 Gy with no risk of skin reactions and 
very low effective doses. On the other hand, complex procedures such as 
endovascular repair of abdominal aortic aneurysms (EVAR), which will commonly 
have prolonged procedural times, can deliver CAKs of 5 to 10 Gy and effective 
doses of 20 to 70 mSv. Moreover, some protocols will mandate abdominal and 





pelvic CT scan follow-up at 1, 3 and 12 months that will contribute a significant 
additional radiation dose to the patient (Kirkwood and others 2018). 
5.39 Patient dose in IR depends on many factors such as the radiation field size, patient 
position, beam on time and radiation detector (see Table 5.1). 
Table 5.1: Factors affecting patient dose in IR. 
Factors affecting patient dose in IR 
Automatic dose rate control 
Beam filtration 
Beam on time or pulse repetition frequency  
Couch material (X-ray attenuation) 
Detector sensitivity 
Examination area 
Field size / Beam collimation 




Patient to detector distance 
Patient to X-ray tube distance 
Time of exposure (sec or min) 
Tube angulation 
X-ray tube voltage (kV) 
X-ray tube current (mA) 
 
5.40 Dose meters such as ionisation chambers measure the amount of energy released 
by incoming X-ray photons rather than the amount of energy actually deposited. 
Because these can be different, the quantity used to calibrate the ionisation 
chambers is called kerma (kinetic energy released per unit mass), which 
approximates to absorbed dose but is not the same. Air kerma is measured with a 
dose meter that has a calibration traceable to a primary standard. The KAP 
(sometimes referred to as dose area product, DAP), is the integral of the air kerma 
over the area of the X-ray beam perpendicular to the central X-ray beam axis 
(ICRU 2005). X-ray tube output is given as the air kerma, measured in Gy, on the 
central beam axis at a certain distance, typically 1 m from the focal spot, and 
normalised to the product of tube current and exposure time with units of Gy/mAs 
(ICRU 2005). 
5.41 The incident air kerma (IAK) is the air kerma on the central axis from the incident 
X-ray beam at the focal spot-to-surface distance, where the patient or phantom 
would intersect the beam. The IAK is measured free-in-air without the presence of 
the patient or phantom. The IAK can also be estimated from the X-ray tube output 
using the inverse squared law with the distance.  





5.42 The entrance surface air kerma (ESAK) is a measure of the dose to the patient’s 
skin at the centre of the X-ray beam. It is recorded in terms of air kerma and the 
value is similar to that in tissue. ESAK can be calculated by measuring IAK with a 
dosemeter at the distance where the beam would enter the patient, and then 
multiplying by a backscatter factor to account for radiation scattered from within the 
patient. The backscatter factor depends on the X-ray spectrum, patient, field size 
and other parameters (Grosswendt 1990, Petoussi-Henss and others 1998, Martin 
and Sutton 2015). A small dosemeter placed directly on the skin can also provide a 
direct measurement of this quantity; this is not done in routine clinical practice for 
simple, practical reasons. 
5.43 Reference or cumulative air kerma (CAK) at the patient entrance reference point is 
a term reserved for fluoroscopic procedures. It is intended to represent the total 
IAK delivered to a reference point approximating to the patient’s entrance surface 
during a procedure. It is used as an indicator of skin dose and as an aid to the 
avoidance of causing tissue reactions during an intervention. As it is specified for a 
fixed position it does not take movement of the X-ray tube into account. 
5.44 The radiation protection quantities effective dose and organ dose (see Chapter 3) 
cannot be measured directly. Instead they must be derived using data obtained 
from computational models applied to mathematical phantoms. To do this the 
radiation field must first be described using physical parameters of the type 
outlined above and then converted to the radiation protection quantities. 
Conversion coefficients can then be derived that connect the physical and radiation 
protection radiation field parameters. 
5.45 The conversion coefficients are derived using reference computational phantoms, 
for an adult male and adult female defined by ICRP (ICRP 2009a). These are voxel 
phantoms, derived from real persons, with the average organ masses as defined in 
ICRP Publication 89 (ICRP 2002). Exposure scenarios are simulated with the voxel 
phantoms and Monte Carlo radiation transport codes used to compute organ doses 
and thence derive conversion coefficients. Organ doses derived using these 
phantoms, DT,R, are generally presented as the average of the adult male and 
female organ doses, and these are used to calculate effective dose. Simpler 
geometric anatomical phantoms have been used for this type of calculation in the 
past, and some of the data that are still used at this time were derived using these 
phantoms. Voxel based paediatric phantoms are also available from ICRP (2020) 
and can be used to derive appropriate conversion factors. 
Peak Skin Dose 
5.46 Peak skin dose is the maximum skin dose experienced by any section of the skin 
surface during an interventional examination and is the most useful quantity for 
estimating the risk of a deterministic skin injury. In practice, skin dose is complex 
and time consuming to measure (Balter 2006, Krajinović and others 2020) and the 
decision to do so must be made before a procedure actually starts (Jones and 
Pasciak 2011). It is therefore commonly calculated indirectly, either by vendor 
specific real time solutions (Bednarek and others 2011, Bordier and others 2015, 
Rana and others 2016) or using offline calculation. Indirectly calculated 2 and 3 
dimensional maps of skin dose can be overlaid on the patient image to show the 
areas where doses are highest. The maps can be colour coded and although there 
is currently no agreed standard, work is being done towards the development of an 






5.47 Real time systems use proprietary information derived from the equipment itself 
coupled with ray tracing algorithms (Bednarek and others 2011, Rana and others 
2016), and are manufacturer specific. Data for offline calculation should ideally 
come from the Radiation Dose Structured Report (RDSR). However, such 
calculations are theoretically possible using image DICOM headers provided that 
information can be obtained from manufacturers about their use of vendor specific 
attributes in the headers (Krajinović and others 2020). The uncertainty in calculated 
peak skin dose can be up to +/- 50% (Balter 2006, Jones 2014, Dabin 2020). 
5.48 Indirect calculation of skin dose is not trivial since it involves analysis of every 
irradiation event in a procedure, modelling of the patient in some way and ray 
tracing. In addition, whilst the position of the imaging table can be precisely 
defined, the precise location of the patient on the table is unknown. All of these 
details contribute to the significant uncertainty already mentioned. Many of the 
approaches used for calculating peak skin dose use a method comparable to that 
proposed by Jones and Pasciak (2011) for systems that are compliant with IEC 
standards (Malchair 2018).  
5.49 The methodology involves implementation of an equation of the form 






where SD is the skin dose, Ka,r is the air kerma at the IEC reference point, Ma is the 
attenuation introduced by the table top and mattress, BSF is the back scatter 
factor, (SPD/SID)2 is a distance correction and fskin is the ratio of mass-energy-
absorption coefficients from skin-to-air. SID is the source IEC reference point 
distance and SPD is the source peak skin distance. Further uncertainty is added 
because of errors in the determination of BSF, Ma and fskin. 
Radiation Dose Structured Report 
5.50 The RDSR is a DICOM information object that records data from interventional 
(and other) procedures. An RDSR object is like an image, with the major difference 
that it does not contain pixel data; instead it contains structured information 
organised in a hierarchical tree structure (Omar and others 2016, AAPM 2019). A 
vast amount of information is stored in the RDSR structure, including data that is 
general for all irradiation events, such as device serial number and performing 
physician, and also data that is specific for each irradiation event, such as tube 
voltage and beam angle (Sechopoulos and others 2015, Hellström 2018). RDSR 
support on equipment used for interventional radiology was mandated by IEC in 
2010 (IEC 2010) and should be available on all equipment subsequently 
manufactured. An entire interventional fluoroscopic sequence involving one pedal 
press will be included in the RDSR as a single irradiation event (Sechopoulos and 
others 2015). For example, if a particular interventional examination requires the 
exposure pedal to be pressed 15 times, 15 individual irradiation events are 
captured. However, there are many attribute fields in the RDSR that are optional 
rather than mandatory (NEMA 2021) and each manufacturer has also taken 
advantage of the possibility to adapt the standard with so-called ‘private fields’ 
(Malchair 2018). There are consequently many differences between the structured 





reports provided by different vendors, which makes the task of interrogating them 
even more complex. 
5.51 An RDSR reader is necessary to covert the DICOM object data into a form that is 
generally accessible. Radiation dose management systems typically enable RDSR 
data to be viewed, manipulated and exported. It should also be noted that current 
PACS (picture archiving and communication system) solutions rarely have an 
RDSR reader, and some legacy PACS cannot even store the RDSR (AAPM 2019). 
There are open source solutions, for example OpenRem3, which also has a simple 
skin dose assessment package.  
5.52 AAPM (2019) recommend that a physicist needs to verify that radiation generating 
equipment has the capability of generating a correct RDSR as part of the 
acceptance test, or as part of a software upgrade for RDSR functionality. In the UK 
context, if hospitals intend to use these reports as a record of aspects of individual 
patient exposure, then all data therein must be validated, and that validation should 
be verified by the MPE carrying out the acceptance check.  
5.53 Understanding of DICOM and RDSR should be a requirement for medical 
physicists involved in optimization of all radiology equipment.  
Conclusions 
5.54 Modern IR systems utilise a pulsed X-ray beam, flat panel detectors and a carbon 
fibre couch, which permit lower patient doses than older equipment. 
5.55 Differences in techniques and procedures between clinical centres are a major 
contributor to dose variations during IC procedures. A range of techniques, 
including tube angulation, beam collimation and last image hold, can be 
manipulated to reduce patient dose. Particular effort should be made in the case of 
paediatric procedures, as at present there are no national guidelines detailing 
standard protocols for paediatric IC. 
5.56 Attendance at MDTs and utilisation of prior 3D diagnostic imaging will permit the 
operator to plan procedures more precisely. 
5.57 Patient radiation dose depends on a large number of factors (see Table 5.1) and is 
a complex process, which starts with the measurement of air kerma. The radiation 
protection quantities effective dose and organ dose are then derived using 
computational models. 
5.58 RDSR capability, first mandated by IEC in 2010, should be included in all systems, 
ensuring the capability to download to local PACS. Attempts should be made to 
achieve international standardisation. 
5.59 The adoption of technology enabling the production of patient skin dose maps 
which can be downloaded into patient record systems is strongly encouraged. 
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Chapter 6: Radiation protection for staff  
Factors affecting staff exposure to radiation during IR procedures 
Effects of occupational radiation exposure 
6.1 A consequence of the burgeoning use of IR procedures is the increase in the 
numbers of individuals involved in delivery of procedures using IR. Moreover, with 
increased workloads, the radiation exposure of staff also has the potential to 
increase (ICRP 2018). This is somewhat offset by improvements in the technology 
which are acting to reduce doses (Panick and others 2018). 
6.2 Current evidence indicates that there is a small dose-dependent risk associated 
with occupational exposure to radiation for staff working in IR especially for those 
receiving the highest doses (Smilowitz and others 2013, Klein and others 2018, 
Tsapaki and others 2018). It has been possible to detect small changes in blood 
markers of interventional staff, although any associated impact on long-term health 
remains uncertain (Borghini and others 2017, El-Sayed and others 2017). 
6.3 In the mid-1980s, a large U.S. study of radiologic technologists was initiated for 
individuals who worked for at least 2 years between 1926 and 1982; this included 
>146,000 individuals , >106,000 were women (Doody and others 2006). 
Subsequently the cohort has been surveyed 3 times and an increased risk of 
breast cancer has been shown (Doody and others 2006, Preston and others 2016).  
6.4 Further analysis within the same cohort of the incidence of self-reported cancers 
and additional evidence of cancer mortality showed an approximately 2-fold 
increased risk of brain cancer mortality and modest elevations in the incidence but 
not mortality of melanoma and breast cancer. No other outcome evaluated showed 
significant excess incidence or mortality (Rajaraman and others 2016b). The 
authors noted that the results could be due to chance or confounded due to 
unmeasured non-radiation risk factors (Rajaraman and others 2016a, b).  
6.5 Lee and others (2018) reported an increased risk of breast cancer in a study of a 
large cohort of medical workers in South Korea (>94,000), although the radiation-
related risks identified were small and varied widely by sex and occupational 
group. The authors cautioned that careful monitoring and radioprotection is 
necessary particularly for female radiologic technologists. 
6.6 Radiation exposure to the lens of the eye is of particular concern in assessing 
occupational risks for the development of cataracts in interventional staff as 
discussed in paragraphs 3.35 to 3.38. It has been noted that standard IR 
workloads have the potential to deliver lens doses which exceed the ICRP 
occupational dose limit unless radiation protection tools are used properly (Seals 
and others 2016, Bera and others 2018).  
6.7 In a systematic review of 8 studies of staff working in IC (1,124 subjects; 1,335 
controls) posterior eye lens opacity was significantly elevated in the IC staff (P < 
0.00001); no significant differences were found in cortical or nuclear lens opacity 





(Elmaraezy and others 2017). Reports have also shown an increased risk in the 
incidence of self-reported cataracts /cataract surgery in the large cohort of U.S. 
radiation technologists described in paragraph 6.3 (Little and others 2018, 
Velazquez-Kronen and others 2019). These studies confirm that IR staff should 
minimise radiation exposure to their eyes taking all the advised precautions as 
described in this report. 
6.8 The above demonstrate the need to ensure that care is taken to reduce radiation 
exposure in line with the ALARP principle. 
Radiation exposure to staff 
6.9 The risk to staff from ionising radiation depends on proximity to the primary beam 
and scatter radiation. The person most at risk is the interventionalist performing the 
procedure as he/she is invariably working adjacent to the patient on the IR table. 
Consequently, this interventionalist will be exposed to the highest staff dose 
resulting from the procedure. The risk to other staff within the team depends on 
their role and their position within the operating theatre relative to the radiation 
beam. 
6.10 The position and design of the IR equipment can influence the level of radiation 
exposure of staff. In particular, floor mounted X-ray tubes are much less 
manoeuvrable than those mounted in the ceiling. Similarly, ceiling-mounted 
shielding is more readily usable. 
6.11 The highest dose rates around a fluoroscopic unit are from radiation scattered back 
from the surface of the patient. Consequently, in IR, doses to the head and hands 
of the operator are substantially lower when the tube is positioned under the 
couch. 
6.12 Equipment design can influence the position of the operator in relation to the 
radiation beam which can also influence staff exposure. 
6.13 The basic principles of time, distance and shielding apply in IR as in all areas of 
radiation protection. This means that personnel should minimise the time for which 
they are exposed to radiation, keep as far from the source of radiation as they can 
whilst still performing their task appropriately and use shielding and/or wear 
protective equipment when necessary. 
6.14 Any increase in patient dose will increase the amount (fluence) of radiation in the 
interventional room because, provided that staff do not expose themselves to the 
radiation beam itself, the scatter from the patient makes up most of the radiation in 
the room. Thus, any measure designed to reduce patient dose will also reduce 
potential staff dose. For example:  
• as the tube angle is increased, the longer path length of the X-ray beam 
through the body will raise the X-ray intensity required to form an adequate 
image, and so will increase the dose to both patient and consequently to staff. 
• reducing the number of frames per second will reduce the scattered radiation. 
The logical extension of this is that use of last image hold will effectively pause 
the radiation dose being delivered to the patient and consequently any staff 
involved. 





• the smaller the field size employed the smaller the volume of the patient that 
will be irradiated. The amount of scattered radiation produced depends on the 
volume irradiated so there will be less scatter and accordingly a reduced dose 
to staff. 
• positioning the patient as close to the detector as possible will reduce the 
patient dose, with consequent reduction in the amount of scattered radiation. 
6.15 It should be noted that many IR procedures, especially in Clinical Radiology, do not 
take long and result in low patient radiation doses. One example of such a 
procedure is a peripherally inserted central catheter (PICC line), which is normally 
a short procedure resulting in a low patient dose. However, staff may well be 
involved in a large number of such procedures and so the cumulative staff dose 
should be controlled.  
Figure 6.1: Doses to the operator at different positions around the patient per Gy 
cm2 KAP for an undercouch X-ray tube angled at 30° to the vertical  
 
Dose values assume that no protection devices or personal protective equipment (PPE) are being 
used. 
6.16 Radiologists and others performing IR procedures stand more frequently on the 
right side of the patient, with the X-ray tube and gantry on their left. Both the 
position of the person performing the procedure and their proximity to the X-ray 
tube have a significant influence on the amount of scatter to which they are 
exposed and therefore the doses they receive (Martin and others 2018). For 
example, the ratio of dose rates on the 2 sides of the couch changes as the 
angulation of the tube is increased. When the X-ray beam is directed at 10° to the 
vertical, the dose rate on the side adjacent to the tube will be double that on the 
side adjacent to the detector. When the angle is increased to 30°, the dose rate 
may be 5 times that on the far side. Staff who need to stand near to the couch 
should avoid the region adjacent to the X-ray tube for oblique and lateral 





projections. When the X-ray tube is positioned below the couch, the primary beam 
is scattered downwards from the base of the couch, so the legs of the operator can 
receive a significant dose. Where no shield is available, the doses to the legs can 
be greater than those to the hands (see Figure 6.1).  
6.17 The mode of access used for interventional procedures has significant implications 
for the radiation dose to the person performing the procedure. Procedures 
involving radial access routes require the operator to stand closer to the X-ray tube 
leading to higher doses, especially to the operator’s hands and eyes, than those 
using femoral access. Radial access, however, often has advantages relating to 
treatment of the patient. For example, transradial artery access for PCI is 
associated with lower bleeding and vascular complications than transfemoral artery 
access, especially in patients with acute coronary syndromes (Mason and others 
2018) and can result in earlier discharge post procedure. Femoral access still 
remains necessary for numerous coronary procedures, many requiring large-bore 
access, including complex high-risk coronary interventions, structural procedures, 
and procedures involving mechanical circulatory support (Sandoval and others 
2017).  
Figure 6.2: How the radiation dose to the hands of the operator varies with access 
point for interventional radiology and cardiology  
 
6.18 Interventional radiologists are required to stand close to the point at which access 
is gained to the body as they manipulate guidewires through catheters. 
Interventional radiologists frequently use the femoral artery for access, but 
increasingly transradial access is being trialled (and adopted) for a range of 
procedures (Posham and others 2016, Kok and others 2018). As outlined above, 
whilst being of benefit to the patient, this exposes the operator to higher levels of 





scatter, especially when manipulations are required, for example in stenting or 
drainage procedures (see Figure 6.2). 
6.19 The variation in operating position also determines the level of radiation exposure 
to the operator’s hands (see Figure 6.2). Manipulation of the equipment close to 
the area of interest will increase the risk of the operator’s hands or fingers being 
exposed directly (Whitby and Martin 2005). 
6.20 Exposure can be reduced for the person administering sedation by using an 
extended cannula. However, monitoring equipment occasionally needs adjustment 
which will involve a member of staff moving closer to the area of exposure, albeit 
for a short period of time. Similarly, the anaesthetist or ODP may need to position 
themselves close to the patient’s head to make adjustments to ventilation 
equipment or to administer IV drugs. 
6.21 Some interventions can be performed using very short intermittent exposures to 
radiation or no exposure at all, that is, a percutaneous nephrostomy is performed 
using ultrasound to guide initial access but can sometimes be performed entirely 
with ultrasound guidance.  
6.22 CT-guided procedures, such as tumour ablation, can be performed with no 
exposure to ionising radiation for the operator but are more time consuming. Use of 
CT fluoroscopy to guide ablation will increase the risk of exposure to the operator 
depending on where they stand in relation to the tube and what protection, if any, 
is provided between them and the tube. There is also a risk of direct exposure of 
hands whilst positioning the ablation probes with the patient positioned in the 
scanner.  
6.23 Where possible staff should stay as far away as practical from the radiation beam. 
However, patients may require re-assurance from a member of the team whilst the 
procedure is taking place and a nurse standing next to the patient’s head or 
holding their hand will be exposed to more scatter than when standing several 
metres away. 
Mitigation of staff doses using protective equipment 
6.24 ICRP (ICRP 2018) recommend that staff in the interventional room should wear 
protective aprons; the interventionalist should be protected by ceiling-suspended 
screens, table-suspended curtains, and shielding drapes when feasible. If shown 
to be necessary by risk assessment or other means, interventionalists should wear 
protective eyewear; however, the ceiling suspended screen provides by far the 
best protection of the head and eyes if used correctly. Other staff, such as nurses 
and anaesthesia personnel, who need to remain near the patient, can benefit from 
protection by movable screens; other personnel can also benefit from protection 
afforded by distance. Staff should leave the area during digital acquisitions unless 
necessary for that aspect of the procedure. A Radiation Protection Advisor (RPA) 
can be consulted to advise on suitable shielding and personal protection. 
6.25 The employer’s radiation risk assessment will identify what personal dosimetry and 
personal protective equipment (PPE) is required for particular work with radiation 
and employees must be trained and instructed on their use. Where local rules are 
provided for an area as per Regulation 18(2) of the Ionising Radiations Regulations 





2017 (IRR17) (IRR 2017), details concerning the use of PPE and personal 
dosimetry should be included as part of the main working instructions intended to 
restrict any exposures in controlled or supervised areas. The wearing of the 
identified personal dosimetry and PPE is not optional and employees who fail to 
adhere to those instructions are likely to be committing an offence under Reg 35 
(2) of the IRR17 (IRR 2017) and/or Section 7 of the Health and Safety at Work etc. 
Act 1974 (HSWA 1974). 
6.26 Mobile protective screens play an important role in staff radiation protection in 
interventional environments. When specified correctly they should provide an area 
behind which dose rates are sufficiently low that members of staff would 
theoretically need no additional protective equipment. Such screens should be at 
least 2 m high, will contain a mixture of flat and angled panels as required and 
should be large enough to provide sufficient shielding for all those who may need 
to be behind them.  
6.27 Any screen designed to protect the operator must also allow clear visibility to all 
entrances into the room, so that in the event of unauthorised entry into the 
interventional room during an exposure the operator is aware immediately. 
6.28 Overhead-suspended shields (Figure 6.3) are generally used in interventional 
procedures to reduce radiation doses to the head and upper body of those staff 
who may need to remain close to the patient during the performance of a 
procedure. They provide the most efficient way to protect the eyes of the operator if 
used correctly, an important consideration given the reduction in the eye dose limit 
to 20 mSv. Shields like this are usually mounted on the ceiling but can be attached 
to an adjacent wall or even on the radiological equipment itself, depending on 
range of procedures that are to be carried out. 
  





Figure 6.3: Example of overhead suspension shield to reduce upper body exposure 
in interventional examinations  
 
6.29 Ceiling suspended shields should be placed as near to the patient as possible, so 
as to interrupt as much scattered radiation as possible, and ideally the cut-out arc 
that is a feature of many screens should be close to the patient contour. The 
operator should be viewing the patient through the screen, with the screen angled 
to maximise the size of the X-ray shadow, and for lateral projections where the 
tube is close to the operator, the shield should be drawn back closer to their side. 
With careful positioning, ceiling suspended screens provide the most effective 
protection of the head and upper body. Some operators find that they limit vision 
and access to the patient, but it is essential for operators to use them as much as 
possible to prevent doses to the eye exceeding the dose limit.  
6.30 There can be poor compliance in the use of protective devices by some staff. A 
reason given for this is the inability of staff to perform selected procedures 
adequately due to inconvenient/almost impossible positioning of the protective 
equipment. This may be due to equipment design faults or the requirements of a 
specific procedure.  
6.31 As outlined above, the legs of interventional radiologists may receive non-trivial 
radiation doses (Whitby and Martin 2003). These may be substantially reduced 
either by the use of lead drapes hung from the table or a short mobile screen 
(Figure 6.4). Not all lead skirts are transferrable from one side of an X-ray table to 
the other, so portable screens should be available where this is an issue.  
  





Figure 6.4: Table mounted shielding used to reduce lower body exposure in 
interventional radiology  
 
6.32 All staff working in an interventional room should wear a lead apron. There are a 
wide range of styles of lead apron, examples being front-only, double-sided or 
wrap-around. Designs that do not provide complete protection for the torso must be 
used with caution to prevent exposure of unprotected areas. When worn correctly, 
a lead apron will reduce the radiation dose from scattered radiation by 95% to 
99%. Weight can be an issue with lead aprons, and it is possible to use so-called 
light-weight aprons; when this option is chosen, it is important that the lead 
equivalence is known and the labelling on the product fully understood (Hiles and 
others 2016). 
6.33 Thyroid shields can significantly reduce thyroid and effective dose and are 
especially important for younger people and female staff who have a greater risk 
from radiation induced thyroid cancer. The British Institute of Radiology (Hiles and 
others 2016) recommend that they should always be worn by people carrying out 
interventional work.  
6.34 Protective eyewear (lead glasses) can reduce the radiation dose to the eye 
considerably. However, the amount of protection provided depends on the angle of 
incidence of the scattered radiation. This is especially important in IR as the 
interventionalist will not generally be looking directly at the patient when performing 
a procedure. For this reason, lead protective eyewear should preferably be of a 
close-fitting wrap-around design. Prescription lead glasses should be worn if the 
interventionalist wears spectacles. Protective eyewear does not eliminate exposure 
of the eye completely, since much of the radiation dose arises from scatter from 
surrounding tissues. 
6.35 It is important that protective equipment is checked regularly for defects. In 
addition, staff should be taught the importance of looking after PPE, for example 





hanging lead aprons up to avoid creases which may lead to a defect in the lead 
protection. Although some staff do this routinely it has been found that this is not 
necessarily true for all users of the equipment.  
Personal Dosimetry  
6.36 IRR17 (IRR 2017) prescribe the dose limits which employers must ensure that 
workers do not exceed. The regulator for IRR2017 is the Health and Safety 
Executive (HSE). In IR procedures, consideration needs to be given to radiation 
doses to a) the whole body, b) the eyes and c) extremities, including fingers, hands 
and legs. Dose limits are expressed in terms of effective dose for whole body 
monitoring and equivalent dose for eyes and extremities. The relevant dose limits 
to be taken into consideration in IR are: whole body 20 mSv per annum, eye 20 
mSv per annum, extremities (hands, including finger tips, and legs) 500 mSv per 
annum. Employees who are likely to receive in excess of certain constraints need 
to be classified. These constraints are: whole body exposures 6 mSv per annum, 
eye 15 mSv per annum, extremities 150 mSv per annum. 
6.37 Once a staff member has notified their employer of a pregnancy, the employer 
must ensure that the equivalent dose to the foetus is as low as reasonably practical 
and is unlikely to exceed 1 mSv during the remainder of the pregnancy. 
6.38 Monitoring for regulatory purposes is called compliance monitoring. Decisions on 
whether to issue personal dosemeters to staff for compliance monitoring purposes 
are based on the risk assessments that are mandated by IRR17 (IRR 2017). When 
whole body dose monitoring is carried out for compliance purposes and only one 
dosemeter is worn, the HSE recommend that the dosemeter should be worn under 
any lead apron. In terms of best practice, ICRP recommend that 2 dosemeters, 
one shielded by the apron (under apron) and one unshielded (over apron) at collar 
level, provide the best estimate of effective dose (ICRP 2013a). It is likely that 
interventionalists will need to wear both an under apron dosemeter and one for 
monitoring dose to the eye lens, for which the optimum position may be on the 
forehead or adjacent to the left eye. Other staff working with X-rays will also need 
to have a method for recording or estimating the dose to the eye. Authoritative 
operational guidance on the personal monitoring requirements for personnel 
working in healthcare (including interventional radiology), can be found in Martin 
and others (2018). An RPA, appointed in accordance with the requirements of 
IRR17, should be consulted on personal dose monitoring requirements. 
6.39 Monitoring may be required for other purposes, for example to understand patterns 
of work or to identify those parts of a work practice that contribute most to the dose 
a member of staff receives. This type of dose monitoring may be used as part of an 
optimisation process to reduce staff doses to a level that is As Low As Reasonably 
Practicable (ALARP), in which case whole body monitors should be worn outside 
the lead apron. 
6.40 Effective and equivalent dose, the quantities which are used to define regulatory 
dose limits for whole body, extremity and eye dose monitoring, are abstract 
quantities which cannot be measured directly. For this reason, so called 
‘operational quantities’ have been defined and it is these that are used for the 
purpose of both environmental and personal monitoring. The quantity used in 





personal monitoring is Hp(d), where p means ‘personal’ and d is the depth in mm 
beneath tissue at which the measuring device is calibrated. Hp(d) is referred to as 
personal dose equivalent. In practice, 3 different depths are commonly used. 
6.41 Dosemeters are calibrated to give the dose equivalent at 10 mm beneath the 
surface when their intended use is whole body monitoring, the dose at 3 mm for 
eye monitoring and at 0.07 mm for extremity (skin) monitoring. It is important that 
dosemeters are only used for the purpose for which they are calibrated and that 
they are worn when issued. Dosemeters that are used for compliance purposes 
must be of a type approved by the HSE and must be read by a dosimetry service 
that is itself approved by the HSE.  
6.42 Dosemeters can be grouped into 2 broad types, passive and active.  
6.43 Passive dosemeters are not powered and generally need to be interrogated or 
read using an external device. They are generally used for compliance monitoring 
and for identifying situations where more sophisticated (active) monitoring may be 
required. Passive dosemeters are fabricated for the most part using Optically 
Stimulated Luminescent (OSL) or Thermo Luminescent (TLD) materials. These 
materials require an external stimulus (light or heat) to release energy deposited in 
them by the incident radiation, which is then emitted as light, and they require 
sophisticated read out devices. OSL dosemeters typically have a threshold for 
detection of 10 µSv and TLD a threshold for detection of 100 µSv. Such 
dosemeters can be read by an external provider or in-house, and results returned 
for analysis. A further type of passive dosemeter that has appeared on the market 
relatively recently uses direct ion storage and is based on the combination of an 
ion chamber and a non-volatile electronic charge storage element. Internal 
electronics allow this type of dosemeter to ‘self-read’ with results being transferred 
to a logging device wirelessly. The threshold for detection is 10 µSv.  
6.44 Passive dosemeters are used in IR for whole body monitoring, skin dose 
monitoring (using ring badges or fingertip sachets) and eye dose monitoring. Given 
their primary role of demonstrating compliance with annual dose limits they tend to 
be worn for 1 to 3 months at a time before being read out. There is therefore an 
inevitable delay between a radiation dose being received by the wearer of a 
passive dosemeter and its notification to the wearer and her/his employer. When 
passive dosemeters are used for compliance monitoring, and staff work for more 
than one employer at different sites (a common occurrence in IR), it is important 
that robust arrangements are made between the differing employers to ensure that 
adequate assessment of the annual dose to any single person can be made. 
6.45 Active or electronic personal dosemeters (APDs) require a power source, 
usually a battery, and generally provide both cumulative dose and dose rate 
information. There is usually a real time display available for the wearer and a built-
in data logging capacity that enables interrogation by a reading device subsequent 
to the wear period; there may also be an audible alarm if a pre-set dose rate is 
exceeded. When used in IR, care must be taken to ensure that the energy range of 
the detector in the APD is suitable for use in diagnostic radiology. The minimum 
threshold detection is typically of the order of 1 µSv. The use of an APD permits: 
• More immediate awareness of received radiation doses than is possible with 






• The potential for more sophisticated and granular analysis of dosimetry data 
than is possible with passive dosemeters. The reader can identify when 
doses were delivered since recording is carried out at discrete time intervals 
rather than being integrated over time.  
• Consequent analysis of doses delivered at different points during individual 
tasks and sub-elements of tasks thus allowing optimisation (in terms of 
ALARP) to be facilitated. 
• The potential for users to wear only one dosemeter over a monitoring period 
when s/he is working for more than one employer since the time when the 
doses were delivered can be identified. 
• The potential for more frequent analysis of compliance related dose data in 
circumstances such as pregnancy, when more vigilance may well be 
required, given the lower dose limits that are applied.  
• Potential for real time display on a central display. Some systems use APDs 
in this way to provide real time information that can be used to make staff 
aware of what cumulative doses and dose rates they are being exposed to 
during any given procedure.  
6.46 Vanhavere and others (2020) carried out an evaluation of 3 types of APD in the 
clinical IR and IC setting across several countries. They compared APD results 
with those from conventional passive dosemeters, both being mounted in a holder, 
so that the relative position was the same. This required that the holders were worn 
by the same person for multiple procedures. Operators wore the holder above their 
lead apron, aiming for a minimum reading of 300µSv; in practice, data above 
100µSv were included in the analysis. This study followed an earlier one by many 
of the team (Vanhavere and others 2012) which showed that, in pulsed radiation 
fields, the response of most APDs decreased when the instantaneous personal 
dose equivalent increased. The later study found that, in the majority of cases, the 
APDs underestimated doses below 2 mSv, although the APD/passive ratio ranged 
from 0.5 to 2. Above 2 mSv, the ratio tended to unity. No single factor – different 
energies, angular response, pulsed field response – was found to account for the 
differences. Different ratios for the same APD were found in some sites, however, 
with the APD/RPL ratio being closer to one. 
6.47 Approved dosimetry services proposing to use APDs to measure radiation doses of 
classified workers in the UK need prior approval from HSE. No approval is required 
for use in monitoring doses to non-classified employees or if the APD is used in 
conjunction with a primary approved dosimeter by classified employees.  
6.48 Evidence suggests that APDs can be used for staff education and optimisation of 
doses (Racadio and others 2014, Baumann and others 2015, Omar and others 
2017). If used for these purposes, they should be worn over any lead protective 
apron. 
Consequences of dose limits 
6.49 Concerns have been raised that staff radiation doses may lead to limitations on the 
number of procedures which an individual can undertake while remaining within the 





dose limits. This would lead to considerations of the staffing levels required to 
provide a service. 
6.50 From the literature, neurointerventionalists appear to be at highest risk from 
radiation. An interventional spinal surgeon (with 9 years of experience) was 
monitored during 52 consecutive fluoroscopic spine procedures, which included 
myelography, selective nerve root block and facet joint block, over 3 months 
(Yamashita and others 2017). A radiophotoluminescence glass ring dosimeter, 
which accumulated the radiation doses measured at the right thumb for each 
month, recorded 122 mSv, 120 mSv, and 126 mSv, giving a total dose of 368 mSv. 
Working at this level throughout the year would give an annual dose of some 1300 
mSv allowing for annual leave, over twice the dose limit for the skin. An alternative 
interpretation of these data is that, even as a classified worker, the surgeon would 
reach the dose limit after only 4 months. 
6.51 Neto and others (2016) measured the radiation doses to various part of the body 
received by the primary operator and assistant during lower limb angiography, 
lower limb angioplasty and EVAR. Seven staff took part and TLD measurements 
were made for 30 of each type of procedure. 
6.52 Dosemeters were worn above shielding equipment (lead apron, thyroid shield, 
among others) and the results corrected by measured shielding factors to yield 
estimated body doses. The doses to the hands, which needed no correction, were 
found to be critical in terms of dose limit compliance. The median and maximum 
recorded doses per procedure are shown in Table 6.1, together with the maximum 
number of each which could be carried out in a year without exceeding the dose 
limit. 
Table 6.1: Hand doses recorded per procedure (uSv) and maximum number of 
procedures carried out per year at median and maximum dose levels by an 
individual to remain within skin dose limits. 




Maximum procedures per 
year 
   Median Maximum 
Primary operator 
Angiography 33.1 11.7 to 149.2 >2500 >2500 
Angioplasty 178.2 35.4 to 645.8 >2500 770 
EVAR 2105.3 826.2 to 4,679.2 560 100 
Assistant operator 
Angiography 37.5 8.5 to 84.3 >2500 >2500 
Angioplasty 33.6 15.7 to 71.1 >2500 >2500 
EVAR 417.7 210.3 to 5,751.3 640 90 
 
6.53 The eye doses were recorded without shielding but, assuming appropriate eye 
shielding to give 60% attenuation, the maximum numbers of procedures which 
could be carried out by an individual to remain within the current limits are shown in 
Table 6.2. 






Table 6.2: Maximum number of procedures carried out per year at median and 
maximum dose levels by an individual to remain within eye dose limits.  
 Maximum procedures per year 
 Median Maximum 
Primary operator 
Angiography >2,500 1,000 
Angioplasty 930 390 
EVAR 140 110 
Assistant operator 
Angiography >2,500 870 
Angioplasty 1,790 950 
EVAR 240 130 
Conclusions 
6.54 Wherever possible, X-ray tubes and shielding should be ceiling-mounted to 
enhance manoeuvrability and usability. The highest dose rates in the IR room are 
from radiation backscattered from the patient and positioning the X-ray tube under 
the couch substantially reduces doses to the head and hands of the operator, 
although this positioning reduces manoeuvrability. 
6.55 Staff should minimise the time for which they are exposed to radiation and 
maximise their distance from the radiation source as is consistent with their duties 
At all times they should utilise shielding and personal protective equipment (for 
example, lead apron, thyroid shield and, if found necessary, protective eyewear) as 
provided by their employer. 
6.56 For compliance dose monitoring, HSE recommend that. the dosemeter is worn 
under the lead apron. A second dosemeter, placed on the forehead or adjacent to 
the left eye, will be necessary to monitor the operator’s eye dose. 
6.57 More information about optimisation of staff radiation doses can be obtained by 
wearing an additional dosemeter over the apron at chest height.  
6.58 Where shown advisable, additional dosemeters may be placed on the operator’s 
hands. 
6.59 Active personal dosemeters offer several advantages over passive dosemeters 
(see paragraph 6.44), principally immediate awareness of radiation dose rate. They 
are of value also in the development of new procedures. 
6.60 Operator hand and eye doses may limit the number of procedures per year which 
can be carried out by an individual. 
 
  





Chapter 7: Image optimisation and 
diagnostic reference levels  
Radiation dose and image quality in IR 
7.1 In patient radiation protection terms, the imperative in medical imaging is to provide 
images which are adequate for the clinical task or question at hand whilst 
delivering the minimum radiation dose to the patient. This is often thought of in 
terms of balancing patient dose and image quality and is termed optimisation. 
Achieving the optimal balance for any application requires an understanding of the 
way in which an image is formed and how different factors influence both the 
quality and the radiation dose received by the patient (Martin and others 1999). 
7.2 The clinical task may be, for example, achieving the correct diagnosis from a 
radiograph or positioning a stent correctly during an image guided procedure. 
Radiation dose is directly related to image noise. Thus, the radiation dose required 
to produce an image that is adequate for the task will be a function of the task 
itself. For example, detection of a renal stone will require less radiation than 
accurate visualisation of an artery during cardiac cineangiography. In addition, as 
well as being dependent on the level of detail required and noise present in the 
image, the correct interpretation of the image is a subjective process, so the 
amount of radiation required will also be dependent on the person who is 
interpreting or using the image. Put succinctly, adequate assessment of an image 
is both task and reader dependent.  
7.3 The task and reader interdependencies are the main reason that much of the focus 
on optimisation has concentrated on methods for reducing radiation dose. Image 
quality is generally assessed as a technical rather than clinical parameter, usually 
in a quality assurance programme as part of a compliance regime. However, there 
is a growing consensus that the optimisation goal goes beyond dose alone and 
should increasingly include more clinically relevant considerations of image quality 
(Samei and others 2018). 
7.4 Nevertheless, there are many ways in which technical and scientific approaches to 
improving image quality whilst reducing patient dose can be incorporated into the 
design of equipment intended to be used for IR. For example, modern X-ray 
equipment features digital flat panel detectors and operates in pulsed rather than 
the traditional continuous mode. The use of short pulses of radiation results in 
sharper images and when combined with reduced frame rates can also result in 
lower patient doses for the same perceived image quality (Aufrichtig and others 
1994, Balter 2014).  
7.5 Flat panel detectors have the advantage of generally better dose efficiency and 
spatial resolution (Seibert 2019) and do not require increased dose when used in 
magnification mode when compared to older image intensifier-based equipment. 
Digital detectors also permit the implementation of image processing algorithms 
such as deblurring, frame averaging and edge enhancement in real time, with 
consequent implications for perceived image quality. 





7.6 As previously described, equipment used for IR is also generally fitted with a host 
of dose saving features, many of which have the added bonus of improving the 
technical aspects of image quality. Increasingly the features come as standard 
equipment, but some remain optional. Common features include;  
• Last image hold - which freezes the last frame viewed on the display and 
thus allows detail to be viewed without exposing the patient, 
• Virtual collimation - which allows the X-ray collimators to be moved using 
last image hold images for guidance, once again reducing patient exposure, 
• Additional beam filtration - which permits insertion of additional beam 
filtration to expressly reduce ESAK, with the intention of reducing the 
possibility of inducing tissue reactions.  
7.7 Additional filtration can also improve image quality if employed in angiographic 
procedures involving contrast agents such as iodine, since it can be used to alter 
the energy of the X-ray beam to more adequately overlap with the k-edge of the 
contrast agent. This will have the effect of improving image contrast.  
Optimisation of interventional procedures 
7.8 Optimisation of IR procedures as for other radiology procedures requires a team 
approach with radiologists, radiographers and medical physics experts working 
together. This process starts from the specification of the equipment, continues 
through the testing phase and extends into clinical implementation. 
7.9 Detailed specifications of performance relating to the intended clinical use of the 
equipment should be made when purchase is being considered. This should 
include the training of staff required and maintenance requirements. The 
specification requires input from radiologists, radiographers, radiology managers, 
medical physics experts (MPEs) and procurement experts.  
7.10 Acceptance tests by the vendor application specialists and their performance 
should be verified by site staff, principally the MPE. This will involve testing of 
automatic dose rate control (ADRC) settings for different modes and 
anatomical/clinical programmes through measurements of dose and image quality. 
It is important to know how the ADRC works in terms of which acquisition 
parameters are changing and based on what algorithms, and that the automatic 
exposure control for individual images is operating satisfactorily.  
7.11 Results of the tests should be fed back to the equipment users to provide 
information on dose levels. Clinical protocols should be checked for consistency 
with other radiology equipment operated by the healthcare organisation to ensure 
that there is a systemic approach to imaging.  
7.12 Initial training of the operators should be provided by the representative of the 
installer / manufacturer (applications specialist) following acceptance and before 
the equipment is put into clinical use.  
7.13 A quality control (QC) programme involving the measurement and analysis of 
aspects of equipment performance in terms of dose and image quality should be in 
place and MPEs with expertise in diagnostic radiology involved in interpretation of 
results. MPEs should understand how the systems work, their characteristics, 





modes of operation and image acquisition, image quality requirements and image 
processing for different clinical programmes and clinical uses. There should be 
close cooperation with equipment service engineers, and clinical staff operating 
and using the equipment. The QC programme should form part of a managed 
quality assurance programme. 
7.14 Results from QC tests should be used in analysing performance of IR equipment in 
surveys of patient dose. Although such surveys are the means through which units 
giving higher doses can more readily be identified, the reasons for any anomalies 
can only be understood from analysis of the equipment performance data. 
7.15 Clinical protocols should be configured through adjustment of settings customised 
to the required image quality and dose saving needs for the clinical task.  
7.16 Protocols for IC examinations are usually developed at a local level and hence may 
vary from one department to another. The National Institute for Health and Care 
Excellence (NICE) has issued guidelines on the safety and efficacy of 
interventional procedures being carried out in the NHS (NICE 2007). All the 
common CHD procedures are identified, and the efficacy of each interventional 
procedure is discussed.  
Diagnostic reference levels (DRLs) 
7.17 As described in paragraphs 3.3 and 5.40 to 5.43, the radiation doses received by 
patients undergoing interventional procedures are recorded in terms of IAK or its 
derivatives. The most commonly recorded quantities derived from IAK are KAP, 
which provides a measure of the radiation dose and beam area product entering 
the patient at any projection, ESAK, which provides a measure of the amount of 
radiation incident on the skin surface relative to air, and CAK, which provides a 
measure of the total amount of radiation incident on the reference position on the 
patient during a procedure. 
7.18 It is not appropriate to apply dose limits to the patient in medical exposures since 
there is, by definition, a direct benefit to the patient. Instead, in the case of 
diagnostic examinations, guidance regarding radiation doses for different 
examinations is provided by the adoption of diagnostic reference levels (DRLs). 
DRLs are intended to act as a guide to the very indistinct border between good and 
normal practice and poor and abnormal practice and are often seen as the first 
step in the optimisation process. They are usually established from surveys of 
measured doses for patients of average size in hospitals, usually at national, but 
also at regional or local levels.  
7.19 National DRLs for a range of diagnostic examinations, which do not apply to 
individual patient examinations, have been set in the UK at the third quartile of 
mean X-ray room examination doses measured in large-scale hospital surveys. 
ICRP (2017) have proposed that future DRLs be set in terms of the third quartile of 
median examination doses.  
7.20 DRLs are essentially an audit tool, so an investigation or intervention might be 
triggered if the mean or median dose for an examination in a hospital exceeds the 
DRL. Conceptually, an investigation could also be triggered in the situation where 
doses are substantially below the DRL value. Defining the DRL in terms of the third 
quartile means that a dose which exceeds a DRL for any particular examination will 





be higher than that which the majority of radiologists agree is needed to produce 
images that are sufficient for the intended clinical purpose.  
7.21 UK regulation requires that if an exposure intended for the individual is significantly 
greater or different to that intended it should be reporting to the appropriate 
enforcement authority. In the case of IR, one of the criteria for reporting is when the 
exposure is in excess of 10 times the local Diagnostic Reference Level (see 
paragraph 7.56).  
7.22 However, whilst DRLs are very useful for diagnostic examinations they are much 
more challenging to implement or interpret in the case of IR because a) such 
procedures are by definition therapeutic, not diagnostic and b) there is a wide 
distribution of patient doses for any given examination. Consequently, the 
conventional DRL methodology is not well-suited to IR procedures (Baiter and 
others 2011). 
7.23 As reported by ICRP (2017), procedure complexity varies for interventional 
procedures because of difference between patients, the lesions being treated and 
disease severity. For these reasons, interventional procedures demonstrate 
substantial variability in the amount of radiation used for individual cases due to 
patient, operator, type of materials and equipment factors. 
7.24 ICRP (2017) recommend that even though interventional procedures are 
therapeutic, the term DRL is retained for use in IR since their purpose is to provide 
a tool for optimisation and the adoption of a different nomenclature is likely to result 
in confusion. They do however recommend that DRLs for interventional procedures 
should be developed differently from those for diagnostic procedures.  
7.25 ICRP (2017) makes recommendations regarding the establishment of DRLs for 
interventional work that take into account procedure complexity; to date very few 
approaches to this have been proposed and an agreed methodology has yet to be 
developed. Quantities that are recommended by ICRP as being suitable for 
establishing DRLs are:  
• KAP (the preferred metric), 
• CAK at the International Standards Organisation (ISO) reference point, 
• fluoroscopy time and 
• the number of radiographic images obtained as part of the procedure  
7.26 As an alternative to assessing complexity, another proposed approach to 
establishing DRLs in IR is to use data taken from a very large number of individual 
measurements such as those from an entire country. This type of data collection 
differs from the traditional approach taken, where median or mean results per X-
ray room are collected, and is more suited to IR (Marshall and others 2000, Baiter 
and others 2011, ICRP 2017)). The summary data are termed an Advisory Data 
Set (ADS, (NCRP 2010)) and comparisons are made between the distribution of 
the ADS and that of the data set measured in an individual hospital, Health Board 
or Trust. Determination of the need for an investigation or report is dependent on 
comparison with the 75th percentile of the ADS. 
7.27 If DRLs based on metrics such as KAP are to be established for IR procedures, 
then large groups of patients will need to be entered into survey cohorts since the 





amount of radiation used is dependent on procedure complexity rather than simple 
patient factors (ICRP 2017).  
7.28 A coherent methodology for the establishment and implementation of DRLs for 
fluoroscopically guided interventions has yet to be developed in the UK, despite 
the requirement to use them for reporting purposes.  
Dose Surveys, DRLs and skin dose 
7.29 As outlined above, the factors that influence both patient dose and image quality 
depend on the patient body habitus (physique), the clinical question, the 
examination, the equipment used to image the patient and the person interpreting 
the eventual image.  
7.30 Nevertheless, knowledge of the distribution of doses delivered to patients is 
undoubtedly the first step in the optimisation process, and because of the nature of 
the distribution, it can only be gained by surveys of real patient doses (not 
phantoms).  
7.31 Patient dose surveys should be undertaken routinely, both for local audit purposes 
and to contribute to the setting of national DRLs. 
7.32 In IR, large numbers of patients are required to demonstrate statistically significant 
dose differences, which may well be smaller than the spread in doses due to 
patient size since both differences in patients’ anatomy, patient disease complexity 
and operator technique contribute to dose variations. 
7.33 Metrics used in surveys should be representative of patient dose, the preferred 
quantity for IR being KAP. Ideally KAP should be transferred automatically to, and 
retrieved from, the RIS or other hospital information system in order to avoid issues 
caused by transcription errors. Preferably, use can be made of the RDSR where 
available. 
7.34 There are no recent UK recommendations for DRLs to be used in IR. The most 
recent data come from a 2010 review (Hart and others 2012) of doses for various 
examinations and interventional procedures which was carried out by the Health 
Protection Agency (now PHE). For these dose surveys, reviews of the national 
reference doses are based on rounded third quartile values of the mean patient 
doses observed for common X-ray examinations or interventional procedures in a 
nationally representative sample of X-ray rooms. They do not take into account 
procedure complexity and do not use aggregated data as described in paragraph 
7.17. The current suggested UK DRLs for interventional procedures are listed in 












Table 7.1: Current UK recommended national reference doses for IR procedures on 
adult patients 
Interventional procedure 
Dose Reference Level 
(DRL) 
(Gy cm2) 
DRL fluoroscopy time per 
exam4 (mins) 
Biliary intervention 43 14 
Facet joint injection 6 1.4 
Hickman line insertion 3 1.5 
Nephrostomy 13 6.7 
Oesophageal stent 13 5 
Pacemaker (permanent) 7 6 
Percutaneous transluminal 
coronary angioplasty 
(PTCA) (single stent)* 
7 6 
* Mean patient weight range 75 to 85 kg instead of 65 to 75 kg. 
Values from Hart and others (2012). 
7.35 For some interventional procedures the sample size was too small to derive 
accurate third quartile doses from the dose distribution to be used as DRLs. Hart 
and others (2012) believe that although the sample sizes are insufficient to be truly 
representative of national practice, the information may still be useful in providing a 
rough indication of typical practice. Instead of the third quartile mean room doses 
as reported in Table 7.1, the average room doses are reported for information 
about at least 5 hospitals, 5 rooms and 30 patients.  
7.36 The Department of Medical and Occupational Radiation Protection of the German 
Federal Office for Radiation Protection has published a list of DRLs for 10 
interventional procedures (Schegerer and others 2019), based on data collected 
between 2012 and 2015 and using pooled data, rather than being taken from the 
distribution of room means. 
7.37 Several publications have looked at the issue of procedure complexity (see for 
example, D'Ercole and others (2012), Padovani and others (2001), Ruiz-Cruces 
and others (2016), Sánchez and others (2020) and Baiter and others (2011)). Most 
of these, but not all, have considered interventional cardiology, possibly because 
a) there are far more of these performed than any other IR procedure, and b) there 
are fewer variables involved (Miller, personal communication, 2020).  
7.38 As an example of the effect of complexity of examinations, a study by Ruiz-Cruces 
and others (2016) concluded that the appropriate scaling factor for DRLs to take 
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complexity into account ranged between 2 and 5 for a selection of non-coronary IR 
investigations.  
7.39 There is a paucity of data on IR DRLs in paediatrics and no national DRLs have 
been established for any procedure in any European country (EC 2018). 
Skin dose monitoring in fluoroscopically guided procedures 
7.40 Complex interventional procedures have the potential for delivering high radiation 
doses to the skin. Substantial numbers of radiation-induced tissue reactions, such 
as erythema, hair loss, and more extensive tissue damage have been reported 
following IR procedures (ICRP 2000, 2013a).   
7.41 The threshold and severity of tissue reaction is linked to peak skin dose and the 
area of skin irradiated. Table 3.3 summarises the tissue reactions of ionising 
radiation. Skin dose will depend on the complexity of the procedure as well as the 
size of the patient, so procedures where there is a potential risk of exceeding a 
peak skin dose of 2 Gy should be identified. Procedures for which there is a risk of 
high skin doses are discussed in Chapter 5. 
7.42 Since radiation damage takes time to repair, patients who have had repeated 
procedures, especially within the previous 2 to 3 months, increase the risk of skin 
injury (ICRP 2000, Martin and others 2017). Previous radiotherapy treatment to the 
area to be irradiated can also increase the risk of skin damage. The potential risks 
should be discussed with patients as part of the consent process.  
7.43 For patients identified as being at risk, it is important that skin dose is monitored 
throughout the IR procedure to prevent skin injury wherever possible. Information 
should be provided to the operator during a procedure in order that appropriate 
modifications to technique (for example, changes in tube angulation, lower dose 
rate settings) can be used when appropriate. In addition, post procedure steps 
should be adopted to ensure that patients have the correct information and are 
provided with appropriate follow up if required.  
7.44 Ideally, knowledge of the actual peak skin dose experienced by any area of the 
skin surface is required to estimate the risk of a deterministic skin injury. As 
detailed in paragraphs 5.46 to 5.48, measurement of peak skin dose is complex 
and usually carried out by indirect methods. The uncertainty in calculated peak skin 
dose can be up to +/-50% (Dabin 2020). 
7.45 A range of software tools have been developed to do this in either real time or after 
a procedure; they are either marketed by major X-ray equipment manufacturers or 
produced by independent companies as part of dose management solutions or as 
free and open source radiation exposure monitoring for the medical physicist 
(OpenREM5). Current reports suggest that the reporting of the peak skin dose 
estimate is not as systematic or harmonised as it might be. A review of currently 
available options is presented in Malchair (2018). 
7.46 Where assessments of peak skin dose are not available, it is possible to use CAK, 
KAP and potentially screening time thresholds for identifying those patients who 
may experience skin damage as a result of a fluoroscopically guided procedure. Of 
these CAK is the most appropriate quantity, as it relates to the air kerma level at 
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the skin of the patient (Martin and others 2017) and so was the quantity used in the 
survey (see Chapter 8). CAK is the total IAK from an entire procedure measured at 
approximately the level of the skin surface and is displayed on all modern 
interventional equipment.  
7.47 The CAK will in general exceed the peak skin dose, since, as the position of the X-
ray tube is changed during procedures, different areas of the skin are irradiated. 
The CAK would only be a measure of the true skin dose if all the fields used 
overlapped. This is unlikely to occur in most specialities, provided that the operator 
uses different tube angulations during every procedure. One specialty where this is 
more likely is neuroradiology, where hair thinning and hair loss may occur more 
readily at lower CAK level (see for example Corrigall and others (2020)). 
7.48 IR of the trunk has the potential to give much higher CAK levels, but here the 
relationship to peak skin dose is uncertain. Effects have not been reported for CAK 
values below 7 to 8 Gy. Maccia and others (2015) did not find any long-term skin 
injury despite a follow-up of patients when CAK was over 7 Gy. However, 
Guesnier-Dopagne and others (2019) reported a 9% incidence of acute 
radiodermatitis and a 20% chronic incidence in patients exposed at similar levels 
when systematic follow-ups were carried out by dermatologists. There may be 
many radiation-induced skin changes that are not detected unless follow-up is 
carried out by a dermatologist. 
7.49 Consequently, translating CAK into the potential risks to patients is difficult. An 
attempt to provide some indicative values linking peak skin dose to both CAK and 
KAP is given in Table 7.2 (Jaschke and others 2020), but the ranges are 
necessarily large. 

















Risk of tissue reaction 
2 to 3 3 to 8 150 to 300 2 to 5 Tissue reactions unlikely to occur 
3 to 5 5 to 12 250 to 800 3 to 8 Small risk of transient erythema and 
epilation. Recovery from hair loss. 
5 to 8 8 to 20 400 to 
1200 
5 to 12 Risk of erythema and epilation in some 
patients. Effects may appear within 2 to 8 
weeks. 
Erythema may be prolonged. 
8 to 12 12 to 30 600 to 
2000 
8 to 16 Transient erythema expected as a prompt 
effect. Skin desquamation, prolonged 
epilation.  
7.50 ICRP recommend that in procedures involving the trunk, a CAK of 5 Gy can be 
used to signify a peak skin dose of 3 Gy and recommend that this value be used as 
a trigger above which clinical follow-up should be performed for early detection and 
management of skin injuries (ICRP 2013a). Recommendations given by the 
National Council on Radiation Protection and Measurements (NCRP 2010), based 





on work done by Stecker and others (2009) propose additional action levels both 
during and post procedure for peak skin dose, CAK, KAP and screening time, and 
these are shown in Table 7.3, together with specific levels for neuroradiology base 
on the discussion in the previous paragraph.  
Table 7.3 Action levels or alerts (Adapted from Stecker and others (2009)) 
Dose Metric During the procedure Post-procedure 
Action level Subsequent alert 
level (increments) 
Trigger level for 
patient follow-up 
Peak skin dose 2 Gy 0.5 Gy 3 Gy 
Cumulated incident air 





1 Gy 5 Gy 
3 Gy 
(Neuroradiology) 
Air kerma area product 
(100 cm2 X-ray field) 
300 Gy cm2 100 Gy cm2 300 Gy.cm2 
(cardiac and neuro 
interventions) 
500 Gy.cm2  
(other procedures) 
Fluoroscopy time 30 min 15 min 60 minutes 
 
7.51 The trigger level of a peak skin dose of 3 Gy is based on the threshold dose for 
tissue reactions at which 1% of all individuals exposed demonstrate the expected 
tissue reaction (ICRP 2012). Therefore, exceeding the 5 Gy CAK trigger level is 
only likely to result in an effect in a small proportion of patients. 
7.52 Alert levels may be set at lower peak skin dose, CAK and KAP level in order to 
alert the interventionalists that the radiation exposures are approaching the trigger 
level, so that they can consider possible further optimisation at an earlier stage. 
They may also consider whether it may be appropriate to consult more 
experienced colleagues.  
7.53 Exceeding a peak skin dose of 3 Gy or a CAK of 5 Gy would trigger follow-up, 
usually 2 to 4 weeks after the procedure to identify any skin effects that might 
require further management. Minor skin reactions, such as transient erythema, 
should not require follow-up, but the patient should be asked to evaluate the skin 
reaction, perhaps record through a photograph, and report skin changes to the 
responsible physician.  
 
 






 Figure 7.1: Flow diagram showing how CAK can be used as a reference level to 
anticipate skin damage. 
Pre-procedure – has patient undergone 
fluoroscopically guided procedure within 14 
days 
Check for any sign of skin injury. If 
found, try to keep this area out of the 
primary beam 
During procedure – does CAK (skin dose) 
reading reach 2000mGy? 
No further action 
Radiographer to alert the operator. 
Operator to consider if a change of beam entry area / projection 
is possible to spare patient skin dose 
At end of procedure - Is final CAK (skin dose) 
between 3000 and 5000mGy? 
Issue “Low Dose” PSD pack Issue “Moderate Dose” 
PSD pack 
Clinician to sign skin dose advice form and discuss the dose 
with the patient. The form should be placed in the patient’s 
notes 






At end of procedure – is final CAK 
(skin dose) > 3000mGy? 
Yes 
No 





7.54 An example of how this advice is implemented in one institution is shown in the 
flow diagram in Figure 7.1. In this instance, a caution level CAK level is set at 2 Gy 
and the peak skin dose reporting level is set at a conservative 3 Gy. If during a 
procedure the caution level is reached, the radiographer must ensure the operator 
(cardiologist/radiologist) is made aware. If the reporting level is reached during the 
procedure, a skin dose advice form is filed in the patient’s notes and the patient is 
issued with an advice note – the advice depends on the CAK (see Chapter 8).  
Reporting requirements 
7.55 Guidance is available in the UK6 on when to report radiation incidents that occur in 
interventional radiology. This guidance has been agreed by all 4 UK nations, but 
incidents are reported to different inspectorates (the Care Quality Commission in 
England, the Regulation and Quality Improvement Authority in Northern Ireland, 
Healthcare Inspectorate Wales and Healthcare Improvement Scotland). As with all 
procedures involving ionising radiation, accidental exposures (where an individual 
has received an exposure where no exposure of any kind was intended) are 
always reportable to the relevant inspectorate (except in England where there are 
threshold effective dose levels for adults and children below which it is not 
necessary to report the accidental exposure). 
7.56 Unintended exposures are where an exposure was intended for the individual but 
the exposure they received was significantly greater or different to that intended. 
Unintended exposures are reportable to the relevant inspectorate where the ratio 
of the dose the patient received compared with that intended is sufficiently high. 
Furthermore, a foetal dose in excess of 1 mGy is reportable where there was a 
failure to follow the local pregnancy enquiry procedure prior to the examination. 
Specific to fluoroscopically guided interventions, an exposure is reportable where 
there has been no procedural failure but the exposure was in excess of 10 times 
the local Diagnostic Reference Level, or if there were observable tissue reactions 
worse than transient erythema as a result of the procedure. 
7.57 IAEA operates a voluntary (and anonymous) self-reporting system which collates 
safety-related event reports as a learning resource. The SAFety in RADiological 
procedures (SAFRAD) database can be accessed online7.  
Conclusions 
7.58 When purchasing an IR system, a detailed specification should be prepared in 
conjunction with all staff groups concerned which includes performance criteria, 
staff training and maintenance requirements. Acceptance testing, quality 
assurance and maintenance programmes should be drawn up. 
7.59 It is not appropriate to implement dose limits to the patient for a given procedure, 
but there is a need to identify the indistinct border between normal and abnormal 
practice. This is provided by the Diagnostic Reference Level; DRLs are essentially 
an audit tool to trigger investigation if the local values are above (or substantially 
 
6 Significant accidental and unintended exposures under IR(ME)R; guidance for employers and duty-holders. 
Care Quality Commission, Healthcare Inspectorate Wales, The Regulation and Quality Improvement Authority 
and Healthcare Improvement Scotland (June 2019). 
7 SAFRAD database 





below) the appropriate DRL. Auditing against DRLs is often considered the first 
step in the optimisation process. 
7.60 There is a proposed international methodology for the establishment of DRLs, but 
this has yet to be fully implemented. The most recent work on DRLs in the UK 
dates from a 2010 review and did not take into account complexity or use 
aggregated data. Only adult values were addressed. As COMARE has found, the 
data on which UK DRLs could be based are not available.  
7.61 Complex IR procedures can lead to a high skin dose which may trigger tissue 
reactions. ICRP recommend that exceeding a peak skin dose of 3 Gy should 
trigger patient follow-up 2 to 4 weeks post procedures. 
  





Chapter 8: Patient pathway  
8.1 Patients will be referred to the IR service from other clinical services. It is important 
that IR operators attend multi-disciplinary team meetings held by specialties 
making regular referrals to the service, which will facilitate planning of the 
procedure (see paragraph 5.22). Written referral guidelines should be available. 
8.2 Patients will expect the procedure to be explained to them by the operator, who 
has the detailed knowledge to explain all treatment options, outline the process, 
discuss all relevant risks and answer queries. 
8.3 In order to ensure adequate discussion of these issues, IR operators should hold 
out-patient clinics with time slots of a sufficient length. This is of particular 
importance in paediatric cases. 
8.4 The patient record should be checked carefully for any recent (3 to 4months) 
procedures that may have involved high radiation doses (for example, 
radiotherapy, previous IR therapy) and may give rise to an increased risk of tissue 
reactions (see paragraph 7.42). 
8.5 In almost all cases, the radiation risk will be small in comparison to clinical risks 
and both will be outweighed by the benefit of the procedure. All of these 
considerations should be clearly explained to the patient. 
8.6 In terms of radiation risks, both stochastic (cancer induction) and deterministic 
aspects (skin reactions, hair thinning, hair loss, among others) should be 
addressed. This is especially important for complex cardiac procedures and 
neurointerventional procedures. During the latter interventions the patient eye dose 
has been reported to be as high as 2Gy when treating an AVM in the anterior fossa 
(Sánchez and others 2016), with 1 in 6 cases for correction of cerebral emboli 
exceeding 500 mGy. 
8.7 Female patients of childbearing potential must be asked about pregnancy status, 
even if this has already been checked by the referrer. The guidance given by HPA 
(2009) should be followed. 
8.8 Some centres have an extensive range of written information for each procedure 
(for example, Appendix D) while others rely mainly on oral discussion. For 
paediatric procedures, illustrative leaflets for the patient should be provided. The 
key is excellent 2-way communication. 
8.9 In all cases, a telephone or email contact should be given for the patient to ask for 
any further information. 
Informed consent 
8.10 IR procedures are frequently employed in order to treat a serious or life-threatening 
condition or to provide a less invasive alternative to a procedure such as surgical 
intervention. In addition to an explanation of the risks of the IR procedure it is 
important to set this in the context of a balance of risks between the IR procedure 
and the underlying condition and/or alternative procedure. 





8.11 IR procedures confer considerable benefit to the majority of patients but by 
necessity carry a degree of risk which includes the risk associated with ionising 
radiation. Shared decision making, consideration of risks and benefits of 
intervention and consent are a dynamic process that is informed by participants 
throughout the patient pathway. Discussion of risks and benefits within the context 
of shared decision making and informed consent is well established within IR 
practice although this process is most frequently focused on the direct risks and 
benefits of the intervention. 
8.12 Risks related to radiation exposure are less well documented and/or discussed 
within many consent pathways. There is considerable evidence that risks related to 
radiation exposure are poorly understood and often underestimated by participants 
in the patient pathway including patients and referrers. 
8.13 Clinicians undertaking interventional procedures should be in a position to consider 
and inform patients of both the direct risks of the procedure and the indirect risks 
such as the risks associated with radiation exposure related to the procedure. In 
addition to patient factors considered in diagnostic examinations, the complexity of 
the procedure makes establishing diagnostic reference levels for IR challenging 
(see paragraphs 7.22 to 7.28) In particular, for more novel complex procedures 
accurate established diagnostic reference levels are unlikely to be available. 
Nevertheless, there is a duty for practitioners to consider the radiation dose within 
the risks of the procedure and inform patients as appropriate. The European 
Directive 2013/59/ Euratom includes direction that “wherever practicable, prior to 
the exposure taking place, the practitioner or the referrer, as specified by Member 
States, ensures that the patient or his/ her representative is provided with adequate 
information relating to the benefits and risks associated with the radiation dose 
from the medical exposure. Similar information as well as relevant guidance shall 
be given to carers and comforters, in accordance with point (b) of Art. 56(5)” (EU 
2013).  
8.14 Legal standards that inform consent processes within the UK have changed 
significantly from an approach based on the ‘prudent doctor’ to one based on a 
‘prudent patient’. The case of Montgomery v Lanarkshire Health Board led to a 
ruling by the UK Supreme Court (2015)8 which some held to change the approach 
to consent, while others felt that it merely reinforced existing GMC 
recommendations. It did, however, formalise patient autonomy, in that it was made 
clear that it was not the medical professional’s role to decide what information 
should be given to the patient; the patient must be given whatever information they 
seek (Farrell and Brazier 2016, Chan and others 2017). The ruling established a 
duty of care to warn of material risks, the test of materiality being defined as 
whether “a reasonable person in the patient’s position would be likely to attach 
significance to the risk, or the doctor is or should reasonably be aware that the 
particular patient would be likely to attach significance to it.”  
8.15 For the reasons above, determining the significance of radiation dose for a 
particular patient will be challenging for clinicians. However, it should be noted that 
the individualised nature of consent means that dose thresholds will not be 
 
8 Montgomery (Appellant) v Lanarkshire Health Board (Respondent) [2015] UKSC 11 - On appeal from [2013] 
CSIH 3 





appropriate. Particular consideration is advised for discussion and disclosure of 
radiation dose for procedures that incur significant dose for benign conditions or in 
paediatric practice. 
8.16 There is a wide range in the approach to obtaining consent. In most cases 
requiring general anaesthesia, admission will take place in the preceding afternoon 
or evening and consent will be obtained then. 
Post IR surveillance 
8.17 ICRP (2000) suggests that patients who receive a cumulative skin dose greater 
than 3 Gy should have a skin assessment within 10 to 14 days of the procedure. If 
a skin injury is suspected, a follow-up appointment should be made with a 
dermatologist. Similar procedures occur in the US where patients are reviewed 30 
days post procedure when the cumulative skin dose is greater than 2 Gy (NCI 
2005). The American Heart Association have issued guidelines specific to IC and 
recommend that all patients who undergo 50 minutes of fluoroscopy are assessed 
for skin injury at both one and 3 month intervals post procedure. In addition, 
patients who are obese and have received 30 minutes of fluoroscopy time are also 
referred for follow-up and assessment (Hirshfeld and others 2004). 
Figure 8.1: Example of advice leaflet given to patient who has potentially been 
exposed to a skin dose exceeding 3 Gy. 
Vascular Patient Information Leaflet – MODERATE RISK 
You have recently undergone a lengthy procedure at …. Hospital. During this procedure 
it was necessary to use an X-ray dose which is potentially large enough to cause a skin 
reaction. Any reaction that occurs is likely to be mild and changes are most likely to 
appear in the area that was examined. 
Possible skin reactions include 
1. Reddening or discolouration of the skin. 
2. Temporary or permanent loss of hair in the irradiated area. 
If you notice any changes to your skin please discuss them with the doctor during your 
follow up clinic appointment or contact the department.  
Please follow the skin care advice below. 
Skin Care Advice 
• The area should be kept clean and checked regularly. 
• Avoid the use of perfumed products. 
• Avoid hot water - use warm water only. 
• Do not scrub the area, pat dry carefully after washing. 
• Avoid man-made fibres, cotton clothes and bed sheets are better. 
• Ensure the areas are well moisturised. Use a plain aqueous cream, such as E45. 
• Avoid shaving or waxing any damaged areas. 
• Avoid direct sunlight and use a sunscreen with factor 30 or higher at all times. 
 





8.18 An example of a UK patient advice note following a procedure where the CAK may 
exceed 3 Gy is shown in Figure 8.1. The issue of such forms should be 
documented in the patient record. 
8.19 Wherever possible, appointment dates for any routine follow-up should be provided 
to the patient prior to discharge. 
8.20 Tracking of dose indicators should be done and made part of the patient's record 
so that careful considerations of further exposure can be properly documented 
during the course of future treatment, and alternative strategies to reduce patient-
specific radiation burden can be developed and implemented (Glatz and others 
2014). Other imaging modalities such as echocardiography and MRI, which do not 
require ionizing radiation, should always be preferred for pre-and post-procedure 
evaluations, particularly in paediatric cases. 
Conclusions 
8.21 IR operators should attend MDT meetings with specialities which make regular 
referrals and hold out-patient clinics to explain proposed procedures to patients. 
8.22 Where appropriate, pregnancy status should be ascertained prior to the procedure.  
8.23 Printed leaflets, including illustrative material for paediatrics, should be provided for 
each procedure. 
8.24  Care should be taken in discussing radiation risk when obtaining informed 
consent, especially for paediatric procedures or those to treat benign conditions 
which may incur a significant dose. 
8.25 Where there is an expectation that skin doses could exceed 3 Gy, a patient advice 
note should be supplied and a follow-up out-patient appointment arranged.  
 
  





Chapter 9: Staffing issues and governance  
Workforce 
9.1 Provision of IR services requires a multi-disciplinary team comprising a variable 
combination of radiologists, radiographers, specialist nurses, clinical physiologists, 
healthcare assistants (HCA) and anaesthetic staff (including operating department 
practitioners). The numbers and types of staff required depends to some extent on 
the type of procedure being performed.  
9.2 Normally at least 5 members are required for a procedure to be performed in a 
safe manner. These include one radiologist/specialist consultant, one nurse or 
HCA to scrub/assist and a qualified nurse to provide sedation should that be 
required, a radiographer and an additional member of staff to supply equipment 
whilst the procedure progresses. While many patients are not sedated during IR, 
an increasing number of complex, time-consuming procedures are being 
performed under general anaesthesia requiring the presence of an anaesthetist 
and ODP within the room. 
9.3 In order to ascertain the number of radiologists working in IR the Royal College of 
Radiologists’ (RCR) undertakes an annual workforce evaluation; however, these 
surveys do not include cardiologists and other specialists who are not trained 
primarily in radiology. The 2018 RCR Workforce Census Report shows there to be 
a total of 674 interventional radiologists working within the UK (RCR 2019). This 
figure includes radiologists, with a primary or secondary interest in IR and so the 
number does not reflect whole-time equivalents. Service provision varies 
considerably both within each of the devolved administrations and also in different 
localities across the UK. 
9.4 This census shows that in England there are 585 interventional radiologists, 
divided into 402 vascular, 116 non-vascular and 67 neuroradiologists. In Wales 
there are only 17 vascular radiologists and one interventional neuroradiologist (see 
Table 9.1) (RCR 2019). On a population basis Wales is the most under-provided 
country within the UK across all of the sub-specialisms. It should be noted that the 
accurate figures for cardiology specialists are not available from this census since 
the majority are trained as cardiologists and are not registered with the RCR (see 
paragraph 9.8 below).  
9.5 The census highlights major percentage increases in interventional practitioners 
since 2014, in non-vascular (77.5%), neuro (67.4%) and cardiac (55.9%) sub-
specialisms. This is further evidence of the burgeoning use of IR procedures 
across an increasingly wide range of specialisms. The more modest increase in 
vascular specialists may in part be related to the fact that this discipline was 
already better developed in 2014 and might also be linked to some vascular-









Table 9.1: Compilation of the Royal College of Radiologists annual census reports 





























Consultant UK 3239 3318 2.4 3482 4.9 3656 3.3 3927 7.4 21.2 
 England 2663 2733 2.6 2870 5.0 3050 4.2 3296 8.1 23.8 
 Scotland 307 304 -1.0 321 5.6 320 -0.2 327 2.2 6.5 
 N Ireland 119 121 1.7 122 0.8 124 1.1 135 8.9 13.4 
 Wales 150 160 6.7 169 5.6 162 -2.8 169 4.3 12.7 
Trainee UK 1035 1323 27.8 1274 -3.7 1497 11.7 1555 3.9 50.2 
 England 883 1120 26.8 1076 -3.9 1244 10.4 1286 3.4 45.6 
 Scotland 92 116 26.1 117 0.9 142 14.2 149 4.9 62.0 
 N Ireland 34 44 29.4 40 -9.1 48 13.3 51 6.3 50.0 
 Wales 26 43 65.4 41 -4.7 63 35.8 69 9.5 165.4 
Radiologist FTE count 
Consultant UK 3048 3125 2.5 3226 3.2 3390 3.4 3622 6.8 18.8 
 England 2503 2575 2.9 2664 3.5 2828 4.1 3038 7.4 21.4 
 Scotland 288 288 0.0 298 3.5 298 0.0 303 1.7 5.2 
 N Ireland 114 114 0.0 112 -1.8 115 1.8 126 9.6 10.5 
 Wales 143 147 2.8 152 3.4 149 -1.3 155 4.0 8.4 
IR subspecialists 
incl. vascular UK 433 433 0.0 433 0.0 435 0.5 479 10.1 10.6 
 England 357 360 0.8   359 (fte) 402 12.0  
 Scotland 42 39 -7.1   38  33 -13.2  
 N Ireland 11 12 9.1   11  14 27.3  
 Wales 23 22 -4.3   19  17 -10.5  
non-vascular UK 80 103 28.8 103 0.0 110 6.8 142 29.1 77.5 
 England 70 89 27.1   88 (fte) 116 31.8  
 Scotland 5 6 20.0   6  6 0.0  
 N Ireland 4 4 0.0   5  5 0.0  
 Wales 1 4 300.0   4  6 50.0  
neuro UK 46 57 23.9 57 0.0 67 17.5 77 14.9 67.4 
 England 40 48 20.0   62 (fte) 67 8.1  
 Scotland 3 6 100.0   3  5 66.7  
 N Ireland 1 2 100.0   2  2 0.0  
 Wales 2 1 -50.0   1  1 0.0  
cardiac UK 111 113 1.8 113 0.0 136 20.4 173 27.2 55.9 
 England 98 98 0.0        
 Scotland 5 6 20.0        
 N Ireland 4 4 0.0        
 Wales 4 4 0.0        
Data from RCR Censuses (RCR 2014, 2016, 2017a, 2018, 2019). 






9.6 It should be noted that this is not a complete census of all clinicians who specialise 
in IR. For example, vascular surgeons also perform the arterial-vascular 
techniques described in Chapter 2. In addition, kidney access for percutaneous 
stone removal is increasingly performed in theatre by urological surgeons. One of 
the main reasons for the involvement of other specialties, is the replacement of 
many previously routine surgical procedures (either totally or in part) with IR (see 
Chapter 2). In some situations, involvement of non-radiology specialists can also 
be attributed to the lack of availability of a consultant interventional radiologist to 
assist/take ownership of the procedure. While in practise this should not be an 
issue, the training requirements of these non-radiology trained practitioners, 
particularly in the understanding of radiation risks for both themselves and their 
patients, need to be evaluated. 
9.7 In the UK, of over 90 neurointerventional practitioners in 2019, only 1 (trained 
primarily as a neurosurgeon) was not an interventional neuroradiologist, although a 
few interventional radiologists have been or are being trained to perform 
thrombectomy. This is typical of many Western European countries, Canada, 
Australia and New Zealand, but there is a wider variation in background of 
neurointerventional operators in the USA and Germany. 
9.8 One of the main uses of IR is in the treatment of patients with heart disease. 
However, the majority of these patients are treated by cardiology specialists. The 
British Cardiovascular Intervention Society (BCIS) commenced auditing of PCI in 
1988, when some 500 procedures were carried out. 
9.9 The 2017 to 2018 audit (BCIS 2019) reported the total number of consultant PCI 
operators (cardiologists and radiologists) as 663, with a 7% increase since 2012 as 
shown in Table 9.2. These data take account of those working on more than one 
site and, by comparing with the RCR data, suggest that there were 546 consultant 
cardiologists involved in providing this service in 2017 to 2018; the remainder being 
provided by consultant interventional radiologists. 
Table 9.2: Number of consultant PCI operators (BCIS 2019) 
Year 2012 2013 2014 2015 2016 2017 to 2018 
Operators 621 630 659 647 660 663 
9.10 The 2018 to 2019 data (BCIS 2020) show a further 4% rise in the number of 
operators to 693. Only 5.8% of these are female. 
9.11 The gender imbalance is seen across all interventional radiology services. 
Reasons for this have been suggested to include radiation protection 
considerations, the need for high flexibility for covering on-calls and heavy 
workload, with the consequent difficulties in balancing roles at home and work. 
These factors have been evaluated in regard to females who work in diagnostic 
radiology, but the real reasons why few women choose IR are poorly understood 
(Perez and others 2016). 
9.12 Although only a single case, Chen and Brunet (2020) reported on the radiation 
doses estimated to have been received by a neurointerventional fellow prior to and 





during pregnancy. No significant differences were observed in mean fluoroscopy 
times, procedure doses or personal radiation exposures measured by collar 
dosemeters before and during pregnancy. During pregnancy, an additional 
dosemeter was worn under 2 lead apron skirts to estimate foetal radiation 
exposure, recording 0mrem for all 6 months. This suggests that foetal radiation 
exposure need not be a matter of concern for female operators provided good 
radiation protection practice is followed 
9.13 Another important pressure on the workforce is the need for out-of-hours (OOH) 
provision since a number of the procedures may need to be carried out in 
emergency situations, for example, embolisation to stop critical haemorrhaging, 
critical cardiology procedures and so on. The British Society of Interventional 
Radiology (BSIR, unpublished data) has recently estimated that only 45% of IR 
units are able to provide comprehensive OOH IR care, potentially putting many 
patients at risk. This is due to several factors. In some centres there are not 
sufficient IR consultants to provide a safe sustainable OOH rota while, in other 
localities, there are radiologists but not enough support staff such as nurses or 
radiographers.  
9.14 The BSIR has indicated that a 1 in 6 on-call rota is suitable for the majority of units 
to function effectively, although it has been proposed that those serving a larger 
population should consider using a 1 in 8 on-call rota, due to a larger OOH case 
load. On this basis, BSIR has estimated a requirement for a further 403 
Interventional Radiologists in order to provide a 1 in 6 on-call rota in each trust in 
the UK (the regional shortfall varying from 22 to 48% of current levels).  
9.15 There does not appear to be the same shortfall in PCI services (Ludman, 2020, 
personal communication), perhaps because of national planning. 
9.16 For those units unable to provide 24 hr OOH cover, BSIR advise that formal 
arrangements should be in place for a neighbouring unit to provide cover with 
agreed protocols for transfer of patients, but this has not currently been uniformly 
adopted within the UK. 
9.17 These figures do not account for annual and study leave and cross cover within a 
department to allow for suitable recovery following an onerous on call period. 
Interventional radiologists will also have diagnostic imaging commitments which 
may or may not be related to their IR work as well as a requirement to attend multi-
disciplinary team (MDT) meetings. In addition, they should have identified out-
patient sessions discussing risk and obtaining patient consent, and clinical time for 
ward visits or follow up as well as audit and registry involvement. All these activities 
will obviously reduce the time available for performing IR procedures. This reduces 
their overall exposure times but puts additional pressure on the staff to provide a 
safe and sustainable service if the number of trained staff is inadequate.  
Medical Physics Experts 
9.18 There is an ongoing shortage of medical physicists with the necessary expertise to 
undertake all the tasks relating to the optimisation of procedures and carrying out 
of performance tests and patient dose surveys. Moreover, a significant number of 
radiology physicists are about to retire. More training posts are required to fulfil this 
need. 
 






9.19 The current RCR consultant training programme requires radiologists to complete 
5 years of training. To be recognised as an interventional radiologist they are 
required to complete 3 full years in this sub-specialism. To meet this requirement, 
they commence IR training in year 4 and complete the 3 year requirement by 
adding an extra year in year 6. Many interventional radiologists will use year 6 to 
gain experience at another centre within the UK or abroad on a recognised 
fellowship scheme. It is seen as important that trainees are exposed to a broad 
spectrum of procedures allowing them to develop the necessary skills to practice at 
consultant level.  
9.20 Regulation 15 of the IRR17 (IRR 2017) requires employers to ensure that those 
that work with radiation receive appropriate information and instruction. This 
includes the risks to health created by exposure to ionising radiation as a result of 
their work, the general and specific radiation protection procedures and 
precautions which should be taken in connection with the work with ionising 
radiation to which they may be assigned and the importance of complying with the 
medical, technical and administrative requirements of the IRR17. As this training 
must take account of the local circumstances and conditions, it cannot be assumed 
that IR trainees have received adequate training during their 5-year training 
programme. Thus, the employer must take steps to ensure that adequate 
information, instruction and training has been or is given prior to them commencing 
work with ionising radiations. Furthermore, the IRR17 also requires that any 
training and information given in accordance with Regulation 15 must be repeated 
at appropriate intervals and documented by the employer. For most employees, 
including interventional radiologists, this ‘refresher’ training should be given every 3 
to 5 years.  
9.21 All operators must receive initial training in patient radiation management when 
beginning work in the interventional radiology suite (ICRP 2009b). Radiation safety 
training should include review of the potential adverse effects of radiation on 
patients and staff, and evaluation of factors that affect patient and staff doses, and 
measures that can be taken to reduce dose. Operators should be informed how to 
estimate patient dose using the DICOM Dose Reports or other surrogate 
parameters of radiation exposure (Stecker and others 2009). There should be 
close cooperation with MPEs who can advise on dose levels delivered by different 
equipment programme options. Trainees and experienced interventional 
radiologists should have a close awareness of radiation dosage and be looking for 
opportunities to minimise exposure. Training should also include understanding of 
the most important tissue reactions and the radiation dose levels, at which they 
may occur (ICRP 2000). 
9.22 Operators should undergo adequate training in interventional techniques prior to 
performing interventional procedures under the supervision of an experienced 
operator until they are judged capable of performing procedures by themselves. 
Simulators may be used for training in catheterization techniques and how to 
manage radiation dose (Willaert and others 2011, See and others 2016, Keefe and 
others 2018). Simulators enable techniques to be repeated, allowing trainees to 
increase their procedural efficiency, and thereby reduce complication rates and 
radiation exposure. 





9.23 Miller and others (2010), ACC (2016), Morishima and others (2016), Sheyn and 
others (2008) and Vano and others (2006) suggest that educating staff about best 
practice and radiation protection is the best way to ensure the ALARA principle is 
maintained. Major improvements in practice were reported after the implementation 
of a safety education initiative in the paediatric interventional suite. Minor changes 
to practice, for example, increased collimation, use of last-image-hold and 
decreased panning during imaging, all contributed to the overall dose reduction to 
patients and staff. There is a need for periodic refresher training in techniques and 
update training in radiation protection and dose levels. Such training should be 
given by a combination of specialists, radiologists / clinicians, medical physicists, 
and radiographers. 
9.24 Similarly, for clinicians not trained as radiologists who are performing IR 
procedures (for example, vascular surgeons, urologists and cardiologists), there is 
a clear need for training in all relevant aspects of ionising radiation and protection. 
Several recognised courses including on-line courses, have become available 
since introduction of the initial IR(ME)R 2000 regulations (IR(ME)R 2000).  
Regulation of radiation exposure during a working life 
9.25 Several members of staff will be present during a procedure, they will be exposed 
to ionising radiation to varying degrees depending on their role and in particular 
where they are required to stand within the IR suite to perform their duties. Another 
major factor contributing to working-life exposure is the number of interventional 
sessions that an individual consultant performs. This varies considerably between 
hospitals and between practitioners, with some doing up to 8 sessions weekly. 
Clearly the number of sessions will be a determinant of the total dose received. 
The same applies to non–medical IR staff, although some of these will rotate 
between different types of imaging within a department, for example, 
radiographers. However, many nurses are routinely assigned to work continually 
with an IR suite. 
9.26 The interventionalist is most at risk from incidental radiation exposure since he/she 
works immediately adjacent to the patient. This group also are more likely to spend 
a considerable proportion of their working life in this role. Over the course of his or 
her career, an IR practitioner is exposed to an estimated 50 mSv to 200 mSv of 
ionizing radiation. The brain is subject to higher-intensity exposure, given the 
proximity of the head to the radiation source. In the past, career exposure to the 
head was estimated to be some 1,000 mSv (Picano and others 2012), but this was 
a figure derived from an estimate of the unshielded dose. The combination of 
modern x-ray units and shielding will have reduced this figure substantially. 
9.27 Interventionalist staff often have a significant case load and will typically spend 
over 60% of their working week in the interventional radiology suite (see above). 
With the burgeoning of IR techniques that have clear clinical benefit, the work load 
is inevitably set to increase and will result in a potential increase in radiation 
exposure of staff (within the bounds of available working time), ameliorated by 
comprehensive radiation protection measures (discussed in Chapter 5).  
  





Classification of staff exposed to radiation in the workplace 
9.28 Regulation 21 of the IRR17 (IRR 2017) states that ‘the employer must designate as 
classified persons those of its employees who are likely to receive an effective 
dose greater than 6 mSv per year or an equivalent dose greater than 15 mSv per 
year for the lens of the eye or greater than 150 mSv per year for the skin or the 
extremities’ (see also paragraphs 432 to 436 of the ACoP and guidance to the 
IRR17 L121 ‘Work with Radiation’ (HSE 2018)). 
9.29 It is important to note that the requirement to classify persons is not just based on 
likely routine exposures but also the exposures that a person could receive as a 
result of a radiation accident. Thus, if the employer’s radiation risk assessment has 
identified reasonably foreseeable accidents where a person could receive more 
that the specified classification thresholds, either as a result of that accident or 
likely to be incurred as a result of any remedial action, then that person must be 
classified. This is despite their possibly low routine exposures. 
9.30 The classification thresholds are not dose ‘limits’ or dose action levels. The 
overarching requirement of the IRR17 is that all exposures should be ALARP and 
that should be the principal aim of radiological protection (IRR 2017). Action to 
reduce exposures should not just be taken because a person is approaching the 
thresholds that would require that person to be classified. Restricting exposures to 
levels which are ALARP should be a continuing and constant process. 
Furthermore, classifying a person does not mean that that person is free to incur 
higher radiation exposures than others – the ALARP principal still applies. 
Conclusions 
9.31 The RCR census results show a marked increase in the number of radiology 
trainees in both 2017 and 2018, with an average increase of approximately 50% 
between 2014 and 2018 across the UK. The numbers of consultants, however, 
rose only by some 20% in the same period. 
9.32 The data for interventional radiologists demonstrate an increase of 30% between 
2014 and 2018; to this must be added an unknown number of practitioners from 
other clinical specialities. In particular, by comparing RCR numbers with those from 
BCIS, it is estimated that there are some 550 cardiologists involved in PCI. 
9.33 A significant gender imbalance is seen across all IR services. 
9.34 With the exception of PCI services, only half of UK IR units are able to provide 
comprehensive out-of-hours services. 
9.35 Even for those completing the current 5-year RCR consultant training programme 
additional local training may be necessary. There is a clear need for formalised 
training for those from other clinical specialities. Employers also must provide 
refresher training at suitable intervals. 
9.36 Employers must designate as ‘classified persons’ those staff who are thought likely 
to exceed the dose constraints set out in IRR17.  
9.37 There is need for more training posts to counter the predicted shortage of medical 
physicists who have the necessary expertise to undertake all the tasks relating to 
the optimisation of procedures. 





Chapter 10: Survey of IR practice in the UK 
2015 to 2017  
Introduction  
10.1 As noted in the preface, the Subcommittee found that there were few data 
available about the use of IR in the UK. It was decided that the only way forward 
was to develop a questionnaire (Appendix E) and distribute it to a sample of 
hospitals around the UK. 
10.2 As with all surveys, there is a compromise to be made between requesting 
detailed information, which makes the reply very time consuming, and the 
expected response rate. This was felt to be a particular problem in requesting 
radiation dosimetry data, since the equipment used presents this in different ways, 
making completing a standard questionnaire difficult, depending on the 
information type requested. 
10.3 Table 2.1 separated the various types of procedure into 3 categories – radiology, 
cardiology and neuroradiology since these may be carried out in different 
locations in a hospital and under different management arrangements. 
10.4 While the RCR Clinical Radiology UK workforce census reports gave information 
on the numbers of radiologists working in IR, there are also a considerable 
number of other medical staff involved such as cardiologists, vascular surgeons 
and neurosurgeons. The survey sought data on both consultant and junior staff 
from all disciplines. The RCR reports do not record the total number of sessions 
worked or the maximum number of sessions worked by an individual, which are 
important in estimating potential radiation dose exposure, and so these questions 
were included. 
10.5 The IR team incorporates other members; radiographers and nurses will usually 
be present, with staff such as physiological measurement technicians and clinical 
physiologists participating in a range of procedures. The same data were 
requested for these 3 groups as for the medical staff. 
10.6 Equipment questions were limited to the number of rooms, type of installation 
(single plane or biplane) and year of installation. 
10.7 There are ongoing studies on how best to monitor staff doses and so a limited 
number of questions were asked, including one on the recently introduced real-
time dosimetry systems. 
10.8 Since the risk to paediatric patients from a given dose of ionising radiation is 
greater than for adults (see Chapter 3), these procedures were separated out. 
10.9 Although some modern equipment records detailed information on patient 
dosimetry, it was decided only to request data on CAK, separately for adult and 
paediatric studies. This was split into 4 bands, commencing with CAK levels 
mandating patient follow-up procedures in the USA and EU. 
10.10 Since regulations relating to permitted eye dose have been amended recently, 
data on staff eye doses was requested in a separate section. This was split into 5 
bands. 





10.11 Since IR procedures are carried out in most hospitals it was thought important to 
spread the survey across all types. Hospitals were classified as large (major 
teaching centres), medium or small using data provided by DHSC. A range of 
hospitals with a broad geographic distribution across the UK were selected to 




10.12 In the surveyed units, a total of 4 to 40 sessions were provided each week by 
between 2 and 14 consultant radiologists, with an individual maximum of between 
2 and 8 sessions per week. In addition, the service was supported by between 0 
and 7 consultants from other disciplines, who contributed a total of up to 14 
sessions per week.  
10.13 Between 1 and 5 junior radiology staff participated in the service with an 
individual maximum of 10 sessions per week. 
10.14 The number of radiographers involved ranged from 6 to 29, the maximum number 
of sessions worked by an individual being 2 to 14 per week. 
10.15 The nurse pool providing the service varied from 3 to 47, the individual maximum 
lying between 4 and 12 sessions per week. 
10.16 Just under half of units reported input from other staff such as physiological 
measurement technicians and clinical physiologists. Their numbers ranged from 2 
to 12, the total number of sessions provided being 3 to 16 per week. 
10.17 Units comprised between 1 and 5 IR rooms; only one-third of units had biplane 
equipment (and then not in all rooms). Seventeen percent of equipment was less 
than 2 years old, 44% between 2 and 5 years old, 30% between 6 and 8 years 
old and 9% greater than 8 years old. 
a) Vascular IR 
10.18 The total number of adult procedures increased by 6.1% between 2015 and 2017. 
The highest CAK for a vascular adult procedure was reported as greater than 
8,000 mGy. The percentages of CAK above 2000 mGy is shown in Table 10.1. 
There were no reports of CAK above 2,000 mGy for paediatric studies. 
Table 10.1: Percentages of cumulative air kerma doses (CAK) above 2,000 mGy for 
vascular investigations 
Cumulative air kerma (mGy) 2016 2017 
2000 to 3000 0.27 0.99 
3000 to 5000 0.14 0.55 
5000 to 8000 0.04 0.18 
>8000 0.09 0.06 





10.19 Only 0.2% of renal dialysis procedures recorded the highest CAK of between 
2,000 and 3,000 mGy. Percentages of non-vascular procedures recording a CAK 
above 2,000 mGy are shown in Table 10.2. 
Table 10.2: Percentages of non-vascular procedures leading to a CAK greater than 
2,000 mGy 
Cumulative air kerma (mGy) 2016 2017 
2000 to 3000 0.60 0.77 
3000 to 5000 0.40 0.03 
5000 to 8000 0 0 
>8000 0 0 
10.20 None of the respondent sites made use of real-time dosimetry systems for staff. 
The highest eye dose recorded was in the range 20 to 50 mSv. The percentages 
of recorded eye dose in each category is shown in Table 10.3. 
Table 10.3: Percentages of recorded eye doses in each category  
Eye dose (mSv) 2015 2016 2017 2018 
5 to 10 6.7 5.5 6.0 6.6 
10 to 15 1.4 2.3 1.7 1.6 
15 to 20 0 1.4 0.4 1.6 
20 to 50 0 0.5 0 0 
 
Cardiology 
10.21 Larger units had 3 or 4 rooms, with smaller units restricted to one; all utilised 
single-plane installations. Equipment had been installed or refurbished since 
2011. 
10.22 Services were provided by between 12 and 19 consultant staff on the larger sites, 
where a total of between 30 and 40 sessions per week were carried out. On 
smaller sites, between 4 and 6 consultants were involved, providing a total of 4 to 
10 sessions. The maximum number of sessions conducted by an individual 
consultant was 2 to 5 per week,  
10.23 The maximum number of sessions attended by an individual radiographer lay 
between 4 and 10 per week, with a similar figure for nursing staff. 
10.24 The total number of procedures carried out rose by 7% between 2015 and 2017, 
with increases of 56% in percutaneous valve insertion and 24% in 
electrophysiological mapping/ablation.  
10.25 The highest recorded CAK for adult procedures was in the range 5,000 to 8,000 
mGy and the percentages of studies resulting in doses above 2,000 mGy in 2016 
and 2017 are shown in Table 10.4. 





Table 10.4: Percentage of studies resulting in cumulative air kerma greater than 
2,000 mGy 
Cumulative air kerma (mGy) 2016 2017 
2000 to 3000 0.9 0.7 
3000 to 5000 0.2 0.3 
5000 to 8000 0.02 0.03 
 
10.26 Around one-third of units employed real-time dosimetry. 
10.27 The highest eye dose recorded was in the range 20 to 50 mSv. The percentages 
of eye dose in each range are shown in Table 10.5. 
Table 10.5: Percentage of recorded eye doses in each category 
Eye dose (mSv) 2015 2016 2017 2018 
5 to 10 5.3 4.4 2.9 5.7 
10 to 20 1.3 2.9 1.0 0 
20 to 50 1.3 0 0 0 
10.28 Data provided by BCIS show that, in 2017 to 2018, 102,258 adult PCI procedures 
were undertaken in 118 centres (98 NHS, 20 private) and 100,294 procedures in 
2018 to 2019. The total workload breakdown is shown in Table 10.6 and PCI 
numbers by country in Table 10.7. 
Table 10.6: UK PCI data for 2017 to 2018 and 2018 to 2019 
 Number of 
centres 
PCI  
2017 to 2018 
PCI  
2018 to 2019 
NHS Interventional 98 101,057 99,253 
Private interventional 20 1,201 1,041 














Table 10.7: Adult PCI numbers by country for 2017 to 2018 and 2018 to 2019 
Country Type PCI 
2017 to 2018 
PCI 
2018 to 2019 
England NHS 83,482 81,559 
 Private 1,074 954 
Scotland NHS 8,998 9,007 
 Private 75 50 
Wales NHS 4,356 4,720 
 Private 52 37 
Northern Ireland NHS 4,221 3,967 
 
10.29 The great majority of centres reported that fewer than 0.05% of patients required 
emergency cardiac surgery due to failure or partial failure of the PCI.  
10.30 Figure 10.1 shows the numbers of adult PCI procedures and coronary artery 
bypass graft surgery (CABG) operations performed in the UK between 2001 and 
2018 to 2019. It can be seen that there was a steep increase between 2001 and 
2006 in PCI, with a slower, but fairly steady, rate of increase since then. The 
overall increase over the whole period is approximately 250%, while the increase 
between 2015 and 2018 is 5.3%, with a decrease of 1.9% in 2018 to 2019. The 
number of CABG procedures has been dropping since 2004 and is now some 
40% less than in 2001.  





















































Adult PCI and CABG procedures
Coronary artery bypass (CABG)
Percutaneous coronary interventions (PCI)





10.31 The increase in PCI numbers in the early years is much greater than the drop in 
CABG numbers, perhaps indicating that the new technique was employed 
primarily to treat patients with early signs of disease. Figure 10.1 shows that the 
number of PCI procedures increased by 10.6% between 2012 and 2017 to 2018, 
while the number of operators increased by 7% (Table 7.2). This suggests that a 
limiting factor on growth is the number of operators. 
Interventional Neuroradiology 
10.32 This specialism is only provided by a limited number of centres within the UK 
(currently 28); data were obtained from 4 major institutions. 
10.33 Three or 4 consultants provided the service, carrying out a total of 4 to 12 
sessions per week with a maximum individual commitment of between 4 and 6 
sessions. There were 1 or 2 junior staff inputting a maximum of 10 sessions. 
10.34 The radiography pool varied between 12 and 16, with a maximum individual 
commitment of 4 to 12 sessions. Between 7 and 26 nurses were involved, the 
maximum number of sessions being 10 to 12 per week.  
10.35 Data on paediatric procedures were returned by only one site, showing no 
difference in numbers between 2015 and 2017. There were no instances of CAK 
above 2,000 mGy. 
10.36 The total number of adult procedures increased by over 7% between 2015 and 
2017. The largest increase was for mechanical thrombectomy in stroke cases, 
demonstrating a 40% increase between 2016 and 2017. 
10.37 The average number of procedures per consultant ranged from between 37 and 
80 per annum in 2015 to between 62 and 94 in 2017. 
10.38 The highest recorded CAK for adult procedures was in the range 5000 to 8000 
mGy and the percentages of studies resulting in doses above 2,000 mGy in 2016 
and 2017 are shown in Table 10.8. 
Table 10.8: Percentage of studies resulting in cumulative air kerma (CAK) greater 
than 2,000 mGy 
Cumulative air kerma (mGy) 2016 2017 
2000-3000 1.2 2.6 
3000-5000 0.5 1.0 
5000-8000 0.2 0.1 
  
10.39 All units provided under apron badges to staff in the IR room, with collar badges 
generally issued only to interventional radiologists. Only one unit used a real-time 
dosimetry system routinely. 
10.40 In terms of eye dose, there were no recorded doses above 10 mSv between 2015 
and 2018, while less than 25% of doses were greater than 5 mSv in any year. 
 






10.41 There are few data on the provision of IR services across the UK. This makes it 
difficult to evaluate trends in clinical practice, establish staffing requirements for 
the various staff groups involved and plan future service provision. 
10.42 The lack of patient dose data hinders the establishment of national DRLs for IR 
procedures. 
10.43 From the surveyed sites, the maximum number of IR sessions per week was 8 for 
consultants, 10 for trainees, 14 for radiographers and 12 for nurses. 
10.44 Some 90% of the equipment on the surveyed sites was 8 or fewer years old. 
10.45 The proportions of surveyed procedures in 2018 leading to a patient CAK in 
excess of 3Gy, and thus requiring follow-up were 0.8% for vascular IR, 0.3% for 
non-vascular IR, 0.3% for IC and 1.1% for INR. 
10.46 No operators in IC or INR recorded eye doses in excess of 15 mSv in 2018, the 
level at which staff require to be classified. Eye doses between 15 and 20 mSv 
were recorded in 1.6% of vascular and non-vascular staff in the same year. 
 
 





Chapter 11: International comparisons  
Introduction 
11.1 In 2014 there were 48 radiologists per million population in the UK (RCR 2015), 
compared to 92 per million in Germany, 112 per million in Spain and 130 per 
million in France.  
11.2 An on-line survey of interventional radiology services was distributed to 1180 
radiology departments across Europe by the European Society of Radiology 
(ESR) and the Cardiovascular and Interventional Radiological Society of Europe 
(CIRSE) in 2017 (ESR and CIRSE 2019). There were 98 answers (response rate 
8.3%) from 21 nations. 
11.3 Fifty-one responses came from hospitals with more than 800 beds, 28 from 
hospitals with 400 to 799 beds, 15 from hospitals with 200 to 399 beds and 4 
hospitals with less than 199 beds provided an answer. Ninety-five percent were 
from teaching hospitals that employed radiologists-in-training. 
11.4 In terms of total radiology staffing, there was a reasonable gender balance; 42% 
of hospitals had more than 50% female radiologists, but the great majority of 
interventional staff were male. 
11.5 Sixty out of 97 hospitals operated an out-of-hours service, somewhat higher than 
in the UK. 
11.6 In 45 of the 72 hospitals providing a neurointerventional service, procedures were 
performed by interventional neuroradiologists. Interventional radiologists were 
directly involved in 19 departments. There were, however, 8 hospitals in which 
neurointerventional services were provided by other specialists, such as 
neurosurgeons, cardiologists, traumatologists, or neurologists. 
11.7 Cardiac interventional procedures were performed in 84 hospitals, the service 
being provided by cardiologists or cardiac surgeons in 83. In only one case was 
the service run by interventional radiologists. 
11.8 The workload of IR practitioners is not confined to performing procedures. Bundy 
and others (2020) surveyed 263 US interventional radiologists for signs of 
burnout using the Maslach Burnout Inventory. Some 95% worked more than 40 
hours per week, with approximately 30% working in excess of 60 hours per week. 
Evidence of burnout was assessed to be present in over 70%. 
Elective abdominal aortic aneurysm repair 
11.9 Jetty and Husereau (2012) reported that the proportion of repairs in Canada 
carried out by EVAR rose from 11.5% in 2005 to 35.5% in 2009. 
11.10 Using data only from Ontario, Salata and others (2018) found a significant 
difference in EVAR rates between men and women. The proportion of repairs 
carried out by EVAR in men rose from around 8% in 2003 to 63% in 2016, with 
the cross-over point being reached in 2010. For women, however the proportion 
was 9% in 2003 and only reached 50% in 2016. The authors suggested that a 
partial reason for the slower uptake in women was related to a size mismatch 





between the endograph delivery systems and the smaller sizes of the femoral and 
iliac arteries in women; they expected this to improve with newer hardware 
developments. 
11.11 The same group (Salata and others 2019) analysed their 2003 to 2016 data to 
find 4,010 matched pairs of patients, one of whom had undergone EVAR and the 
other an open repair. The mean follow-up was 4.4 years with a maximum of 13.8 
years. The EVAR group demonstrated a higher 1-year survival rate (94% vs 91%) 
but there was no significant difference in long-term survival. The EVAR patients, 
however, showed a substantially better long term major adverse cardiac event 
free survival (32.6% versus 14.1%).  
11.12 The 2019 Annual Report from the UK National Vascular Registry (Waton and 
others 2019) noted that the proportion of procedures carried out by EVAR rose 
from 54% in 2009 to 66% in 2013 and has remained stable since. The 30-day 
mortality rate was 0.4% for EVAR and 3.2% for open procedures.  
11.13 The UK Health Technology Assessment report (Patel and others 2018) followed 
up 1,252 patients recruited to the EVAR-1 trial between 1999 and 2004 (626 each 
treated by EVAR or open procedure) over a mean of 12.7 years. They found early 
lower mortality in the EVAR group, but a worse longer-term outcome with 9.3 
deaths per 100 person-years versus 8.9 in the open procedure group. They also 
suggested that EVAR had a higher lifetime cost (mean £19,672 vs £15,876). It 
was noted that the current position may be more favourable to EVAR given the 
development of improved devices.  
11.14 In the Netherlands, a retrospective study of some 2000 patients treated between 
2007 and 2012 is being carried out (Geraedts and others 2020). This aims to 
determine the appropriateness of postoperative surveillance as well as long-term 
outcomes.  
11.15 A 2016 survey of Australasian vascular surgeons(Lo and others 2016) found that 
some 70% of elective abdominal aortic aneurysm repairs were carried out by 
EVAR but that only 25% of ruptured aneurysms were repaired by endovascular 
procedures (REVAR). Eighty percent of respondents identified a lack of 
endovascular facilities (including appropriate anaesthetic facilities) as responsible 
for the difference, with 55% also reporting a lack of ancillary staff. Over 75%, 
however, felt that REVAR offered a reduced intraoperative blood loss, a lower 
complication rate and a shorter length of stay. 
Cardiology 
11.16 Table 11.1, derived from Barbato and others (2020) shows the number of adult 
PCI procedures carried out per million population across European countries and 
is an amalgamation of2016 and 2017 data. It can be seen that the UK has a lower 









Table 11.1: Numbers of PCI procedures per million population (2016 or latest year) 
(Barbato and others 2020) 
PCI procedures Countries 
Under 1,000 Romania, Egypt 
1,000 to 1,499 UK, Spain 
1,500 to 1,999 Denmark, Greece 
2,000 to 2,499 Sweden, Netherlands Belgium 
2,500 to 2,999 Slovenia, France, Italy, Turkey 
More than 3,000 Switzerland, Poland, Germany 
 
11.17 Table 11.2 derived from Barbato and others (2020) depicts the number of 
interventional cardiologists per million population among European countries and 
again the UK features a lower ratio than most other countries.  
Table 11.2: Numbers of interventional cardiologists per million population (2016 or 
latest year) (Barbato and others 2020) 
Interventional cardiologists Countries 
Under 10 Romania, Egypt 
10 to 14 UK, Netherlands, Sweden 
15 to 19 Spain, Poland, Denmark, Italy, Slovenia 
20 to 24 Turkey, France, Greece, Belgium 
25 to 29 Switzerland 
More than 30 Germany 
 
11.18 Table 11.3 derived from (Barbato and others 2020) shows the number of hospitals 
per million population which have continuous availability of catheterisation 
laboratories across European countries. 
Table 11.3: Numbers of catheter laboratories available 24/7 per million population 
(2016 or latest year) (Barbato and others 2020) 
Number of laboratories Countries 
Less than 1 Denmark, Egypt 
1.0 to 1.9 UK, Netherlands, Slovenia, Spain 
2.0 to 2.9 Sweden, Greece 
3.0 to 3.9 Italy, France, Switzerland 
Greater than 4 Poland, Belgium, Germany 





11.19 The NCRP (NCRP 2019) conducted a survey of the radiation doses associated 
with medical exposures in the USA in 2016. A wide range of data sources were 
utilised, including a comprehensive literature survey, returns from various US 
government agencies, data from professional societies and commercial surveys. 
The data were found to be inherently fragmentary in nature and not collected by 
the sources on a uniform basis. 
11.20 It was estimated that the number of non-cardiac interventional fluoroscopy 
procedures carried out in the USA declined from 12 million in 2006 to 4.6 million 
in 2016. The main reasons for the apparent drop lie in the definitions used in 
2006 and procedures which then used fluoroscopy but which do not now do so. 
The associated per capita effective dose reduced from 0.20 to 0.13 mSv. 
11.21 The number of cardiac interventional fluoroscopy procedures reduced from 4.6 
million in 2006 to 4.1 million in 2016, with more coronary diagnostic and 
percutaneous interventions being carried out as a single procedure. The per 
capita effective dose reduced from 0.23 to 0.12 mSv.  
11.22 Comparing extrapolations from several sources, an estimate of 850,000 PCI 
procedures were carried out in the USA in 2016, compared to some 500,000 in 
2009 (NCRP 2009).  
11.23 It was noted that, as a result of a programme of dose reduction measures, there 
had been a drop of approximately 50% in patient dose for the most complex PCI 
procedures since 2016.  
11.24 The US data show an increase of 70% between 2009 and 2016, compared to 
21% in the UK. 
11.25 Taking the 2016 data for both countries, the numbers of PCI procedures per 
million population were approximately 2,630 for the USA and 1,530 for the UK. 
11.26 Giustino and others (2020) reported data from the EXCEL (Evaluation of XIENCE 
Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main 
Revascularization) trial in the USA. This trial randomised 1,900 patients to either 
PCI or CABG and, during 3-year follow up, there were 346 repeat 
revascularisations required. These occurred in 12.7% of PCI patients vs 7.6% of 
CABG patients. 
Neurointervention  
11.27 Endovascular therapy is established as the standard of care for patients suffering 
acute ischaemic stroke. The UNMASK EVT survey was carried out by Ospel and 
others (2020) to establish how endovascular therapy decisions made by 
physicians under the constraints of local resources differed from those they would 
have made in the absence of any constraints. A total of 607 physicians took part, 
of whom 218 were from North America and 136 from 25 European countries. 
11.28 A ‘resources gap’ was defined as the difference between the ideal (no 
constraints) and actual rates of endovascular therapy. The deficit in resources 
was <5% for the majority of North American states/provinces and European 
countries. In Europe, Austria, the Czech Republic, Estonia, Norway and Romania 





recorded deficits between 5 and 20%. The largest deficits recorded from the 
North America/Europe group were 30% for Poland and 33% for the UK. 
11.29 The numbers of respondents per European country were low (9 from the UK) and 
there were no data to establish the reason(s) for the resources gap. The latter did 
not correlate with either GDP per capita or healthcare metrics. and it was 
suggested that local factors such as on-call availability or regional/national factors 
such as an insufficient network of comprehensive stroke centres could be 
responsible. 
11.30 As noted in paragraph 2.43, the UIA caseload in the UK is well below that of other 
countries. 
11.31 In 2013, the National Confidential Enquiry into Perioperative Deaths (NCEPOD) 
report, ‘Managing the Flow? A review of the care received by patients who were 
diagnosed with an aneurysmal subarachnoid haemorrhage’, highlighted the need 
for 7-day INR services for ruptured cerebral aneurysm treatment and although 
progress has been made, not all regions are yet able to provide this (NCEPOD 
2013).  
Oncology 
11.32 As noted above (see paragraph 2.62), transarterial chemoembolization (TACE) is 
accepted as the mainstay of treatment for hepatocellular carcinoma. Young and 
others (2019) carried out an online survey of techniques used by practising 
members of the 5 largest interventional radiology societies in Chinese and 
English. A total of 1,160 responses were obtained from 62 countries. 
11.33 Significant differences in practice were found. Doxorubicin was more widely used 
as the cytotoxic agent in North America, Europe and South Korea than in Japan 
and China (p=0.0001). There were differences also in how the dose of cytotoxic 
agent was determined. For single and multiple carcinomas, drug-eluting bead 
TACE was most popular in North America and Europe, while conventional TACE 
was most popular in Japan, Korea and China (both p=0.0001).  
DRLs 
11.34 In Ireland, national DRLs are derived for the most common procedures using the 
European Commission methodology as set out in RP-109 and RP-130. The 
Medical Exposure Radiation Unit (MERU) of the Irish HSE collects data from 
multiple locations on the median patient dose for 30 patients for each procedure. 
From this, the 75th percentile of the dose distribution is chosen as the DRL. These 
are approved by the National Radiation Safety Committee and published in the 
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Table 11.4 Irish National DRLs (HSE 2017) 
Examination DRL in DAP(Gycm2) 
Colon 13 
Biliary tract 16 
Cerebral procedures (for example embolization) 62 
Cardiac studies 55 
PTCA 75 
All peripheral procedures 30 
All pelvic or abdominal procedures 70 
11.35 In Germany, DRLs for diagnostic and IR procedures were updated in 2018 
(Schegerer and others 2019). Values for 9 IR procedures were added. Data (DAP 
and fluoroscopy time) were collected for tens of thousands of procedures carried 
out between 2012 and 2017 from a range of sources. In accordance with ICRP 
recommendations (ICRP 2017), the DRLs were defined by the 75th percentile of 
the dose distributions, although the results were checked for plausibility and 
against values from other countries. The new values are shown in Table 11.5, the 
75th percentile of reported fluoroscopy time being included for guidance. 
Table 11.5: DRL values and fluoroscopy times for IR procedures in Germany 
Type of procedure DRL (Gy.cm2) Fluoroscopy time (min) 
75th percentile 
Recanalization of cerebral artery 180 35 
EVAR of cerebral artery 250 54 
PCI 48 13 
Combined CA and PCI 55 13 
TAVI 80 18 
EVAR 
 thoracic aorta 230 19 
 infrarenal abdominal aorta 230 33 
 suprarenal abdominal aorta 230 52 
TACE 230 25 
PTA of 
 pelvis 90 17 
 thigh and knee 40 18 
 lower leg and foot 25 31 
 
 





Table 11.6: Reference levels and fluoroscopy times for IR procedures in France.  
Type of procedure DRL (Gy.cm2) Fluoroscopy time 
(min) 
75th percentile 
Cerebral angiography (all) 90 11 
 1 cerebral vessel 30 4 
 2 cerebral vessels 75 7 
 More than 2 cerebral vessels 105 13 
Spinal angiography 185 26 
Embolisation in the head for aneurysm 190 58 
Embolisation in the head for AVM 285 68 
Lower limb arteriography without stenting 75 6 
Hepatic chemoembolisation 250 28 
Bronchial artery embolisation 135 38 
Uterine fibroid embolisation 175 29 
Uterine artery embolization (postpartum 
haemorrhage) 
255 22 
Renal artery embolization 325 25 
TIPS 185 39 
Vertebroplasty (all) 70 11 
 1 vertebra 60 9 
 2 vertebrae 60 10 
 More than 2 vertebrae 110 14 
 
11.36 A similar survey was conducted in France (Etard and others 2017), collecting 
data from 36 hospitals and covering some 4,600 procedures carried out in 2015. 
Over 90% of the studies were carried out on systems fitted with flat panel 
detectors. Air Kerma area product and fluoroscopy time were obtained for 10 to 
30 patients for each of 15 types of procedure with large variations in patient dose 
for the same procedure being noted. As per ICRP guidance (ICRP 2017) the 
reference levels were calculated as the 75th percentile of the distribution and are 
shown in Table 11.6. 
11.37 Data on PCI dosimetry in France were published by Georges and others (2017), 
based on data from over 42,000 patients in 61 hospitals. The suggested 
reference level was 78 Gy.cm2, with a 75th percentile fluoroscopy time of 15 
minutes. 





11.38 Heilmaier and others (2017) published locally-generated DRLs from a single 
hospital in Switzerland, based on adult patient studies carried out in 2014 to 
2016. Each procedure was split into ‘simple’, ‘standard’ and ‘difficult’ categories 
by the operators, leading to low sample numbers in each category. 
11.39 Difficulties in comparing data from different sites were emphasised, particularly 
differences in equipment and the exact definitions of procedures. 
11.40 An extract from the data produced is shown in Table 11.7, DRLs being set from 
the rounded 75th percentile. 
Table 11.7: Suggested DRLs from Heilmaier and others (2017) 







































































11.41 The UK has a significantly lower number of radiologists per million population 
than most European countries. 
11.42 A lower proportion of UK IR services are able to provide a comprehensive out-of-
hours service than those in other European countries. 
11.43 The UK has one of the lowest numbers of interventional cardiologists, IC facilities 
and PCI procedures proportional to population in Europe, although the latter may 
be a consequence of different reimbursement systems. 





11.44 In a North America-European survey, the largest ‘resource gap’ in the provision of 
interventional neuoradiology services was found to be in the UK. 
11.45 The data suggest that there is an unmet need for several procedures in the UK. 
11.46 The UK lags behind several European countries in developing DRLs for IR 
procedures, although an internationally agreed methodology has yet to be 
established. 
  





Chapter 12: Conclusions 
12.1 The development of IR has revolutionised the therapeutic interventions for many 
medical conditions and IR is now used in a wide range of clinical specialities. 
These interventions have now superseded conventional surgical techniques and/or 
provided treatments which were previously not possible. 
12.2 The ability to perform many procedures using IR (fluoroscopic imaging) allows 
treatments to be carried out in a minimally invasive manner and with a much-
reduced need for prolonged anaesthesia. This allows for many patients to be 
treated as day cases, significantly reducing the requirement for hospitalisation and 
the need for post-operative intensive care. Patient recovery is also much quicker. 
12.3 The efficiency of these techniques allows for many frail and elderly patients the 
opportunity to have life-saving interventions that were previously not possible. 
12.4 Radiologists and radiographers who perform IR techniques have specialised 
training in the use of radiation for a wide range of purposes. However, consultants 
trained in other disciplines also increasingly use IR techniques. These staff also 
require specific training in all of the factors associated with the safe use of 
procedures involving ionising radiation. 
12.5 Workforce evaluations by the RCR and BSIR suggest that the current numbers of 
staff trained in IR procedures are insufficient, compromising the availability of 
treatments to patients. In addition, the low numbers of trained staff increases their 
workload and potential radiation exposure.  
12.6 In comparison to majority of European countries the UK is poorly provided with 
sufficient specialist cover to provide a 24/7 IR service. 
12.7 Clinical outcomes in INR are well demonstrated to be linked favourably to higher 
volume practice and there is some evidence that doses are also. The appropriate 
control of patient and staff doses will be achieved best in high volume, well-
equipped centres with the appropriate equipment infrastructure and 
governance/audit procedures in place. With better staffed rotas, staff doses are 
more widely distributed as well as trending lower with reduced average exposures 
per procedure compared to those for smaller, less well staffed, lower volume units. 
12.8 Given that these large units are not geographically perfectly distributed then 
networking and patient transfer to such units is a pragmatic way to ensure 24/7 
INR provision for all while also maximising clinical outcomes and reducing overall 
costs and radiation exposures. 
12.9 Recommendations 1 and 10 of the NCEPOD report, ‘Managing the Flow? A review 
of the care received by patients who were diagnosed with an aneurysmal 
subarachnoid haemorrhage’ (NCEPOD 2013) highlight the need for the 
establishment of networks between secondary and regional units and the provision 
of 7-day INR services for ruptured cerebral aneurysm treatment. These have not 
been fully implemented across the UK. 
12.10 As with any procedure there is a risk of complications associated with each 





intervention but in the vast majority of IR interventions the risks are much reduced 
as compared with previous conventional surgical/therapeutic interventions. 
12.11 IR interventions use fluoroscopic imaging which involves exposure of patients to 
low doses of ionising radiation. The possible associated stochastic risk, mainly of 
cancer, is low and for most patients these risks are minimal compared to the 
benefits accruing from the IR procedure. 
12.12 Infants and children are more radiosensitive than young adults to the induction of 
cancer by radiation, although the increased risk is small in comparison to the 
benefits of IR procedures. Children form only a small proportion of the total 
population receiving IR; however, this effect of age at exposure should be borne in 
mind.  
12.13 Tissue reactions (deterministic effects) may become apparent following exposure 
to ionising radiation, normally above a threshold of 0.5 Gy; for most patients this is 
unlikely as they are seldom observed below absorbed doses of 2 Gy and the vast 
majority of IR procedures result in doses that are well below this level. In 
procedures in which local tissue doses may be higher than 1 Gy, it will be prudent 
to include a follow-up protocol and to provide additional advice to the patient. 
12.14 Tissues that may be particularly affected by tissue reactions in IR procedures are 
the skin, the lens of the eye and the cardiovascular system, although cataract and 
CVD may not conform to the classical definition of effects occurring above a dose 
threshold. 
12.15 As with all techniques involving exposure to ionising radiation every effort should 
be made to reduce patient doses the risk in accordance with the ALARP principle. 
12.16 As yet, there is no industry standard method for the automated calculation and 
recording of patient dose associated with each procedure. It should be common 
practice for the dose information from each procedure to be included in the 
electronic patient record. This would facilitate practitioners in the planning and 
justification of subsequent exposures. 
12.17 It is noted that there are international efforts to harmonise the output of skin dose 
maps.  
12.18 IR procedures are complex, requiring a number of specialist professionals, 
normally about 5 to 8, to be present during the procedure. All of these individuals 
will be exposed to a low dose of ionising radiation during each procedure; 
consequently, over a working lifetime they will have a cumulative dose that 
requires close monitoring. For this reason, all possible precautions should be in 
place to minimise exposure.  
12.19 The wearing of protective equipment provided by the employer is a legal 
requirement. The wearing of appropriate dosemeters is also a legal requirement. 
Passive dosemeters are most commonly utilised, but APDs offer significant 
advantages as set out in paragraph 6.36. APDs can be used to particular benefit 
by staff working on more than one site and/or for more than one employer to 
indicate the dose received on each.  
12.20 It is not appropriate to apply dose limits to the patient in medical exposures since 





there is, by definition, a direct benefit to the patient. Instead, the adoption of DRLs 
is intended to act as a guide to the very indistinct border between good and normal 
practice and poor and abnormal practice as part of the optimisation process. They 
are usually established from surveys of measured doses for patients in different 
hospitals, usually at national, but also at regional or local levels.  
12.21 National DRLs for a range of diagnostic examinations, which do not apply to 
individual patient examinations, have been set in the UK at the third quartile of 
mean X-ray room examination doses measured in large-scale hospital surveys. 
ICRP (2017) have proposed that future DRLs be set in terms of the third quartile of 
median examination doses.  
12.22 DRLs are essentially an audit tool, so an investigation or intervention might be 
triggered if the mean or median dose for an examination in a hospital exceeds the 
DRL. Conceptually, an investigation could also be triggered in the situation where 
doses are substantially below the DRL value.  
12.23 The continuous refinement of DRLs allows for improvements to be made in driving 
dose reduction, in line with the ALARP principle.  
12.24 As yet, few UK DRLs have been proposed for IR procedures and there is a 
particular lack in the paediatric field. ICRP (2017) has discussed this topic in depth 
and has suggested the implementation of interventional DRLs using either 
complexity analysis or alternatively large data sets. The UK should develop, in 
collaboration with international partners, a consistent methodology taking into 
account ICRP recommendations that can be used to define and generate 
interventional DRLs. 
12.25 The Subcommittee initially sought to establish what data were available to it, 
including basic information on the range and numbers of procedures being 
undertaken, the types of staff groups, the numbers of staff and the range of 
radiation doses to patients and staff involved in service delivery. Despite wide 
enquiries, it was found that few data were available. 
12.26 In light of this situation, the Subcommittee found it necessary to carry out a sample 
survey of hospitals across the UK, using the questionnaire shown in Appendix D. 
This was designed to collect only data germane to the remit. Regrettably, only a 
small proportion of sites approached made returns, although the figure was in line 
with other postal surveys. 
12.27 In order to inform decisions on service delivery, data such as those collected via 
the survey are key and mandatory returns from all UK sites (both NHS and private) 
should be required. 
12.28 There is a range of rare genetically-inherited autosomal recessive conditions 
(Table 3.4) which have been identified that are known to display a markedly 
increased sensitivity to radiation. In addition, there are some dominantly-inherited 
autosomal disorders, such as Gorlin syndrome, which show the same sensitivity. 
These rare conditions are particularly relevant when considering radiation 
exposures of children. 
12.29 If a patient presents with one of these syndromes, caution should be exercised in 
the use of radiation-related procedures. Prior to the use of any procedure, the 





advice of a clinical geneticist/expert in radiosensitivity disorders may be advisable. 
12.30 The majority of IR inventions in children are used to correct CHD. The cardiac 
interventions received by these children carry much less risk than previous open-
heart surgical techniques. However, since these individuals are likely to have a 
productive and unfettered life following the corrective intervention, the possible risk 
of the exposure to ionising radiation should be acknowledged and doses entered 
carefully in the patient record to facilitate follow-up. 
12.31 The continued development of techniques in paediatric IR should be supported, 
together with research into methods of further radiation dose reduction. 
12.32 Staff working in IR suites have specific training requirements that include a 
knowledge and understanding of the risks associated with IR.  
12.33 Modern IR systems are highly complex and dependent upon software control. 
Although extensive manuals may be available (often through the internet), it is 
important that all staff understand and are familiar with all facets of the operation of 
the equipment prior to use. This is facilitated by practical courses offered by 
manufacturers or suppliers. 
12.34 Where procedural protocols can be amended by local staff, care must be taken to 
ensure that the equipment performs as expected and the local MPE consulted 
before use on patients. 
12.35 When employing locally-amended protocols, it is important to ensure that these 
have been reloaded correctly following any maintenance or upgrade of the 
equipment, since the latter may involve a reset to the original manufacturer’s 
settings. 
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Chapter 13: Recommendations 
13.1 This report considers the available evidence on radiation dose issues associated 
with the use of interventional radiology (IR), both for staff and patients. It is 
acknowledged that the range of IR procedures is likely to continue to expand and 
the report provides recommendations which consider the potential future 
requirements for facilities, equipment and staff in this field. The following 
recommendations should be reviewed and developed as more evidence becomes 
available.  
Recommendation 1 
13.2 COMARE recommends that all healthcare staff undertaking image guided 
procedures in the UK should have completed a course of formal training including 
radiation protection for staff and patients. Existing courses should be updated 
regularly and, where necessary, new courses established through liaison between 
the Department of Health and Social Care (DHSC), the Health Departments of the 
devolved administrations and appropriate professional organisations. All existing 
and future IR training curricula should include the radiation dose structured report 
(RDSR). 
Recommendation 2 
13.3 DHSC and the Health Departments of the devolved administrations should consult 
with relevant professional organisations and Health Education England, NHS 
England and NHS Improvement (or the corresponding devolved organisations) to 
recommend minimum acceptable staffing arrangements for IR service provision 
including out of hours services. In the context of this report, this may reduce 
individual radiation doses, while it may also attract more staff to the field. 
Recommendation 3 
13.4 NHS England and the Health Departments of the devolved administrations should 
ensure that recommendations 1 and 10 of the NCEPOD “Managing the Flow? A 
review of the care received by patients who were diagnosed with an aneurysmal 
subarachnoid haemorrhage” report (NCEPOD 2013) relating to the establishment 
of networks and of 24/7 IR service provision are fully implemented across the UK. 
Recommendation 4 
13.5 Current IR equipment is capable of automatic patient dose reporting and 
production of real time skin dose maps. COMARE recommends that the UK 
supports international efforts to harmonise outputs, with manufacturers adopting 
standard measurement methods and ensuring that these can be downloaded to 
PACS/RIS for inclusion in the patient record.  
Recommendation 5 
13.6 The Committee recommends that the use of real-time electronic personal 
dosemeters (APDs) should be promoted for all staff. They offer particular benefit 





during training and in the development/introduction of novel IR procedures.  
Recommendation 6 
13.7 COMARE recommends the rapid establishment and reinforcement of national IR 
DRLs, especially for paediatric IR procedures. The UK should collaborate with 
ICRP and international partners to develop an agreed methodology. Resources 
should be made available to enable Public Health England and its equivalents in 
the devolved administrations to include IR procedures in UK dose surveys to 
provide standardised data to support regular updating of national DRLs. 
Recommendation 7 
13.8 The Committee recommends that DHSC and the Health Departments of the 
devolved administrations should include within regulations a requirement for health 
care providers (both NHS and private) to submit IR procedure numbers, 
summarised patient and staff dose data and staffing data modelled on Appendix E 
annually. 
Recommendation 8 
13.9 COMARE continues to recognise the importance of the radiosensitivity of high-risk 
groups as a factor in a range of clinical applications involving ionising radiation. 
The Committee reiterates the recommendation made in the 16th COMARE report 
(COMARE 2014; Recommendation 1, page 69) that the UK is actively involved in 
further research in this area. Professional bodies and medical and scientific 
societies should continue to provide educational opportunities to increase the 
understanding of clinical staff regarding all of the potential risks to patients, and not 
just the dose received, from radiological procedures. This is particularly relevant for 
children who receive repeat exposures to medical interventions that involve the use 
of ionising radiation. In addition, staff should be aware of the increased 
susceptibility to ionising radiation to individuals with rare, predominantly autosomal 
recessive genetic disorders. 
Recommendation 9 
13.10 The Committee recommends that appropriate grant-funding bodies support further 
research into paediatric IR procedures and associated radiation doses, particularly 
those associated with the treatment of congenital heart disease (CHD), since these 
patients may undergo multiple higher dose procedures. 
Recommendation 10 
13.11 The Committee reiterates recommendation 7 from its 16th Report, that optimisation 
of protocols offers significant potential for dose reduction. This can best be 
achieved at local level through active promotion and cooperation between 
professional groups. COMARE recommends that in conjunction with the production 
of new regulations for medical exposures, DHSC provides supporting guidance on 
optimisation, including a requirement for radiology services to consider formally 
appointing a team of radiation protection champions, consisting of a radiologist, a 





radiographer and a medical physicist. 
Recommendation 11 
13.12 Equipment manufacturers have a significant role to play in contributing to the 
overall safety regime for IR when introducing new technology and in training for 
staff, which is essential to maximise the benefits of new technology. COMARE 
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Appendix A: Abbreviations and Glossary 
Acronym Meaning 
ADRC automatic dose rate control 
AEC automatic exposure control 
AF adult female 
ALARA as low as reasonably achievable 
ALARP as low as reasonably practicable 
AM adult male 
APD active personal dosimeter 
ASD atrial septal defect 
a-Si amorphous silicon 
AVM arteriovenous malformation 
BCIS British Cardiovascular Intervention Society 
BHF British Heart Foundation 
BIR British Institute of Radiology 
BSC best supportive care 
BSIR British Society of Interventional Radiology 
CA coronary angiography 
CABG coronary artery bypass graft surgery 
CAK cumulative air kerma 
CHD congenital heart disease  
CMOS complementary metal-oxide-semiconductor 
COMARE Committee on Medical Aspects of Radiation in the Environment 
CRC colorectal cancer 
CRYO cryotherapy 
CSF cerebrospinal fluid 
CT computed tomography 
CTO chronic total occlusion 
DAP dose area product 
DEB drug eluting bead 
DHSC Department of Health and Social Care 
DICOM Digital Imaging and Communications in Medicine 
DIMOND Digital Imaging: Measures for Optimising Radiological Information Content 
and Dose 
DNA deoxyribonucleic acid 






DRL diagnostic reference level 
DSB double strand break 
E effective dose 
ECG electrocardiogram 
ECMO extracorporeal membranous oxygenation 
ECRP endoscopic retrograde cholangio-pancreatography 
EGFR epidermal growth factor receptor 
EP electrophysiology 
ESAK entrance surface air kerma 
EVAR endovascular aneurysm repair 
f/s frames per second 
FEVAR fenestrated endograft 
FGI fluoroscopically guided intervention 
GA general anaesthetic 
GI gastrointestinal 
GUCH grown up congenital heart disease 
Gy Gray 
HCA healthcare assistant 
HCC hepatocellular carcinoma 
HPA Health Protection Agency 
HSE Health and Safety Executive 
HVL half value layer 
IAK incident air kerma 
IC interventional cardiology 
ICD implantable cardioverter-defibrillator 
ICRP International Commission on Radiological Protection 
ICRU International Commission on Radiation Units and Measurements 
IFN interferon 
ILI isolated limb infusion 
ILP isolated limb perfusion 
INR interventional neuroradiology 
IR interventional radiology 
IR(ME)R Ionising Radiation (Medical Exposures) Regulations 
IRE irreversible electroporation 






IRR Ionising Radiation Regulations 
ISO International Standards Organisation 
IVC inferior vena cava 
JoPIIRR Justification of Practices Involving Ionising Radiation Regulations  
KAP kerma area product 
kV kilovolt 
LAO left anterior oblique 
mAs milliamp-seconds 
MCRC metastatic colorectal cancer 
MDT multi-disciplinary team 
MIRD medical internal radiation dose 
MRI magnetic resonance imaging  
MWA microwave ablation 
NCAP National Cardiac Audit Programme 
NCEPOD National Confidential Enquiry into Patient Outcome and Death 
NICE National Institute for Health and Care Excellence 
ODP operating department practitioner 
OOH out of hours 
OSL optically stimulated luminescence 
PA posterior-anterior 
PACS picture archiving and communication system 
PCI percutaneous coronary intervention 
PDA patent ductus arteriosus 
PHE Public Health England 
PIC paediatric interventional cardiology 
PICC peripherally inserted central catheter 
PPCI primary percutaneous coronary intervention 
PPE personal protective equipment 
PPI permanent pacemaker insertion 
PSD peak skin dose 
PTC percutaneous transhepatic changiography 
PTCA percutaneous transluminal coronary angiography 
RAO right anterior oblique 
RCR Royal College of Radiologists 






RDSR radiation dose structured report 
RFA radiofrequency ablation 
RIG radiologically inserted gastronomy 
RILD radiation-induced liver cancer 
RIS radiological information system 
RoI Republic of Ireland 
RPA radiation protection adviser 
RPS radiation protection supervisor 
SABR stereotactic ablative radiotherapy 
SACT systemic anti-cancer therapy 
SAH subarachnoid haemorrhage 
SIRT selective internal radiotherapy 
SNR signal to noise ratio 
SSNP Sentinel Stroke National Audit Project 
STEMI segment elevation myocardial infarction 
SV Sievert 
TACE trans arterial chemo-embolisation 
TEVAR thoracic endovascular aortic repair 
TIPS transjugular porto-systemic shunt creation 
TLD thermos luminescent dosimeter 
TNF tumour necrosis factor 
μGy micro-Gray 
μSv micro-Sievert 
UIA unruptured intracranial aneurysm 
VAD ventricular assist devices 
VIR vascular interventional radiology 
 
Term Definition 
ABLATION The surgical removal of body tissue 
ABSORBED DOSE The quantity of energy imparted by ionising radiation to a unit mass of 
matter such as tissue. Absorbed dose has the units of joules per 
kilogram (J kg–1) and the specific name gray (Gy), where 1 Gy = 1 J 
kg–1 
AIR KERMA The amount of Kerma in a specified mass of air; measured in Gray 
(Gy) 






ALARA As low as reasonably achievable: the principle of radioprotection 
stating that whenever ionising radiation has to be applied to humans, 
animals or materials exposure should be as low as reasonably 
achievable 
ALARP As low as reasonably practicable: the principle used in radiation 
protection in the UK that doses to people should be as low as possible 
once all the ‘reasonable’ methods of dose reduction have been 
employed 
ANEURYSM An excessive localised swelling of the wall of an artery 
ANGIOGRAM An X-ray of one or more blood vessels, used in diagnosing 
pathological conditions 
ATHEROSCLEROSIS A disease of the arteries characterised by the deposition of fatty 
material on their inner walls. 
BARIATRIC A patient having obesity, with a body mass index that is equal to or 
greater than 30. 
BENIGN Non-cancerous or non-malignant. A benign tumour may grow but it 
does not invade surrounding tissue or spread to other parts of the body 
BILIARY Relating to bile or the bile duct 
CARCINOGEN An agent that causes cancer 
CARCINOMA A cancer arising in the epithelial tissue of the skin or of the lining of the 
internal organs 
CARDIAC Pertaining to the heart 
CARDIOLOGIST A doctor who specialises in the study or treatment of heart diseases 
and heart abnormalities 
CATARACT An opacity, partial or complete, on the lens of the eye which may 
impair vision and, if dense enough, can cause blindness 
CATHETER A flexible tube inserted through a narrow opening into a body cavity, 
particularly the bladder, for removing fluid 
CHEMOTHERAPY The treatment of disease by the use of chemical substances, 
especially the treatment of cancer by cytotoxic and other drugs 




A special radiographic technique that uses a computer to assimilate 
multiple X-ray images into a 2-dimensional cross-sectional image 
CONCOMITANT Naturally accompanying or associated with 
CONGENTIAL Present from birth 
CONTRAST AGENT A substance that is introduced into or around a structure and, because 
of the difference in absorption of X-rays by the contrast medium and 
the surrounding tissues, allows radiographic visualisation of the 
structure 
DESQUAMATION Skin peeling 






DETERMINISTIC A deterministic health effect has a severity that is dependent on dose 
and is believed to have a threshold level below which no effect is seen 




Dose levels in medical radiation diagnostic practices for typical 
examinations for groups of standard-sized patients or standard 
phantoms for broadly defined types of equipment 
DIALYSIS The clinical purification of blood by dialysis, as a substitute for the 
normal function of the kidney 
DOSE A measure of the amount of radiation received. More strictly it is 
related to the energy absorbed per unit mass of tissue (see Absorbed 




A measure of radiation risk calculated by multiplying the absorbed 
dose by the area irradiated (in Gy per cm2) 
DOSIMETER A device used to measure an absorbed dose of ionizing radiation 
EFFECTIVE DOSE Effective dose is the sum of the weighted equivalent doses in all the 
tissues and organs of the body. It takes into account the biological 
effectiveness of different types of radiation and variation in the 
susceptibility of different organs and tissues to radiation damage. Thus 
it provides a common basis for comparing exposures from different 
sources. Unit = sievert (Sv) 
ELECTROCARDIOGR
AM (ECG) 
A record or display of a person's heartbeat produced by 
electrocardiography 
EMBOLISATION The artificial or natural formation or development of a blood clot, air 
bubble, piece of fatty deposit, or other object which has been carried in 
the bloodstream to lodge in a vessel and cause an embolism 
EPIDEMIOLOGY The study of factors affecting health and illness of populations, 
regarding the causes, distribution and control 
EPIGENETIC Relating to or arising from non-genetic influences on gene expression 
EPILATION The removal of hair by pulling it from the roots or hair loss due to 
chemical damage or exposure to ionising radiation 
EQUIVALENT DOSE The quantity obtained by multiplying the absorbed dose by a factor to 
allow for the different effectiveness of the various ionising radiations in 
causing harm to tissue. Unit = sievert (Sv) 
ERYTHEMA Superficial reddening of the skin, usually in patches, as a result of 
injury or irritation causing dilatation of the blood capillaries 
FLUOROSCOPY An imaging technique that uses X-rays to obtain real-time moving 
images of the interior of an object 
GRAY (Gy) The international (SI) unit of absorbed dose. One gray is equivalent to 
one joule of energy absorbed per kilogram of matter such as body 
tissue 
HAEMORRHAGE An escape of blood from a ruptured blood vessel 






IMMUNOLOGICAL Relating to the structure and function of the immune system 
INCIDENCE This is the number of new cases of a disease arising in a population 
over a specific period of time, usually one year 
INTERVENTIONAL 
RADIOLOGY 
A range of techniques which rely on the use radiological image 
guidance (X-ray fluoroscopy, ultrasound, computed tomography or 
magnetic resonance imaging) to precisely target therapy 
INVASIVE Involving entry into the living body (as by incision or by insertion of an 
instrument) 
IONISING RADIATION Radiation that is sufficiently energetic to remove electrons from atoms 
in its path. In human or animal exposures ionising radiation can result 
in the formation of highly reactive particles in the body which can 
cause damage to individual components of living cells and tissues 
IRRADIATION The process by which an item is exposed to radiation, either 
intentionally or accidentally 
ISO-CENTRE The intersection of the central scan plane with the axis of rotation of 
the X-ray tube and detector around the patient 
JUSTIFICATION Consideration that a medical exposure shall show a sufficient net 
benefit, weighing the total potential diagnostic or therapeutic benefits it 
produces, including the direct health benefits to an individual and the 
benefits to society, against the individual detriment that the exposure 
might cause, taking into account the efficacy, benefits and risks of 
available alternative techniques having the same objective but 
involving no or less exposure to ionising radiation 
LATENCY PERIOD The interval between exposure to a carcinogen, toxin, or disease-
causing organism and development of a consequent disease 
LESION A region in an organ or tissue which has suffered damage through 
injury or disease, such as a wound, ulcer, abscess, or tumour 




The use of nuclear magnetic resonance of protons to produce proton 
density images 
MALIGNANT Cancerous growth, a mass of cells showing uncontrolled growth, a 
tendency to invade and damage surrounding tissues and an ability to 
seed daughter growths to sites remote from the primary growth 
MEDIAN Denoting the middle term (or mean of the middle 2 terms) of a series 
arranged in order of magnitude 
METABOLIC Relating to or deriving from the metabolism of a living organism 
METASTASES The development of secondary malignant growths at a distance from a 
primary site of cancer 
MODALITY The method of application of a therapeutic agent or regimen 








Monte Carlo methods are a statistical approach for modelling X-ray 
interactions in and through tissue, and are used to determine an 
estimate of radiation dose 
MORBIDITY The condition of being diseased 
MORTALITY Death 
MUTATION A permanent transmissible change in the genetic material, which may 
alter a characteristic of an individual or manifest as disease 
NECROSIS The death of most or all of the cells in an organ or tissue due to 
disease, injury, or failure of the blood supply 
NEONATE An infant less than 4 weeks old 
NEURORADIOLOGIST A radiologist who specializes in the use of radioactive substances, X-
rays and scanning devices for the diagnosis and treatment of diseases 
of the nervous system 
NON-IONISING 
RADIATION 
Any type of electromagnetic radiation that does not carry enough 
energy per quantum (photon energy) to ionise atoms or molecules 
OCCLUSION The blockage or closing of a blood vessel or hollow organ 
OPERATOR Any person who is entitled to carry out the practical aspects of a 
medical exposure 
OPTIMISATION Consideration that a medical exposure be conducted as efficiently and 
effectively as possible using the lowest reasonably practicable 
radiation exposure, consistent with the intended purpose. The 
optimisation process consists of a chain of responsibilities extending 
from appropriate manufacture, selection and maintenance of 
equipment to the exposure parameters selected for the individual 
examination 
PAEDIATRIC Of, or relating to, the medical care of children 
PATIENT DOSE The ionising radiation dose to a patient or other individual undergoing 
a medical exposure 
PERCUTANEOUS Made, done, or effected through the skin 
PERFUSION The passage of fluid (such as blood) through a specific organ or area 
of the body (such as the heart) 
PHANTOM Object generally comprised of tissue substitute materials used to 




PACS (picture archiving and communication system) is a standard 
healthcare technology for short- and long-term storage, retrieval, 




A diagnostic examination involving the acquisition of physiological 
images based on the detection of radiation through the emission of 
positrons. The positrons are emitted from a short-lived radionuclide 
incorporated into a metabolically active substance administered to the 
patient prior to the examination 






PRACTITIONER A registered health care professional, who is entitled to take clinical 
responsibility for an individual medical exposure in accordance with 
national requirements 
PROGNOSIS A prediction of the probable course and outcome of a disease and the 
prospects of recovery as indicated by the nature of the disease and the 
symptoms of the case 
QUARTILE Each of 4 equal groups into which a population can be divided 




An RPA is an expert in radiation protection, certified as competent by 
an HSE approved body, to advise the employer in radiation safety for 





An RPS is a line manager, or person of similar status, working in and 
having knowledge of the equipment and practices in a radiation 
controlled area – appointed under IRR99 to ensure local rules are 
adhered to in that area 
RADIOGRAPHER A trained healthcare professional typically certified or licensed to 
produce medical imaging (such as X-rays or CT scans) for diagnosis 
or screening 
RADIOLOGIST A medically qualified doctor who specialises in the use of imaging 
techniques (X-rays, ultrasound, CT, MR, fine needle biopsy and so on) 
for diagnosis (diagnostic radiologist) or one who specialises in the use 
of imaging techniques in assisting treatment – for example, in inserting 
catheters into blood vessels or in choking the blood supply of a tumour 




A radiology information system is networked software used for 
managing radiological records and associated data in multiple 
locations. It is often seen used in conjunction with a picture archiving 
and communication system (PACS) to manage workflow 
RADIONUCLIDE  A type of atomic nucleus which is unstable, and which may undergo 
spontaneous decay to another atom by emission of ionising radiation 
(usually alpha, beta or gamma) 
RADIOSENSITIVITY The relative susceptibility of cells, tissues, organs, organisms, or any 
other substances to the effects of radiation 
RADIOTHERAPY The treatment of disease with ionising radiation. The purpose of 
radiotherapy is to deliver an optimal dose of either particulate or 
electromagnetic radiation to a particular area of the body with minimal 
damage to normal tissues. The source of radiation may be outside the 
body of the patient (external radiotherapy) or it may be a radionuclide 
that has been implanted or instilled into abnormal tissue or a body 
cavity 
RESECTION The process of cutting out tissue or part of an organ 






RISK The probability that an event will occur, that is, that an individual will 
become ill or die before a stated period of time or age. This is also a 
non-technical term encompassing a variety of measures of the 
probability of a (generally) unfavourable outcome 
SENSITIVITY A measure for assessing the results of diagnostic and screening tests. 
Sensitivity is the proportion of people who test positive for a disease 
that have that disease. A highly sensitive test will essentially rule out 
those who do not have disease 
SEPSIS A serious condition resulting from the presence of harmful 
microorganisms in the blood or other tissues and the body’s response 
to their presence, potentially leading to the malfunctioning of various 
organs, shock, and death 
SIEVERT (Sv) The international (SI) unit of effective dose obtained by weighting the 
equivalent dose in each tissue in the body with the ICRP-
recommended tissue weighting factors and summing over all tissues. 
Because the sievert is a large unit, effective dose is commonly 
expressed in millisieverts (mSv) – one millisievert is one-thousandth of 
one sievert. The average annual radiation dose received by members 
of the public in the UK is 2.7 mSv 
SOMATIC Relating to all tissue cells the body, as distinct from germ cells 
STENOSIS The abnormal narrowing of a passage in the body 
STENT A splint placed temporarily inside a duct, canal, or blood vessel to aid 
healing or relieve an obstruction 
STOCHASTIC Stochastic effect or ‘chance effect’ is a classification of radiation effects 
that refers to the random, statistical nature of the damage. The severity 
is independent of dose. Only the probability of an effect increases with 
dose 
TORSO The main part of the human body, without the limbs and head; the 
trunk 
TOXINS Poisons of plant or animal origin, especially one produced by or 
derived from microorganisms and acting as an antigen in the body 
TUMOUR Mass of tissue formed by unregulated growth of cells; can be benign or 
malignant 
ULTRASOUND The use of ultrasonic waves for diagnostic or therapeutic purposes, 
specifically to visualise an internal body structure, monitor a 
developing foetus, or generate localised deep heat to the tissues 
URINARY Relating to or denoting the system of organs, structures, and ducts by 
which urine is produced and discharged, in mammals comprising the 
kidneys, ureters, bladder, and urethra 
VASCULAR Of, relating to, or containing blood vessels 
VISCERAL Relating to the internal organs in the main cavities of the body 






X-RAY An image obtained using high energy radiation with waves shorter than 
those of visible light. X-rays possess the properties of penetrating most 
substances (to varying extents), of acting on a photographic film or 
plate (permitting radiography), and of causing a fluorescent screen to 
give off light (permitting fluoroscopy). In low doses X-rays are used for 
making images that help to diagnose disease, and in high doses to 
treat cancer 
  





Appendix B: Organisation of an IR suite 
B.1 IR involves a wide range of complex treatment protocols which inevitably requires 
a dedicated IR facility designed to treat specific indications (for example, cardiac, 
neuro, among others). An IR suite normally comprises several distinct areas 
including a patient preparation/recovery area, plant room(s), radiation protection 
equipment storage room, scrub facility, clean utility, dirty utility/disposal area and 
one or more IR rooms, each with a control room. 
B.2 The IR facility should be designed to accommodate patients with disabilities as well 
as space for the transfer of patients from a stretcher to the equipment in the IR 
room. Access doors and patient support tables should be designed to cope with 
bariatric patients.  
B.3 Attention should be paid to the décor to provide a calming atmosphere, particularly 
in paediatric units. 
B.4 The IR room(s) require a sterile environment. IR suites should be constructed to 
full operating theatre standards. This has implications for surface finishes, airflow 
and filtration, temperature and humidity control. Electrical backup must be 
available. IR equipment can generate a high heat load, which affects the capacity 
of the air handling system. Advice contained in Health Building Note 6 (NHS-
Estates 2001) should be followed.  
B.5 It is crucial to allow sufficient space for an IR suite to operate in a safe and efficient 
manner. Not only must there be adequate space for the equipment, staff and 
consumables, but access and space for emergency responders.  
B.6 Adequate patient preparation and recovery areas must be provided which have the 
capacity to cope with any surge in case volumes, unexpected delays or adverse 
events. This will have oxygen, suction, PACS access, monitoring equipment and 
basic resuscitation equipment. 
B.7 Most procedures will be undertaken with sedation, except in INR where most are 
performed under general anaesthesia (GA). Sedation will be done either on the 
ward or within the IR suite preparation/recovery room. Sedated patients will require 
monitoring of blood pressure, oxygen saturation and electrocardiogram (ECG) 
during interventional procedures, possibly using trolley-mounted monitoring 
equipment. Only a small number of procedures, such as those involving children or 
more complex procedures, will require GA.  
B.8 Adequate radiation shielding must be incorporated into the walls and, where 
appropriate, floor and ceiling of the IR room, as agreed with the local RPA. This will 
be dependent primarily upon the equipment installed and expected workload. Floor 
and ceiling loading calculations should account for shielding as well as equipment. 
B.9 Floor-mounted IR equipment is usually secured by anchored bolts in the floor; less 
common is a through-bolt design with a plate on the underside of the floor slab. 
Ceiling-mounted IR equipment is usually supported from a universal grid of Unistrut 
steel attached directly to the ceiling slab. Such a grid usually extends over most of 





the ceiling area so that it does not need to be amended when equipment is 
changed. The ceiling grid also facilitates the mounting of moveable shielding 
screens and ancillary equipment and so is much more flexible than floor mounting; 
it is to be preferred for a single-plane installation.  
B.10 The C-arms are sensitive to mechanical vibration and so any nearby sources 
should be isolated or eliminated. 
B.11 Medical oxygen, medical compressed air and medical vacuum, together with 
nitrous oxide and active anaesthetic gas scavenging, should be provided from wall-
mounted outlets or a ceiling-mounted pendant. 
B.12 The IR room should contain PACS viewing systems for review of relevant images 
before, during, or after procedures. Bulk storage of consumables will be sited 
within the support area, but storage should be provided within the IR room for basic 
and common procedural equipment (for example, needles, wires, catheters) as 
well as critical equipment (for example, coils). 
B.13 Each IR room should be equipped with a power injector and there should be a 
backup available in the near vicinity. Power injectors have clear advantages in 
terms of image quality and radiation dose to both staff and patients (Layton and 
others 2006). They also reduce contrast usage. 
B.14 Each IR room should have a real-time colour duplex ultrasound system. The dirty 
utility area should contain facilities to clean the ultrasound probes.  
B.15 The general lighting should be coordinated with the patient table and tube stand to 
ensure that fluoroscopic imaging perception is not adversely affected. Locally 
controlled variable lighting levels should be provided to avoid reflection on 
monitoring screens. 
B.16 For paediatric units, the ambience of the special procedures suite, pre-procedure 
rooms, and anaesthetic bay should be made as child-friendly as possible. This 
includes using comforting lighting, allowing parents to accompany the child into the 
anaesthetic bay, and providing reassuring media, such as posters, toys, music, or 
other distractions. 
B.17 The control room should be immediately accessible from the IR room, but also 
have direct access from outside the suite. There should be clear views of the entire 
IR room. Typically, 2 workstations per IR room are necessary, each connected to 
the PACS and Radiology Information System (RIS). One of the patient monitors 
must be powered independently of the X-ray equipment to allow continuous 
monitoring of the patient should a malfunction of the X-ray system occur. 
B.18 An appropriate area must be provided for storage of radiation safety equipment 
such as lead aprons, thyroid shields and glasses that are properly apportioned to 
the number of staff and operators. Sufficient space is needed to ensure that 
wrinkling or folding of lead aprons does not occur. 
B.19 A high quality fixed angiographic X-ray system is required. Most manufacturers 
offer a range of equipment tailored to particular applications. Single plane systems 





are still the most common, with bi-plane essential in neurological applications. The 
smallest focal-spot size provided on typical dual focal-spot x-ray tubes is larger 
than necessary for small paediatric patients. A triple focal-spot X-ray tube with 
nominal sizes of 0.3, 0.6, and 1 mm provides more flexibility for paediatric 
applications. 
B.20 Originally, the X-ray output was continuous, but modern systems employ a 
variable-rate pulsed mode. Combined with a last-image-hold facility, where the last 
image of a series is left on the display for the operator to study, this leads to lower 
doses for both staff and patients. Higher frame rates are often needed to 
accommodate the more rapid heart rates of small children. 
B.21 Image intensifier systems have been superseded by the amorphous silicon (a-Si) 
flat panel detector. Compared to image intensifiers, the flat detector’s more direct 
signal conversion path with no optical lens results in uniform image brightness and 
no geometric distortion. The solid-state detector provides greater reliability and no 
image degradation over time. By its design, the flat-panel detector produces a 
digital signal, offering the possibility of further image processing.  
B.22 More recently, the uneven atomic structure of the a-Si detector has been replaced 
by complementary metal-oxide-semiconductor (CMOS) technology using 
crystalline silicon, which has fewer power requirements, resulting in a general 
lower noise level compared to a-Si technology.  
B.23 Due to the smaller pixel sizes of the CMOS detector (100 µm x 100 µm) with less 
dark current, a higher spatial resolution as well as a greater sensitivity can be 
achieved, which leads to images that are less grainy and dim. Using pixel binning, 
the output signal-to-noise ratio (SNR) and thereby also the dynamic range can be 
improved considerably. This allows a significant reduction in patient dose while 
maintaining a clinically-acceptable image quality. The ultra-fast readout technology 
of the new crystalline silicon detector allows for higher frame rates in 3D imaging, 
up to 99 f/s, with a low radiation dose of 6 nGy per pulse. (Siemens) 
B.24 Flat panels are available in a range of sizes. Large view systems have been 
developed specifically for oncology applications. 
B.25 Detailed specifications of performance relating to the intended clinical use of the 
equipment should be made when purchase is being considered. This should 
include the training of staff required and maintenance requirements. The 
specification requires input from IR operators, radiographers, radiology managers, 
medical physics experts (MPEs) and procurement experts.  
B.26 Acceptance tests of new IR equipment must be carried out to ensure that the IR 
equipment supplied has provided what has been ordered, that it functions 
according to the manufacturer’s and purchaser’s specification and is safe to use. 
The MPE and radiation protection adviser will be involved in these tests. 
B.27 All equipment must be subject to a scheduled maintenance programme. Where 
computer-controlled equipment which permits user-defined protocols is in use, it is 
important to ensure that the latter are reloaded properly following maintenance 
procedures, which may have reset systems to manufacturers’ default settings.  





Appendix C: Total number of cases 
submitted to the National Congenital Heart 
Disease Audit (NCHDA) in financial years 
2003 to 2017 
Year Surgical Hybrid Catheter Diagnostic 
catheter 
Total 
 Interventional EP/Pacing ICD 
2003 to 2004 4,497 0 2,928 - - - 7,425 
2004 to 2005 4,346 0 3,032 - - - 7,378 
2005 to 2006 4,638 3 3,490 - - - 8,131 
2006 to 2007 4,794 7 3,769 - - - 8,570 
2007 to 2008 4,771 10 3,616 - - - 8,397 
2008 to 2009 4,949 14 3,910 - - - 8,873 
2009 to 2010 5,262 6 3,963 - - - 9,231 
2010 to 2011 5,852 6 4,310 - - - 10,168 
2011 to 2012 5,710 29 4,498 - - - 10,237 
2012 to 2013 5,849 16 4,372 - - - 10,237 
2013 to 2014 6,024 50 3,720 944 109 - 10,847 
2014 to 2015 5,662 62 3,511 1,037 117 - 10,389 
2015 to 2016 5,630 53 3,731 1,347 126 1,631 12,518 
2016 to 2017 5,642 48 3,837 1,459 154 1,878 13,018 
Reference - NCAP (2018a) 
Note: Primary Extracorporeal Membranous Oxygenation (ECMO), Ventricular Assist Devices (VAD) and 
lung transplants are counted as surgical activity; interventional, Electrophysiology(EP)/Pacing and 
Implantable cardioverter-defibrillator (ICD) devices are counted as catheter procedures, collated 
separately until 2013/14 financial year. Hybrid procedures are those with a combination of surgical 
and transluminal catheter interventions undertaken at the same time in the operating theatre. 
Diagnostic catheter data were included in the data set from 2015 to 2016 onwards.  





Appendix D: Reproduction of a procedure 
information leaflet from Guys and St 
Thomas’ NHS Foundation Trust 
 























Appendix E: Survey of interventional 
radiology (IR) practice in the UK 2015 to 
2017 - Questionnaire 
Survey of interventional radiology (IR) practice in the UK 2015 to 
2017 
 
This survey is being carried out in order to produce a report requested by UK Health 
Departments and your assistance would be greatly appreciated. The questionnaire has been 
split into 3 sections to reduce the workload on any one individual and we should be grateful if 
you could pass these to the appropriate person. 
If dosimetry information is maintained centrally (i.e. by the radiation protection section) please 
forward a copy of the document to them also for completion. 
The data are requested for calendar years. 
Contact details will be retained only until compilation of the data is complete and the names of 
contacts and hospitals involved will not be published in the report. 










Age range for paediatric procedures:  





Section 1 - Radiology 
Staffing and Rooms 
1. Number of consultant radiologists participating in IR service:  
2. Estimated total number of consultant IR sessions per week:  
3. Maximum number of IR sessions by an individual consultant per week:  
4. Number of junior radiologists participating in IR service:  
5. Estimated total number of junior staff IR sessions per week:   
6. Maximum number of IR sessions by an individual junior per week:  
 
7. Number of other consultants (that is, vascular surgeons) participating in IR service:  
8. Estimated total number of consultant IR sessions per week:  
9. Maximum number of IR sessions by an individual consultant per week:  
10. Number of other junior staff participating in IR service:  
11. Estimated total number of junior staff IR sessions per week:  
12. Maximum number of IR sessions by an individual junior per week:  
 
13. Number of radiographers (all grades) participating in IR service:  
14. Estimated total number of IR sessions per week:  
15. Maximum number of IR sessions by an individual radiographer per week:  
 
16. Number of nurses (all grades) participating in IR service:  
17. Estimated total number of IR sessions per week:  
18. Maximum number of IR sessions by an individual nurse per week:  
 
19. Number of other staff (that is, physiological measurement technicians or clinical 
physiologists) participating in IR service: 
 
20. Estimated total number of IR sessions per week:  
 
21. Number of rooms equipped for IR: 
22. Number of dedicated IR rooms within radiology:  Single Plane Biplane 
23. No of hybrid rooms:  
24. Please supply the year of installation of each room in the row below 
 
Radiation Monitoring: 
25. Do you provide under apron badges to staff in your IR rooms?  
26. Do you provide collar badges to staff in the IR rooms?  
27. Do you use a real time dose monitoring system such as Philips Dosewise or 
Raysafe I2/I3 in your IR rooms? 
 
Hospital:       Person returning survey: 
Contact details (email, telephone):  





Estimated total numbers of procedures carried out on adult patients each calendar year  
 
 2015 2016 2017 
Vascular    
Peripheral angioplasty/stent    
Aortoiliac angioplasty/stent    
Endovascular stent graft‐ abdominal aorta    
Endovascular stent graft‐ thoracic aorta    
Gastrointestinal embolisation    
Transjugular portosytemic shunt    
Central venous catheter or port insertion    
Selective Internal Radiotherapy (SIRT)    
Transcatheter chemoembolisation    
Pulmonary Arterial Venous Malformation    
Nephrolithotomy (in dept. or theatre)    
Uterine Fibroid Embolisation    
Prostatic embolisation    
Stroke intervention – coil embolisation    
Stroke intervention – mechanical thrombectomy    
Other    
Renal dialysis intervention    
Fistula angioplasty/stent    
Fistula thrombectomy    
Dialysis line insertion    
Other    
Non vascular    
Nephrostomy Insertion    
Ureteric stent insertion    
Percutaneous Nephrolithotomy (inc. in theatre)     
Percutaneous Gastrostomy    
Gastrointestinal stent insertion    
Biliary drainage/stenting    
Vertebroplasty    











Estimated total numbers of procedures carried out on paediatric patients each calendar year  
 2015 2016 2017 
Vascular    
Central venous catheter or port insertion    
Other    
 
Renal dialysis intervention    
Fistula thrombectomy    
Dialysis line insertion    
Other    
 
Non vascular    
Nephrostomy Insertion    
Other    
 
Cumulative Air Kerma Survey 
 
 2016 2017 
 Adult Paed Adult Paed 
Vascular     
No of patients with CAK >2000 & < 3000 mGy     
No of patients with CAK >3000 & < 5000 mGy     
No of patients with CAK > 5000 & < 8000 mGy     
No of patients with CAK > 8000 mGy     
 
Renal dialysis intervention     
No of patients with CAK >2000 & < 3000 mGy     
No of patients with CAK >3000 & < 5000 mGy     
No of patients with CAK > 5000 & < 8000 mGy     
No of patients with CAK > 8000 mGy     
 
Non vascular     
No of patients with CAK >2000 & < 3000 mGy     
No of patients with CAK >3000 & < 5000 mGy     
No of patients with CAK > 5000 & < 8000 mGy     
No of patients with CAK > 8000 mGy     
 






Eye Dose Survey* (please supply what data you can) 
 2015 2016 2017 2018 to date 
Vascular     
No. of staff monitored for eye dose     
No. with eye dose >5 ≤10 mSv     
No. with eye dose > 10 ≤15 mSv     
No. with eye dose >10≤ 20 mSv     
No. with eye dose >20 ≤ 50 mSv     
No. with eye dose >50 mSv      
 
Renal dialysis intervention if monitored 
separately 
    
No. of staff monitored for eye dose     
No. with eye dose >5 ≤10 mSv     
No. with eye dose > 10 ≤15 mSv     
No. with eye dose >10≤ 20 mSv     
No. with eye dose >20 ≤ 50 mSv     
No. with eye dose >50 mSv     
 
Non-vascular     
No. of staff monitored for eye dose     
No. with eye dose >5 ≤10 mSv     
No. with eye dose > 10 ≤15 mSv     
No. with eye dose >10≤ 20 mSv     
No. with eye dose >20 ≤ 50 mSv     
No. with eye dose >50 mSv     
*Please record the quantity that you record in terms of compliance with the Ionising Radiations 
Regulations 1999 or 2017 as applicable. If your monitoring regime or work practice makes it difficult to 
distinguish between modalities, please enter ’AF’ for the modality already accounted for.   





Section 2 – Cardiac 
 
Staffing and Rooms 
1. Number of consultant cardiologists and radiologists participating in IR service:  
2. Estimated total number of consultant IR sessions per week:  
3. Maximum number of IR sessions by an individual consultant per week:  
4. Number of junior cardiologists and radiologists participating in IR service:  
5. Estimated total number of junior staff IR sessions per week:   
6. Maximum number of IR sessions by an individual junior per week:  
   
7. Number of radiographers (all grades) participating in IR service:  
8. Estimated total number of IR sessions per week:  
9. Maximum number of IR sessions by an individual radiographer per week:  
 
10. Number of nurses (all grades) participating in IR service:  
11. Estimated total number of IR sessions per week:  
12. Maximum number of IR sessions by an individual nurse per week:  
 
13. Number of other staff (that is, physiological measurement technicians or 
clinical physiologists) participating in IR service: 
 
14. Estimated total number of IR sessions per week:  
 
15. Number of rooms equipped for IR: 
16. Number of dedicated IR rooms within cardiology:  Single Plane Biplane 
17. No of hybrid rooms:  
18. Please supply the year of installation of each room in the row below 
 
Radiation Monitoring: 
19. Do you provide under apron badges to staff in your IR rooms?  
20. Do you provide collar badges to staff in the IR rooms?  
21. Do you use a real time dose monitoring system such as Philips Dosewise or 




Person returning survey: 













Estimated total numbers of procedures carried out on adult patients each calendar year  
 
 2015 2016 2017 
Interventional Cardiology    
Coronary angioplasty/stent    
Pacemaker insertion    
Electrophysiological mapping/ablation    
Percutaneous valve insertion    
Other    
Estimated total numbers of procedures carried out on paediatric patients each calendar year  
 
 2015 2016 2017 
Interventional Cardiology    
Pacemaker insertion    
Electrophysiological mapping/ablation    
Percutaneous valve insertion    
Other    
Cumulative Air Kerma Survey 
 
 2016 2017 
 Adult Paed Adult Paed 
Interventional Cardiology     
No of patients with CAK >2000 & < 3000 mGy     
No of patients with CAK >3000 & < 5000 mGy     
No of patients with CAK > 5000 & < 8000 mGy     
No of patients with CAK > 8000 mGy     
Eye Dose Survey* (please supply what data you can) 
 2015 2016 2017 2018 to date 
No. of staff monitored for eye dose     
No. with eye dose >5 ≤10 mSv     
No. with eye dose >10≤ 20 mSv     
No. with eye dose >20 ≤ 50 mSv     
No. with eye dose >50 mSv     
*Please record the quantity that you record in terms of compliance with the Ionising Radiations 
Regulations 1999 or 2017 as applicable.  
 
 






Section 3 – Neuroradiology 
 
Staffing and Rooms 
1. Number of consultant radiologists participating in IR service:  
2. Estimated total number of consultant IR sessions per week:  
3. Maximum number of IR sessions by an individual consultant per week:  
4. Number of junior radiologists participating in IR service:  
5. Estimated total number of junior staff IR sessions per week:   
6. Maximum number of IR sessions by an individual junior per week:  
 
7. Number of radiographers (all grades) participating in IR service:  
8. Estimated total number of IR sessions per week:  
9. Maximum number of IR sessions by an individual radiographer per week:  
 
10. Number of nurses (all grades) participating in IR service:  
11. Estimated total number of IR sessions per week:  
12. Maximum number of IR sessions by an individual nurse per week:  
 
13. Number of other staff (that is, physiological measurement technicians or 
clinical physiologists) participating in IR service: 
 
14. Estimated total number of IR sessions per week:  
 
15. Number of rooms equipped for IR: 
16. Number of dedicated IR rooms within neuroradiology:  Single Plane Biplane 
17. No of hybrid rooms:  




19. Do you provide under apron badges to staff in your IR rooms?  
20. Do you provide collar badges to staff in the IR rooms?  
21. Do you use a real time dose monitoring system such as Philips Dosewise or 




Person returning survey: 
Contact details (email, telephone):  





Estimated total numbers of procedures carried out on adult patients each calendar year  
 2015 2016 2017 
Interventional Neuroradiology    
Coil embolisation aneurysm    
Embolisation of AVM    
Spinal AVM embolisation    
Stroke intervention – coil embolisation    
Stroke intervention – mechanical thrombectomy    
Other    
Estimated total numbers of procedures carried out on paediatric patients each calendar year  
 2015 2016 2017 
Interventional Neuroradiology    
Embolisation of AVM    
Spinal AVM embolisation    
Other    
Cumulative Air Kerma Survey 
 2016 2017 
 Adult Paed Adult Paed 
Interventional Neuroradiology     
No of patients with CAK >2000 & < 3000 mGy     
No of patients with CAK >3000 & < 5000 mGy     
No of patients with CAK > 5000 & < 8000 mGy     
No of patients with CAK > 8000 mGy     
Eye Dose Survey* (please supply what data you can) 
 2015 2016 2017 2018 to date 
No. of staff monitored for eye dose     
No. with eye dose >5 ≤10 mSv     
No. with eye dose >10≤ 20 mSv     
No. with eye dose >20 ≤ 50 mSv     
No. with eye dose > 50 mSv     
*Please record the quantity that you record in terms of compliance with the Ionising Radiations 
Regulations 1999 or 2017 as applicable. If your monitoring regime or work practice makes it difficult to 
distinguish between modalities, please enter ’AF’ for the modality already accounted for.  






Appendix F: The Committee on Medical 
Aspects of Radiation in the Environment 
F.1 The Committee on Medical Aspects of Radiation in the Environment (COMARE) 
was established in November 1985 in response to the final recommendation of the 
report of the Independent Advisory Group chaired by Sir Douglas Black (Black 
1984). COMARE’s terms of reference are: 
“to assess and advise Government and the Devolved Authorities on 
the health effects of natural and man-made radiation and to assess the 
adequacy of the available data and the need for further research” 
F.2 In the course of providing advice to Government and the devolved authorities for 
over thirty years, COMARE has published to date 18 major reports and many other 
statements and documents mainly related to exposure to naturally occurring 
radionuclides, such as radon and its daughters, or to man-made radiation. The 
most recent published COMARE report provided a review of the health effects, 
benefits and risks arising from the use of ionising radiation in dual-energy X-ray 
absorptiometry (DXA) scans in sports performance assessments. 
F.3 The Department of Health and Social Care asked COMARE to review the evidence 
on the issues with radiation doses associated with interventional radiology for both 
staff and patients. Issues to be considered in the report included differences in 
equipment and training which can lead to higher doses, the legislation concerning 
classified workers and the protocols involved in producing clinically acceptable 
images for treatment. COMARE reconstituted its Medical Practices Subcommittee, 
with a new membership consisting of committee members and external experts, to 
conduct this work. The Subcommittee’s terms of reference are: 
“to advise COMARE on the health effects arising from medical and 
similar practices involving the use of ionising and non-ionising radiation 
through assessment of the available data and to inform COMARE of 
further research priorities.” 
F.4 When the Subcommittee had finished its review, the report was presented to 
COMARE for consideration by the full committee, with the aim that the information 
would be presented to the Department of Health and Social Care in due course. 
That information is contained in this, our nineteenth report. 
 
  





COMARE Reports  
Eighteenth report Medical radiation dose issues associated with dual-energy X-ray 
absorptiometry (DXA) scans for sports performance assessments and 
other non-medical practices, Chilton, July 2019. 
Seventeenth report Further consideration of the incidence of cancers around the nuclear 
installations at Sellafield and Dounreay. PHE, Chilton, September 
2016. 
Sixteenth report Patient radiation dose issues resulting from the use of CT in the UK. 
PHE, Chilton, August 2014. 
Fifteenth report Radium contamination in the area around Dalgety Bay. PHE, Chilton, 
May 2014. 
Fourteenth report Further consideration of the incidence of childhood leukaemia around 
nuclear power plants in Great Britain. HPA, Chilton, May 2011. 
Thirteenth report The health effects and risks arising from exposure to ultraviolet 
radiation from artificial tanning devices. HPA, Chilton, June 2009. 
Twelfth report The impact of personally initiated X-ray computed tomography 
scanning for the health assessment of asymptomatic individuals. 
HPA, Chilton, December 2007. 
Eleventh report The distribution of childhood leukaemia and other childhood cancer in 
Great Britain 1969 to 1993. HPA, Chilton, July 2006. 
Tenth report The incidence of childhood cancer around nuclear installations in 
Great Britain. HPA, Chilton, June 2005. 
Ninth report Advice to Government on the review of radiation risks from 
radioactive internal emitters carried out and published by the 
Committee Examining Radiation Risks of Internal Emitters (CERRIE). 
NRPB, Chilton, October 2004. 
Eighth report A review of pregnancy outcomes following preconceptional exposure 
to radiation. NRPB, Chilton, February 2004. 
Seventh report Parents occupationally exposed to radiation prior to the conception of 
their children. A review of the evidence concerning the incidence of 
cancer in their children. NRPB, Chilton, August 2002. 
COMARE and 
RWMAC* joint report  
Radioactive contamination at a property in Seascale, Cumbria. 
NRPB, Chilton, June 1999. 
Sixth report A reconsideration of the possible health implications of the radioactive 
particles found in the general environment around the Dounreay 
nuclear establishment in the light of the work undertaken since 1995 
to locate their source. NRPB, Chilton, March 1999. 
Fifth report The incidence of cancer and leukaemia in the area around the former 
Greenham Common Airbase. An investigation of a possible 
association with measured environmental radiation levels. NRPB, 
Chilton, March 1998. 
 
* Radioactive Waste Management Advisory Committee. 





Fourth report The incidence of cancer and leukaemia in young people in the vicinity 
of the Sellafield site, West Cumbria: further studies and an update of 
the situation since the publication of the report of the Black Advisory 
Group in 1984. Department of Health, London, March 1996. 
COMARE and 
RWMAC* joint report  
Potential health effects and possible sources of radioactive particles 
found in the vicinity of the Dounreay nuclear establishment. HMSO, 
London, May 1995. 
Third report Report on the incidence of childhood cancer in the West Berkshire 
and North Hampshire area, in which are situated the Atomic 
Weapons Research Establishment, Aldermaston and the Royal 
Ordnance Factory, Burghfield. HMSO, London, June 1989. 
Second report Investigation of the possible increased incidence of leukaemia in 
young people near the Dounreay nuclear establishment, Caithness, 
Scotland. HMSO, London, June 1988. 
First report The implications of the new data on the releases from Sellafield in the 
1950s for the conclusions of the Report on the Investigation of the 
Possible Increased Incidence of Cancer in West Cumbria. HMSO, 




* Radioactive Waste Management Advisory Committee. 
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